AU600912B2 - 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines - Google Patents
2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines Download PDFInfo
- Publication number
- AU600912B2 AU600912B2 AU63156/86A AU6315686A AU600912B2 AU 600912 B2 AU600912 B2 AU 600912B2 AU 63156/86 A AU63156/86 A AU 63156/86A AU 6315686 A AU6315686 A AU 6315686A AU 600912 B2 AU600912 B2 AU 600912B2
- Authority
- AU
- Australia
- Prior art keywords
- amino
- oxo
- carbonyl
- compound
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines Chemical class 0.000 title claims description 201
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 379
- 150000001875 compounds Chemical class 0.000 claims description 340
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 248
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 133
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims description 53
- 239000002253 acid Substances 0.000 claims description 52
- 239000001257 hydrogen Substances 0.000 claims description 48
- 229910052739 hydrogen Inorganic materials 0.000 claims description 48
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 41
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 36
- 125000000217 alkyl group Chemical group 0.000 claims description 35
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 20
- 125000002252 acyl group Chemical group 0.000 claims description 18
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 17
- 125000000623 heterocyclic group Chemical group 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 10
- 125000001589 carboacyl group Chemical group 0.000 claims description 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 230000003213 activating effect Effects 0.000 claims description 7
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 7
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentane carboxylic acid Natural products OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 claims description 5
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 3
- 125000006371 dihalo methyl group Chemical group 0.000 claims description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 3
- 125000004970 halomethyl group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000004953 trihalomethyl group Chemical group 0.000 claims description 3
- 229910018509 Al—N Inorganic materials 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 150000001735 carboxylic acids Chemical class 0.000 claims 3
- 101100173542 Caenorhabditis elegans fer-1 gene Proteins 0.000 claims 1
- UJHBVMHOBZBWMX-UHFFFAOYSA-N ferrostatin-1 Chemical compound NC1=CC(C(=O)OCC)=CC=C1NC1CCCCC1 UJHBVMHOBZBWMX-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 261
- 239000000243 solution Substances 0.000 description 193
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 165
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 160
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 136
- 239000000203 mixture Substances 0.000 description 135
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 132
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 111
- 238000003756 stirring Methods 0.000 description 106
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 102
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 93
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 85
- 239000000725 suspension Substances 0.000 description 75
- 238000002844 melting Methods 0.000 description 72
- 230000008018 melting Effects 0.000 description 72
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 66
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 52
- 238000010511 deprotection reaction Methods 0.000 description 52
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 51
- 239000012038 nucleophile Substances 0.000 description 48
- 239000000047 product Substances 0.000 description 43
- 239000007787 solid Substances 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- 239000002904 solvent Substances 0.000 description 37
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 36
- 239000002244 precipitate Substances 0.000 description 36
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 34
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 32
- 239000000706 filtrate Substances 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 28
- 238000001914 filtration Methods 0.000 description 28
- 238000001816 cooling Methods 0.000 description 26
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000005457 ice water Substances 0.000 description 24
- MSPCIZMDDUQPGJ-UHFFFAOYSA-N N-methyl-N-(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)N(C)C(=O)C(F)(F)F MSPCIZMDDUQPGJ-UHFFFAOYSA-N 0.000 description 22
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
- 229920001577 copolymer Polymers 0.000 description 22
- 239000000463 material Substances 0.000 description 22
- 125000001841 imino group Chemical group [H]N=* 0.000 description 20
- 125000006239 protecting group Chemical group 0.000 description 20
- 239000002585 base Substances 0.000 description 19
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 19
- 239000011541 reaction mixture Substances 0.000 description 19
- 239000013058 crude material Substances 0.000 description 18
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 18
- 239000013078 crystal Substances 0.000 description 17
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 16
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 16
- 239000003480 eluent Substances 0.000 description 16
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 description 15
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- 230000007062 hydrolysis Effects 0.000 description 15
- 238000006460 hydrolysis reaction Methods 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- 150000002148 esters Chemical class 0.000 description 14
- 238000001704 evaporation Methods 0.000 description 14
- 230000008020 evaporation Effects 0.000 description 14
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 229910052736 halogen Inorganic materials 0.000 description 11
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 11
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 10
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 10
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 9
- NDVMCQUOSYOQMZ-UHFFFAOYSA-N 2,2-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)C(C(N)=O)[Si](C)(C)C NDVMCQUOSYOQMZ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 9
- NQXRQYKIEKLAHI-VIFPVBQESA-N benzyl n-[(3s)-2-oxoazetidin-3-yl]carbamate Chemical compound C=1C=CC=CC=1COC(=O)N[C@H]1CNC1=O NQXRQYKIEKLAHI-VIFPVBQESA-N 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 9
- 150000002367 halogens Chemical class 0.000 description 9
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- 239000006188 syrup Substances 0.000 description 9
- 235000020357 syrup Nutrition 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 8
- 239000003039 volatile agent Substances 0.000 description 8
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- 125000004076 pyridyl group Chemical group 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
- IEDZXMPDRSEYCZ-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-1h-pyridine-2-carbohydrazide Chemical compound N1C(C(=O)NN)=CC(=O)C(OCC=2C=CC=CC=2)=C1 IEDZXMPDRSEYCZ-UHFFFAOYSA-N 0.000 description 6
- TUJMNQZMSQDVAR-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-1h-pyridine-2-carboxylic acid Chemical compound N1C(C(=O)O)=CC(=O)C(OCC=2C=CC=CC=2)=C1 TUJMNQZMSQDVAR-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- LDECUSDQMXVUMP-UHFFFAOYSA-N benzyl 3-[6-[[2-(butylamino)-1-[3-methoxycarbonyl-4-(2-methoxy-2-oxoethoxy)phenyl]-2-oxoethyl]-hexylamino]-6-oxohexyl]-4-methyl-2-oxo-6-(4-phenylphenyl)-1,6-dihydropyrimidine-5-carboxylate Chemical compound O=C1NC(C=2C=CC(=CC=2)C=2C=CC=CC=2)C(C(=O)OCC=2C=CC=CC=2)=C(C)N1CCCCCC(=O)N(CCCCCC)C(C(=O)NCCCC)C1=CC=C(OCC(=O)OC)C(C(=O)OC)=C1 LDECUSDQMXVUMP-UHFFFAOYSA-N 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000006073 displacement reaction Methods 0.000 description 5
- 125000001072 heteroaryl group Chemical group 0.000 description 5
- 239000012948 isocyanate Substances 0.000 description 5
- 150000002513 isocyanates Chemical class 0.000 description 5
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 5
- QLZVZVUBCWNUIK-UHFFFAOYSA-N 3-(4-oxo-5-phenylmethoxy-1h-pyridin-2-yl)prop-2-enoic acid Chemical compound N1C(C=CC(=O)O)=CC(=O)C(OCC=2C=CC=CC=2)=C1 QLZVZVUBCWNUIK-UHFFFAOYSA-N 0.000 description 4
- KIDVXDFSLNXGEA-UHFFFAOYSA-N 5-hydroxy-4-oxo-1h-pyridine-2-carbohydrazide Chemical compound NNC(=O)C1=CC(=O)C(O)=CN1 KIDVXDFSLNXGEA-UHFFFAOYSA-N 0.000 description 4
- GMYHFMYEZAGTBN-UHFFFAOYSA-N 5-hydroxy-4-oxo-1h-pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC(=O)C(O)=CN1 GMYHFMYEZAGTBN-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000010933 acylation Effects 0.000 description 4
- 238000005917 acylation reaction Methods 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- AYFRBQBYYKCOGN-VIFPVBQESA-N benzyl n-[(3s)-1-(chlorosulfonylcarbamoyl)-2-oxoazetidin-3-yl]carbamate Chemical compound O=C1N(C(=O)NS(=O)(=O)Cl)C[C@@H]1NC(=O)OCC1=CC=CC=C1 AYFRBQBYYKCOGN-VIFPVBQESA-N 0.000 description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 4
- SIOVKLKJSOKLIF-UHFFFAOYSA-N bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)OC(C)=N[Si](C)(C)C SIOVKLKJSOKLIF-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 4
- 150000002960 penicillins Chemical class 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229910003446 platinum oxide Inorganic materials 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000008259 solid foam Substances 0.000 description 4
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 3
- NUWSROZTGBWJGI-UHFFFAOYSA-N 1-tritylpiperazine-2,3-dione Chemical compound O=C1C(=O)NCCN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 NUWSROZTGBWJGI-UHFFFAOYSA-N 0.000 description 3
- ZVLYUUNXCFPSCP-UHFFFAOYSA-N 2-(aminomethyl)-5-phenylmethoxy-3h-pyridin-4-one Chemical compound O=C1CC(CN)=NC=C1OCC1=CC=CC=C1 ZVLYUUNXCFPSCP-UHFFFAOYSA-N 0.000 description 3
- GCBWDZYSLVSRRI-UHFFFAOYSA-N 3-aminoazetidin-2-one Chemical compound NC1CNC1=O GCBWDZYSLVSRRI-UHFFFAOYSA-N 0.000 description 3
- IWJLZADTSIIYBX-UHFFFAOYSA-N 5-(benzyloxy)-2-(hydroxymethyl)-1,4-dihydropyridin-4-one Chemical compound N1C(CO)=CC(=O)C(OCC=2C=CC=CC=2)=C1 IWJLZADTSIIYBX-UHFFFAOYSA-N 0.000 description 3
- RAFXAEJBIFWFJJ-UHFFFAOYSA-N 5-hydroxy-2-[(2-oxoimidazolidin-1-yl)methyl]-1h-pyridin-4-one Chemical compound O=C1C(O)=CNC(CN2C(NCC2)=O)=C1 RAFXAEJBIFWFJJ-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- 239000002198 insoluble material Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- JTHRRMFZHSDGNJ-UHFFFAOYSA-N piperazine-2,3-dione Chemical compound O=C1NCCNC1=O JTHRRMFZHSDGNJ-UHFFFAOYSA-N 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical group OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- PNRJTZWTPTYXAR-BYPYZUCNSA-N (3s)-3-amino-n-[[(5-hydroxy-4-oxo-1h-pyridine-2-carbonyl)amino]sulfamoyl]-2-oxoazetidine-1-carboxamide Chemical compound O=C1[C@@H](N)CN1C(=O)NS(=O)(=O)NNC(=O)C1=CC(=O)C(O)=CN1 PNRJTZWTPTYXAR-BYPYZUCNSA-N 0.000 description 2
- GVQHPNWWLJEBOS-UHFFFAOYSA-N (4-methoxyphenyl)methyl n-[(4-oxo-5-phenylmethoxy-1h-pyridine-2-carbonyl)amino]carbamate Chemical compound C1=CC(OC)=CC=C1COC(=O)NNC(=O)C1=CC(=O)C(OCC=2C=CC=CC=2)=CN1 GVQHPNWWLJEBOS-UHFFFAOYSA-N 0.000 description 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 2
- DHIVBEZCBBHIPZ-UHFFFAOYSA-N 1-aminoimidazolidin-2-one Chemical compound NN1CCNC1=O DHIVBEZCBBHIPZ-UHFFFAOYSA-N 0.000 description 2
- SJUUTZRXMNIKJS-UHFFFAOYSA-N 1-benzyl-2-[(2-oxoimidazolidin-1-yl)methyl]-5-phenylmethoxypyridin-4-one Chemical compound O=C1NCCN1CC1=CC(=O)C(OCC=2C=CC=CC=2)=CN1CC1=CC=CC=C1 SJUUTZRXMNIKJS-UHFFFAOYSA-N 0.000 description 2
- MAXMIIXSFGCZJY-UHFFFAOYSA-N 1-benzyl-4-oxo-5-phenylmethoxypyridine-2-carboxylic acid Chemical compound C=1N(CC=2C=CC=CC=2)C(C(=O)O)=CC(=O)C=1OCC1=CC=CC=C1 MAXMIIXSFGCZJY-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
- WAIAKIHTKCUWEP-UHFFFAOYSA-N 2-(1-benzyl-5-hydroxy-4-oxopyridin-2-yl)acetic acid Chemical compound OC(=O)CC1=CC(=O)C(O)=CN1CC1=CC=CC=C1 WAIAKIHTKCUWEP-UHFFFAOYSA-N 0.000 description 2
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 2
- MWCAFTLNLOBKEE-UHFFFAOYSA-N 2-oxo-3-[(4-oxo-5-phenylmethoxy-1h-pyridine-2-carbonyl)amino]imidazolidine-1-carboxylic acid Chemical compound O=C1N(C(=O)O)CCN1NC(=O)C1=CC(=O)C(OCC=2C=CC=CC=2)=CN1 MWCAFTLNLOBKEE-UHFFFAOYSA-N 0.000 description 2
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 2
- DGXDHEVQIHCUAB-UHFFFAOYSA-N 3-[(5-hydroxy-4-oxo-1h-pyridine-2-carbonyl)amino]-2-oxoimidazolidine-1-carboxylic acid Chemical compound O=C1N(C(=O)O)CCN1NC(=O)C1=CC(=O)C(O)=CN1 DGXDHEVQIHCUAB-UHFFFAOYSA-N 0.000 description 2
- NVEQKTJCRXBWHS-UHFFFAOYSA-N 3-azidoazetidin-2-one Chemical compound [N-]=[N+]=NC1CNC1=O NVEQKTJCRXBWHS-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 2
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- YMEMQHRQAVYSMQ-UHFFFAOYSA-N N-(2-aminoethyl)-5-hydroxy-4-oxo-1H-pyridine-2-carboxamide 4-methylbenzenesulfonic acid Chemical compound Cc1ccc(cc1)S(O)(=O)=O.NCCNC(=O)c1cc(=O)c(O)c[nH]1 YMEMQHRQAVYSMQ-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- NNEDRWCGFQMNLA-UHFFFAOYSA-N [4,5-bis(phenylmethoxy)pyridin-2-yl]methanol Chemical compound C=1C=CC=CC=1COC=1C=NC(CO)=CC=1OCC1=CC=CC=C1 NNEDRWCGFQMNLA-UHFFFAOYSA-N 0.000 description 2
- FIQUCCCHXWLQHY-UHFFFAOYSA-N [[2-oxo-3-[(4-oxo-5-phenylmethoxy-1h-pyridine-2-carbonyl)amino]imidazolidine-1-carbonyl]amino]carbamic acid Chemical compound O=C1N(C(=O)NNC(=O)O)CCN1NC(=O)C1=CC(=O)C(OCC=2C=CC=CC=2)=CN1 FIQUCCCHXWLQHY-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000002393 azetidinyl group Chemical group 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- NNVNDLCNXISESU-UHFFFAOYSA-N benzyl 4,5-bis(phenylmethoxy)pyridine-2-carboxylate Chemical compound C=1C(OCC=2C=CC=CC=2)=C(OCC=2C=CC=CC=2)C=NC=1C(=O)OCC1=CC=CC=C1 NNVNDLCNXISESU-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- FVJGSIPDWKFERK-UHFFFAOYSA-N benzyl n-(2-oxoazetidin-1-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NN1CCC1=O FVJGSIPDWKFERK-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229920006026 co-polymeric resin Polymers 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 125000004966 cyanoalkyl group Chemical group 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 125000002632 imidazolidinyl group Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- GDSZKJQZJLWWEQ-LURJTMIESA-N n-[3-[[(3s)-3-amino-2-oxoazetidine-1-carbonyl]sulfamoyl]-2-oxoimidazolidin-1-yl]-5-hydroxy-4-oxo-1h-pyridine-2-carboxamide Chemical compound O=C1[C@@H](N)CN1C(=O)NS(=O)(=O)N1C(=O)N(NC(=O)C=2NC=C(O)C(=O)C=2)CC1 GDSZKJQZJLWWEQ-LURJTMIESA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000000160 oxazolidinyl group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- WXLMEMLCQSXRTL-UHFFFAOYSA-N tert-butyl 2-(2-phenylmethoxycarbonylhydrazinyl)acetate Chemical compound CC(C)(C)OC(=O)CNNC(=O)OCC1=CC=CC=C1 WXLMEMLCQSXRTL-UHFFFAOYSA-N 0.000 description 2
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 description 2
- 125000004306 triazinyl group Chemical group 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- QTXCNIPPVJQMCF-UHFFFAOYSA-N (2-methyl-4-oxoazetidin-3-yl)carbamic acid Chemical compound CC1NC(=O)C1NC(O)=O QTXCNIPPVJQMCF-UHFFFAOYSA-N 0.000 description 1
- GRARBOUBIQMWKH-NVNXEXLPSA-N (2s,3s)-3-amino-n-[[(5-hydroxy-4-oxo-1h-pyridine-2-carbonyl)amino]sulfamoyl]-2-methyl-4-oxoazetidine-1-carboxamide Chemical compound C[C@H]1[C@H](N)C(=O)N1C(=O)NS(=O)(=O)NNC(=O)C1=CC(=O)C(O)=CN1 GRARBOUBIQMWKH-NVNXEXLPSA-N 0.000 description 1
- YVHRUCNIHHHRLI-QMMMGPOBSA-N (3s)-3-amino-n-[3-[(5-hydroxy-4-oxo-1h-pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]sulfonyl-2-oxoazetidine-1-carboxamide Chemical compound O=C1[C@@H](N)CN1C(=O)NS(=O)(=O)N1C(=O)N(CC=2NC=C(O)C(=O)C=2)CC1 YVHRUCNIHHHRLI-QMMMGPOBSA-N 0.000 description 1
- LGUWWUHMFFFMBJ-QMMMGPOBSA-N (3s)-3-amino-n-[3-[[2-(5-hydroxy-4-oxo-1h-pyridin-2-yl)acetyl]amino]-2-oxoimidazolidin-1-yl]sulfonyl-2-oxoazetidine-1-carboxamide Chemical compound O=C1[C@@H](N)CN1C(=O)NS(=O)(=O)N1C(=O)N(NC(=O)CC=2NC=C(O)C(=O)C=2)CC1 LGUWWUHMFFFMBJ-QMMMGPOBSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- PODSUMUEKRUDEI-UHFFFAOYSA-N 1-(2-aminoethyl)imidazolidin-2-one Chemical class NCCN1CCNC1=O PODSUMUEKRUDEI-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- WJRBXQOEUIZAGP-UHFFFAOYSA-N 1-[(1-benzyl-4-oxo-5-phenylmethoxypyridin-2-yl)methyl]-4-tritylpiperazine-2,3-dione Chemical compound C1CN(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C(=O)C(=O)N1CC(N(C=1)CC=2C=CC=CC=2)=CC(=O)C=1OCC1=CC=CC=C1 WJRBXQOEUIZAGP-UHFFFAOYSA-N 0.000 description 1
- RESZVTSFSXEQII-UHFFFAOYSA-N 1-[(2-benzyl-4-oxo-5-phenylmethoxy-1,3-dihydropyridin-2-yl)methyl]-3-(2-chloroethyl)urea Chemical compound C1C(=O)C(OCC=2C=CC=CC=2)=CNC1(CNC(=O)NCCCl)CC1=CC=CC=C1 RESZVTSFSXEQII-UHFFFAOYSA-N 0.000 description 1
- ILVHRPSTCQMRSY-UHFFFAOYSA-N 1-aminopiperazine-2,3-dione Chemical compound NN1CCNC(=O)C1=O ILVHRPSTCQMRSY-UHFFFAOYSA-N 0.000 description 1
- QRZDXXAAUDLHLS-UHFFFAOYSA-N 1-benzyl-2-(chloromethyl)-5-phenylmethoxypyridin-4-one Chemical compound C=1N(CC=2C=CC=CC=2)C(CCl)=CC(=O)C=1OCC1=CC=CC=C1 QRZDXXAAUDLHLS-UHFFFAOYSA-N 0.000 description 1
- BCMYXYHEMGPZJN-UHFFFAOYSA-N 1-chloro-2-isocyanatoethane Chemical compound ClCCN=C=O BCMYXYHEMGPZJN-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- PISMJKGQNDOCGA-UHFFFAOYSA-N 2-(1,3-thiazol-4-yl)acetic acid Chemical compound OC(=O)CC1=CSC=N1 PISMJKGQNDOCGA-UHFFFAOYSA-N 0.000 description 1
- LTIAISOLFAANNB-UHFFFAOYSA-N 2-(1-benzyl-4-oxo-5-phenylmethoxypyridin-2-yl)acetonitrile Chemical compound C1=C(OCC=2C=CC=CC=2)C(=O)C=C(CC#N)N1CC1=CC=CC=C1 LTIAISOLFAANNB-UHFFFAOYSA-N 0.000 description 1
- LJUFWZQRDABBTO-UHFFFAOYSA-N 2-(1-benzyl-5-hydroxy-4-oxopyridin-2-yl)-n-(2-oxoimidazolidin-1-yl)acetamide Chemical compound C1CNC(=O)N1NC(=O)CC1=CC(=O)C(O)=CN1CC1=CC=CC=C1 LJUFWZQRDABBTO-UHFFFAOYSA-N 0.000 description 1
- OOYGSFOGFJDDHP-UHFFFAOYSA-N 2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)C(O)C(CO)O2)O)C(N)CC1N OOYGSFOGFJDDHP-UHFFFAOYSA-N 0.000 description 1
- GPGCHSWSWRIOOJ-UHFFFAOYSA-N 2-(chloromethyl)-5-phenylmethoxy-1h-pyridin-4-one Chemical compound N1C(CCl)=CC(=O)C(OCC=2C=CC=CC=2)=C1 GPGCHSWSWRIOOJ-UHFFFAOYSA-N 0.000 description 1
- ZGEXYNBHYVEWKT-UHFFFAOYSA-N 2-(hydroxymethyl)-5-phenylmethoxypyran-4-one Chemical compound O1C(CO)=CC(=O)C(OCC=2C=CC=CC=2)=C1 ZGEXYNBHYVEWKT-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- KYNYDOGKVPHFNF-UHFFFAOYSA-N 2-phenylmethoxy-3H-pyridin-4-one Chemical compound C(C1=CC=CC=C1)OC1=NC=CC(C1)=O KYNYDOGKVPHFNF-UHFFFAOYSA-N 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- LQUSVSANJKHVTM-UHFFFAOYSA-N 3-hydroxy-3h-pyridin-4-one Chemical group OC1C=NC=CC1=O LQUSVSANJKHVTM-UHFFFAOYSA-N 0.000 description 1
- PHKYYUQQYARDIU-UHFFFAOYSA-N 3-methyl-9h-carbazole Chemical compound C1=CC=C2C3=CC(C)=CC=C3NC2=C1 PHKYYUQQYARDIU-UHFFFAOYSA-N 0.000 description 1
- MWHFMAMJIYHCLW-UHFFFAOYSA-N 3-phenylmethoxypyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CC=C1OCC1=CC=CC=C1 MWHFMAMJIYHCLW-UHFFFAOYSA-N 0.000 description 1
- UFMCXADYCRDAHQ-UHFFFAOYSA-N 4,5-bis(phenylmethoxy)pyridine-2-carbaldehyde Chemical compound C=1C=CC=CC=1COC=1C=NC(C=O)=CC=1OCC1=CC=CC=C1 UFMCXADYCRDAHQ-UHFFFAOYSA-N 0.000 description 1
- IXRKNBBPCDBCFY-UHFFFAOYSA-N 4-oxo-3-phenylmethoxypyridine-1-carboxylic acid Chemical compound OC(=O)N1C=CC(=O)C(OCC=2C=CC=CC=2)=C1 IXRKNBBPCDBCFY-UHFFFAOYSA-N 0.000 description 1
- QRCNLMIBDQGEHC-UHFFFAOYSA-N 4-oxo-3H-pyridine-2-carboxamide Chemical compound C(N)(=O)C1=NC=CC(C1)=O QRCNLMIBDQGEHC-UHFFFAOYSA-N 0.000 description 1
- RGZZNPNSZZJJSH-UHFFFAOYSA-N 4-oxo-5-phenylmethoxypyran-2-carboxylic acid Chemical compound O1C(C(=O)O)=CC(=O)C(OCC=2C=CC=CC=2)=C1 RGZZNPNSZZJJSH-UHFFFAOYSA-N 0.000 description 1
- VZSOLQXJYRJEMM-UHFFFAOYSA-N 4-oxo-n-(2-oxoimidazolidin-1-yl)-5-phenylmethoxy-1h-pyridine-2-carboxamide Chemical compound C=1C(=O)C(OCC=2C=CC=CC=2)=CNC=1C(=O)NN1CCNC1=O VZSOLQXJYRJEMM-UHFFFAOYSA-N 0.000 description 1
- JYKZIOMYJRDGJQ-UHFFFAOYSA-N 4h-pyran-2-carboxylic acid Chemical compound OC(=O)C1=CCC=CO1 JYKZIOMYJRDGJQ-UHFFFAOYSA-N 0.000 description 1
- NTWXQDISUWBDPV-UHFFFAOYSA-N 5-hydroxy-4-oxo-1h-pyridine-2-carbaldehyde Chemical compound OC1=CNC(C=O)=CC1=O NTWXQDISUWBDPV-UHFFFAOYSA-N 0.000 description 1
- SCFDEORBGQKORJ-UHFFFAOYSA-N 5-hydroxy-4-oxo-n-(2-oxoimidazolidin-1-yl)-1h-pyridine-2-carboxamide Chemical compound O=C1C(O)=CNC(C(=O)NN2C(NCC2)=O)=C1 SCFDEORBGQKORJ-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- KYARBIJYVGJZLB-UHFFFAOYSA-N 7-amino-4-hydroxy-2-naphthalenesulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 KYARBIJYVGJZLB-UHFFFAOYSA-N 0.000 description 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- IVVPRJNZVRCZGB-UHFFFAOYSA-N N-(2-aminoethyl)-5-hydroxy-4-oxo-1H-pyridine-2-carboxamide dihydrochloride Chemical compound NCCNC(=O)C=1NC=C(C(C1)=O)O.Cl.Cl IVVPRJNZVRCZGB-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N Picolinic acid Natural products OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- CVQUWLDCFXOXEN-UHFFFAOYSA-N Pyran-4-one Chemical compound O=C1C=COC=C1 CVQUWLDCFXOXEN-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- QTXCNIPPVJQMCF-HRFVKAFMSA-N [(2s,3s)-2-methyl-4-oxoazetidin-3-yl]carbamic acid Chemical compound C[C@@H]1NC(=O)[C@H]1NC(O)=O QTXCNIPPVJQMCF-HRFVKAFMSA-N 0.000 description 1
- MQRMSUHIJNJUBV-ZETCQYMHSA-N [(3s)-1-[[3-[(5-hydroxy-4-oxo-1h-pyridine-2-carbonyl)amino]-2-oxoimidazolidin-1-yl]sulfonylcarbamoyl]-2-oxoazetidin-3-yl]carbamic acid Chemical compound O=C1[C@@H](NC(=O)O)CN1C(=O)NS(=O)(=O)N1C(=O)N(NC(=O)C=2NC=C(O)C(=O)C=2)CC1 MQRMSUHIJNJUBV-ZETCQYMHSA-N 0.000 description 1
- FNLYDUJEHOBNDD-ZETCQYMHSA-N [(3s)-1-[[[3-[(5-hydroxy-4-oxo-1h-pyridine-2-carbonyl)amino]-2-oxoimidazolidine-1-carbonyl]amino]sulfamoylcarbamoyl]-2-oxoazetidin-3-yl]carbamic acid Chemical compound O=C1[C@@H](NC(=O)O)CN1C(=O)NS(=O)(=O)NNC(=O)N1C(=O)N(NC(=O)C=2NC=C(O)C(=O)C=2)CC1 FNLYDUJEHOBNDD-ZETCQYMHSA-N 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000005276 alkyl hydrazino group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 description 1
- 150000001539 azetidines Chemical class 0.000 description 1
- 150000001541 aziridines Chemical class 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- HANBFXPIYDKGNA-ZDUSSCGKSA-N benzyl n-[(3s)-1-[(5-hydroxy-4-oxo-1h-pyridin-2-yl)methylsulfamoylcarbamoyl]-2-oxoazetidin-3-yl]carbamate Chemical compound O=C1C(O)=CNC(CNS(=O)(=O)NC(=O)N2C([C@@H](NC(=O)OCC=3C=CC=CC=3)C2)=O)=C1 HANBFXPIYDKGNA-ZDUSSCGKSA-N 0.000 description 1
- RXUBZLMIGSAPEJ-UHFFFAOYSA-N benzyl n-aminocarbamate Chemical compound NNC(=O)OCC1=CC=CC=C1 RXUBZLMIGSAPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 238000012474 bioautography Methods 0.000 description 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- ITVPBBDAZKBMRP-UHFFFAOYSA-N chloro-dioxido-oxo-$l^{5}-phosphane;hydron Chemical compound OP(O)(Cl)=O ITVPBBDAZKBMRP-UHFFFAOYSA-N 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 230000003009 desulfurizing effect Effects 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 description 1
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002390 heteroarenes Chemical class 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- ACYBVNYNIZTUIL-UHFFFAOYSA-N n'-benzylethane-1,2-diamine Chemical compound NCCNCC1=CC=CC=C1 ACYBVNYNIZTUIL-UHFFFAOYSA-N 0.000 description 1
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 1
- KSZDKMBTCNECPN-UHFFFAOYSA-N n,n-dimethylformamide;5-hydroxy-4-oxo-1h-pyridine-2-carbaldehyde Chemical compound CN(C)C=O.OC1=CNC(C=O)=CC1=O KSZDKMBTCNECPN-UHFFFAOYSA-N 0.000 description 1
- JGCLDEFBULMSDY-UHFFFAOYSA-N n-(2,3-dioxopiperazin-1-yl)-4,5-bis(phenylmethoxy)pyridine-2-carboxamide Chemical compound C=1C(OCC=2C=CC=CC=2)=C(OCC=2C=CC=CC=2)C=NC=1C(=O)NN1CCNC(=O)C1=O JGCLDEFBULMSDY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000009935 nitrosation Effects 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 125000002071 phenylalkoxy group Chemical group 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- WUXHWFYSHCWQMM-UHFFFAOYSA-N tert-butyl n-[(4-oxo-5-phenylmethoxy-1h-pyridine-2-carbonyl)amino]carbamate Chemical compound N1C(C(=O)NNC(=O)OC(C)(C)C)=CC(=O)C(OCC=2C=CC=CC=2)=C1 WUXHWFYSHCWQMM-UHFFFAOYSA-N 0.000 description 1
- VXKWYPOMXBVZSJ-UHFFFAOYSA-N tetramethyltin Chemical compound C[Sn](C)(C)C VXKWYPOMXBVZSJ-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000002053 thietanyl group Chemical group 0.000 description 1
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- VIYXXANHGYSBLY-UHFFFAOYSA-N trimethylsilyl 2,2,2-trifluoroacetate Chemical compound C[Si](C)(C)OC(=O)C(F)(F)F VIYXXANHGYSBLY-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 125000005289 uranyl group Chemical group 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
I'
AUSTRALIA
Patents A ct 0 0 9 12 COMPLETE SPECIFICATION
(ORIGINAL)
Class Int. Class Application Number: Lodged: 31561/6 Complete Specification Lodged: Accepted: Published: Priority This ocunent contains thle aedr'It -made under Section 49 and is correct for printing.
Related Art: APPLICANT'S REF.: M-7 80, 479-S Namne(s) of Applicant(s): Address(es) of Applicant(s): 00~I 0 CO *a 00 o C oo 00 0 0 0 00 00 0 0 ~0 00 0 0 00 0 0 0 0 40 0 E. R. SQUIBB SONS, INC.
Lawrenceville-Princeton Road, Princeton, New Jersey 08543-4000, United States of America Actual Inventor(s): HERMANN BREUER UWE D. TREUNER WILLIAM H. KOSTER ROBERT ZAHLER Address for Service is: PHILLIPS, ORMONDE AND FITZPATRICK 00 o 0 00 0 Patent and Trade Mark Attorneys 367 Collins Street Melbourne, Australia, 3000 Complete Specification for the invention entitled: 2-OXO-1-[[ii(SUBSTITUTED SULFONYL)AMINO] CARBONYL] -AZETIDINES The iollowing statement is a full description of this invention, including the best method of performing it known to P19/3/84 GC24Oa 2-OXO-l- ii[(SUBSTITUTED SULFONYL)ANINO]- CARBONYLl AZETIDINES 0000 00 0 60000 000 U W 0 0-0 0 Compounds having the formula
IR
12 R -NH I R
CH
C-N-C-NH-SO 2-R and pharmaceutically acceptable salts thereof, exhibit antibacterial activity. In formula I, and throughout the specification, the symbols are as defined below.
R is -A 1-N 0
H
-A
1 26 LJ::Nr
H
0 I
OH
-A -N N- A N M 1 5~ 0~ H 0
H
H
,or _i_ GC240a -2- 0 0OH -NH-A4- N
H
R
1 is an acyl group derived from a carboxylic acid;
R
2 and R 3 are the same or different and each is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, substituted phenyl or a 4, 5, 6 or 7-membered heterocycle (hereinafter referred to as Rx), or one of R2 and R 3 is hydrogen and the other is azido, halomethyl, dihalomethyl, trihalomethyl, alkoxycarbonyl, 2-phenylethenyl, 2-phenylethynyl, carboxyl, -CH 2
X
1 [wherein X 1 is azido, amino hydroxy, carboxyl, alkoxycarbonyl, alkanoylamino, phenylcarbonylamino, (substituted phenyl)carbonylamino, alkylsulfonyloxy, phenylsulfonyloxy, (substituted phenyl)sulfonyloxy, 0 0 o a 20 phenyl, substituted phenyl, cyano, -NX6X 7 -S-X2' or -O-X 2 (wherein A, X 2
X
6 and X7 are as hereinafter defined)], -S-X 2 or -0-X 2 [wherein X o o is alkyl, substituted alkyl, phenyl, substituted Iphenyl, phenylalkyl, (substituted phenyl)alkyl, alkanoyl, phenylalkanoyl, (substituted phenyl)- I5 alkanoyl, phenylcarbonyl, (substituted phenyl)- 0 o° alkanoyl, phenylcarbonyl, (substituted phenyl)x 0 03 o 4 carbonyl, or heteroarylcarbonyl], or a 13
-S-C-X
4 [wherein one of X 3 and X 4 is hydrogen and
X
x o A° the other is hydrogen or alkyl, or X 3 and X 4 when 0 ca ^3 4 b taken together with the carbon atom to which they are attached form a cycloalkyl group; and X 5 is formyl, alkanoyl, phenylcarbonyl, (substituted phenyl)carbonyl, phenylalkylcarbonyl, (substituted GC240a -3phenyl)alkylcarbonyl, carboxyl, alkoxycarbonyl, aminocarbonyl (NH 2 (substituted amino)carbonyl, or cyano or -NX 6
X
7 [wherein A is -CH=CH-,
-(CH
2 )m-NH-, or -CH2-S-CH 2 m is 0, 1 or 2, and X 6 and X 7 are the same or different and each is hydrogen, alkyl, phenyl or substituted phenyl, or X 6 is hydrogen and X7 is amino, substituted amino, alkanoylamino or alkoxy, or X 6 and X7 when taken together with the nitrogen atom to which they are attached form a 4, 5, 6 or 7-membered heterocycle]; 0
II
A
I is a single bond, -NH- or 0 -NH-NH-8-; 0 o A 2 is a single bond, -CH 2
-CH
2 or 20 -C-NH-NH-; 6000 0R 0 -NH-NH-, -NH--NH-CH NH-CH -CH2-C-NH-, or -CH2-C-NH-CH 2 2 -C :0 A is -(CH 2 -(CH)y-NH-, 0 0 CH X 1 o I I H2X w -NHe-NH-NH- X is ca l or -l a 0o0. +wherein X is hydrogen, carboxyl or carbamoyl and p is 0 o- 1, and y is 2, 3, or 4;
A
5 is a single bond, -CH 2 -NH-CH2-, 00 0 o0 or -C-NH-(CH) wherein q is 0 or 1; o A 6 is a single bond, -CH=CH- or -(CH2) t wherein t is 1, 2, 3 or 4.
The above symbols Al, A 2
A
3
A
4
A
and A 6 are used to represent groups of multiple GC240a atoms. These groups are inserted in the structural formulas shown herein in the order in which they are presented from left to right). For example, if R and A 1 is o 96 01 4 4 4444 8 o 1 9 4 444 4 r or u 4 a i 4 4 9 9*| 9 4 9 4 491 4 94 (Io 1 4 44 4 44 0 4 o t i 4 49«
OB
0 9 1 0
I
o o
HH
-C-NH-N N (NT
Y
Listed below are definitions of various terms used to describe the p-lactams of this invention.
These definitions apply to the terms as they are used th.oughout the specification (unless they are 20 otherwise limited in specific instances) either individually or as part of a larger group.
The terms "alkyl" and "alkoxy" refer to both straight and branched chain groups. Those groups having 1 to 10 carbon atoms are preferred.
25 The terms "cycloalkyl" and "cycloalkenyl" refer to cycloalkyl and cycloalkenyl groups having 3,4,5,6 or 7 carbon atoms.
The term "substituted alkyl" refers to alkyl groups substituted with one or more (preferably 1, 2 or 3) azido, amino (-NH 2 halogen, hydroxy, carboxy, cyano, alkoxycarbonyl, aminocarbonyl, alkanoyloxy, alkoxy, phenyloxy, (substituted phenyl)oxy, mercapto, alkylthio, phenylthio,
_:I
5 (substituted phenyl)thio, alkylsulfinyl, or alkyl-sulfonyl groups.
The terms "alkanoyl", "alkenyl", and "alkynyl" refer to both straight and branched chain groups. Those groups having 2 to 10 carbon atoms are preferred.
The terms "halogen" and "halo" refer to fluorine, chlorine, bromine and iodine.
The term "substituted phenyl" refers to a phenyl group substituted with 1, 2 or 3 amino (-NH 2 halogen, hydroxyl, trifluoromethyl, alkyl (of 1 to 4 carbon atoms), alkoxy (of 1 to 4 carbon atoms), alkanoyloxy, aminocarbonyl, or carboxy groups.
The term "a 4,5,6 or 7-membered heterocycle" (referred to as "R as used herein the description and claims refers to substituted and unsubstituted, aromatic and non-aromatic groups containing one or more (preferably 1, 2 or 3) nitrogen, oxygen or sulfur atoms.' The substituents O 0 being selected from oxo halogen, hydroxy, nitro, amino, cyano, trifluoromethli, alkyl of 1 to 4 carbons, alkoxy of 1 to 4 carbons, alkylsulfonyl, phenyl, substituted a o O CH=Nphenyl, 2-furfurylideneamino L), benzylideneamino and substituted alkyl groups (wherein the alkyl group has 1 to 4 carbons). One type of "4,5,6 or 7-membered heterocycle" is the "heteroaryl" group. The term °0 "heteroaryl" refers to those 4,5,6 or 7-membered r wa ti E p y aryl groups are substituted and unsubstituted pyrid uranyl, pyrrolyl, thienyl, 1,2,3-triazolyl ,-triazolyl, imidazolyl, thiazolyl i-aiazolyl, pyrimidinyl, oxazolyl, triazinyl, etrazolyl. Exemplary nonaromatic Rcocyo 1 P fully or partially saturated *0 04 0 6I~ i r_ heterocycles which are aromatic. The heteroaryl groups are selected from substituted and unsubstituted pyridinyl, furanyl, pyrrolyl, thienyl, 1,2,3-triazolyl, 1,2,4-triazolyl, imidazolyl, thiazolyl, thiadiazolyl, pyrimidinyl, oxazolyl, triazinyl, and '.etrazolyl. The nonaromatic heterocycles (iLe' fully or partially saturated heterocyclic groups) are selected from substituted and unsubstituted azetidinyl, oxetanyl, thietanyl, piperidinyl, piperazinyl, imidazolidinyl, oxazolidinyl, pyrrolidinyl, tetrahydropyrimidinyl, dihydrothiazolyl and hexahydroazepinyl. The substituted 4,5,6 or 7-membered heterocycles are selected from 1-alkyl-3-azetidinyl, 2-oxo-l-imidazolidinyl, I t GC24Oa heteEC-YGJG P) -6unsubstituted azetidinyl, oxetanyl, thi y1, piperidinyl, piperazinyl, imida inyl, oxazolidinyl, pyrrolidi ,tetrahydropyrimidinyl, dihydrothiazol hexahydroazepinyl. Exemplary -of the 'ituted 4,5,6 or 7-membered heterocycles 3-alkylsulfonyl-2-oxo-l-imidazolidinyl, 3-benzylideneamino-2-oxo-l-imidazolidinyl, 3-alkyl-2-oxo-1-imidazolidinyl, 3-phenyl (or substituted pheny))-2-oxo.-1-imidazolidinyl, 3-benzyl-2-oxo-1-imidazolidinyl, 3-(2-amirioethyl)- 2-oxo-l-imidazolidinyl, 3-amino-2-oxoimidazolidinyl, 3- [(alkoxycarbonyl )amino] 2-oxo-1-imidazolidinyl, 3-[2-[(alkoxycarbonyl)amino]ethyl]-2-oxo-1-imidazolidinyl, 2-oxo-1pyrrolidinyl, 2-oxo-3-oxazolidinyl, 4-hydroxy-6methyl-2-pyrimidinyl, 2-oxo-1-hexahydroazepinyl, 2-oxo-3-pyrrolidinyl, 2-oxo-3-tetrahydrofuranyl, 2, 3-dioxo-1-piperazinyl, 2, 5-dioxo-1-piperazinyl, 4 4-alkyl-2,3-dioxo-l-piperazinyl, and 4-phenyl-2,3- 0 0 dioxo-1-piperazinyl.
The term "substituted amino" refers to a gro~up having the formula -NX X 9 wherein Xis 010125 hydrogen, alkyl, phenyl, substituted phenyl, phenylalkyl or (substituted phenyl)alkyl, andX9 is alkyl, phenyl, substituted phenyl, phenylalkyl, (substituted phenyl)alkyl, hydroxy, cyano, alkoxy, 0 phenylalkoxy, or amino (-NHl) 00 2 GC240a 7- The term "acyl" refers to all organic radicals derived from an organic acid a carboxylic acid) by removal of the hydroxyl group. Certain acyl groups are, of course, preferred but this preference should not be viewed as a limitation of the scope of this invention. Exemplary acyl groups are those acyl groups which have been used in the past to acylate B-lactam antibiotics including 6-aminopenicillanic acid and derivatives and 7-aminocephalosporanic acid and derivatives; see, for example, Cephalosporins and Penicillins, edited by Flynn, Academic Press (1972), German Offenlegungsschrift 2,716,677, published October 10, 1978, Belgian patent 867,994, published December 11, 1978, United States patent 4,152,432, issued May 1, 1979, United States patent 3,971,778-, issued July 27, 1976, United States patent 4,172,199, issued October 23, 1979, and British patent 1,348,894, published March 27, 1974. The portions of these references describing various acyl groups are incorporated herein by reference. The following list of acyl groups is presented to further exemplify the term "acyl"; it should not be regarded as limiting that term. Exemplary acyl groups are: 4 4t Aliphatic groups having the formula 1R
-C-
i wherein R a is alky?; cycloalkyl; alkoxy; alkenyl; Si GC240a cycloajikenyl; cyclohexad jenyl; or aJJkyl or alkenyJ.
substituted with one or more halogen, cyano, nitro, amtino, mercapto, alkylthio, or cvanometnhylthio group)s.
Carbocyclic aromatic groums having the :Formula Rb Rd 0 _(CH 2 )n-C- 7
R
R C Rbd
CH-C-
R
R
000 b 11 CH 252 R b R d 0 -CH 2 0 00 CC240 a
R
-CH2-C- o wherein n is 0, 1, 2 or 3; Rb R, and Ra each is independently hydrogen, halogen, hydroxyl, nitr, amnocyano, trifluoromethyl, alkyl of 1to 4carbon atoms, alkoxy of 1 to 4 carbon atosor ninomethyl; and R e is amino, hydroxyl, a carboxyl salt, protected carboxyl, formyloxy, a sulfo salt, a sulfoaxnino, salt, azido, halogen, hydrazino, alkylhydrazino, phenylhydrazino, or [(alkylthio) thioxomethyl] thio.
Preferred carbocyclic aromatic acyl groups include those having the formula 4. 0 -0 CH 2 -11, 0430 CH 2 NH 2
"AA'
0 HO- H -C-
R
e GC24 Oa (R is nreferablv a carboxNvl salt or sulfa salt) and 0
R
e is preferably e a carboxyl (c) formula salt or sulfo salt).
Heteroaromatic groups having the 0 Rf-(CH 2
)C?
0 It Rf-CH-C-
R
e 0 Rf-O-CH 2
-C-
0 Rf-S-CH 2
C-
0 0 Rf -C-Cwherein n is 0, 1, 2 or 3; R eis as defined above; and R- is a substituted or unsubstituted 6- or 7-membered heterocyclic ring containing 1,2,3 or 4 (preferably 1. or 2) nitrogen, oxygen and sulfur atoms. Exemplary heter-ocyclic 4 44 o 44 4 4 4 44,, 44 44 4 4 4 a -II- GC24Oa rings are thienvil, furyl, p yrrolyl, pyridinyl, pyrazolyl, pyrazinyl, thiazolyl, pyrimidinyl, thiadiazolyl and tetrazolyl. Exemplary substituents are halogen, hydroxyl, nitro, amino, protected amino, cyano, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, or 0 HOOC-CH-CH -0-C-NH- 1 2 NH2 Preferred heteroaromatic acyl groups include those groups of the above formulas wherein R f is 2-amino-4-thiazolyl, halo-4-thiazolyl, 4-aininopyrimid.n-2-yl, 5-amino-l,2, 4-thiadiazol-3-yl, 2-thienyl, 2-furanyl, or 6-aminomyridin-2-yl.
LI C4-Substituted-2 ,3-dioxo-l1-piperazinyl) carbonyl] aminoJ arylacety. groups having the formula 0 0 -C-CH-NH-C-N N-Rh wherein R 9is an aromatic group (including carbocyclic aromatics such as those of the formula Rb, 2 and heteroaromatics as included within the definition of R f and R h is alkyl, substituted 4 GC240a -12alkyl (wherein the alkyl group is substituted with one or more halogen, cyano, nitro, amino or mercapto groups), arylmethyleneamino -N=CH-R wherein R is as defined above), g g 9 arylcarbonylamino -NH- -R wherein R is as defined above) or alkylcarbonylamino.
Preferred [[(4-substituted-2,3-dioxo-lpiperazinyl)carbonyl]amino]arylacetyl groups include those wherein Rh is ethyl, phenylmethyleneamino or 2-furylmethyleneamino.
(Substituted oximino)arylacetyl groups having the formula -C=N-0-R i
R
g wherein R is as defined above and R i is hydrogen, g i .alkyl, cycloalkyl, CH2-(CH2)1, 2 or 3' 2-pyrrazolylmethyl,
S-C-COOH
0 0 0 20 (2-oxo-3-pyrrolidinyl)methyl, alkylaminocarbonyl, S-o arylaminocarbonyl -C-NH-R wherein R is as o 0o defined above) or substituted alkyl (wherein the alkyl group is substituted with one or more halogen, cyano, nitro, amino, mercapto, alkylthio, aromatic group (as defined by R carboxyl ,'ooo (including salts thereof), amido, alkoxycarbonyl, '00 phenylmethoxycarbonyl, diphenylmethoxycarbonyi, hydroxyalkoxyphosphinyl, dihydroxyphosphinyl, 30 hydroxy(phenylmethoxy)phosphinyl, dialkoxyphosphinyl or tetrazolyl substituents).
0 0 G'C240 a -13- Pre.'erred (substituted oxyimnino) arylacet%-l groups include those wherein R is 2-amino-4g t.hiaz-olvil. Also nre'ferred are those groups wherein R.i is meth-yl, ethyl11, carboxvmethyl, B l-carbox-v-l-methvlethvl, 2,2,2-trif--luoroeth\j. or l-carboxycyclopropyl.
(Acylamino) arylacety. groups having the formula 0 0
-C-CH-NH-C-R.
P
wherein PR is as defined above and R. is g 3 R (CH2)n--,amino, alkylainino, (cyanoalkyl)amino, amido, alkylarnido, (cyanoalkyl)anido, NH NH 0 2 -Cl-Ch 2 CUNH-U C 3
OHO
H
OH
N C N- K, NCE or 4 t HO- H48 0 01 0 0 4 4' 14 GC24O0athe above formula include those grusahreins those arouns wherein R i~s TDhen\j. or 2-thienvi.
[[U3-Subst ituted-2-oxo-l-imidazolii$ -ciny\l] carbony!] amino] arvlacetJ. groups having '1 tne formula 0 0 0 C -C-CH-NH-C-N N-R g 2- 2 wherein R is as defined above and R is g k hydi-ogen, alkylsulfonyl, arylmethyleneamino -N=CH-R wherein R is as defined g g above), -C-R m(wherein R mis hydrogen, alkyl or halogen substituted alkyl), aromatic group (as defined by R 9above), alkyl or substituted above (wherein the alkyl. group is substituted 25 ~or 2enyl.t Alouso)rfre retoegop dinl kron drmioen, metylsgupsn ohemethyleneanino or 2-furylmethyleneamino.
'L t GC240a The compounds of this invention form basic salts with various inorganic and organic bases which are also within the scope of this invention. Such salts include ammonium salts, S alkali metal salts, alkaline earth metal salts, salts with organic bases, dicyclohexylamine, benzathine,- N-methyl-D-glucamine, hydrabamine and the like. The pharmaceutically acceptable salts are preferred, although other salts are also useful, in isolating or purifying the product.
Some of the compounds of this invention may be crystallized or recrystallized from solvents containing water. In these cases, water of hydration may be formed. This invention contemplates stoichiometric hydrates as well as compounds containing variable amounts of water that may be produced by processes such as 101 lyophilization.
20 The p-lactams of formula I contain at least one chiral center--the carbon atom in the 3-position of the p-lactam nucleus to which the acylamino substituent is attached.
This invention is directed to those p-lactams which have been described above, wherein the stereochemistry at the chiral center in the 3-position of the p-lactam nucleus is the same as the configuration at the carbon atom in the 6-position of naturally occurring penicillins '3 30 penicillin G\ and as the configuration at the carbon atom in the 7-position of naturally occurring cephamycins cephamycin Also 3 included within the scope of this invention are 0 racemic mixtures which contain the above-described p-lactams.
L_
i r-.-rr r rr-r -ri.ii- GC240a 1 -16- The p-lactams of formula I, and pharmaceutically acceptable salts thereof, have activity against gram-positive and gram-negative organisms. The compounds of this invention can be used as agents to combat bacterial infections (including.urinary tract infections and respiratory infections) in mammalian species, such as domesticated animals dogs, cats, cows, horses, and the like) and humans.
For combating bacterial infections in mammals, a compound of this invention can be administered to a mammal in need thereof in an amount of about 1.4 mg/kg/day to about 350 mg/kg/day, preferably about 14 mg/kg/day to about 100 mg/kg/day. All modes of administration which have been used in the past to deliver penicillins and cephalosporins to the site of the infection are also contemplated for use with p-lactams of this invention. Such methods of administration include oral, intravenous, intramuscular, and as a suppository.
The P-lactams of formula I can be prepared from a 3-protected amino-2-azetidinone having the formula II R R
-NH
CH--C-R
3 In formula II, and throughout the specification, the symbol "R4" refers to an amino protecting group. These groups are well known in the field of p-lactam chemistry, and the particular group chosen is not critical. Benzyloxycarbonyl, i GC240a -17trityl, and t-butoxycarbonyl are exemplary protecting groups. The reaction of a p-lactam of formula II with an isocyanate having the formula III O=C=N-SO2-Y wherein Y is a leaving group such as chlorine, yields the corresponding compound having the formula IV R 12
R
4
-NH
CH----R
N--NH-SO2-Y The reaction is preferably run in an inert organic solvent, ethyl acetate, tetrahydrofuran, dimethoxyethane, dichloromethane, acetonitrile or mixtures of these solvents. Displacement of the leaving group with the desired group can be accomplished using the appropriate nucleophile having the formula V RH, optionally in the presence of a base triethylamine), and yields the corresponding compound having the formula VI R2
R
4 -NH I- R 3 4 N--NH-SO 2
-R
0 Alternatively, the displacement of the leaving group can be accomplished by reaction of a compound of formula IV with a protected form of a compound of formula V. Following the displacement reaction, the protecting groups can be removed using art-recognized techniques to yield a compound of formula VI.
;tlcn~----iir-z GC240a -18- Protected forms of a compound of formula V, and of all reactants described herein which contain a 3-hydroxy-4-pyridone moiety, include those compounds wherein the hydroxyl group is protected, those compounds wherein the hydroxyl group and the ring nitrogen are protected, and those compounds wherein both pyridone oxygens are protected. Exemplary protecting groups are silyl trimethylsilyl), benzyl and acyl acetyl). If silyl is used, later deprotection can be accomplished using hydrolysis or fluoride mediated cleavage. If benzyl is used, later deprotection can be accomplished by hydrogenolysis.
If acyl is used, later deprotection can be accomplished by hydrolysis.
Deprotection of a compound of formula VI using conventional techniques yields the corresponding key intermediate having the formula 0 o4 VII R' 12 o 20 NH *~2 CH- C-R jI I 3 oC a-N-C-NH-S 2 -R or a salt thereof. The particular deprotection reaction used will, of course, depend on the protecting group present. If, for example, R is a t-butoxycarbonyl protecting group, deprotection can be accomplished by treatment of a compound of formula VI with acid formic acid or trifluoroacetic acid). If, for example, R 4 is a benzyloxycarbonyl protecting group, deprotection can be accomplished by catalytic hydrogenation of a °CC compound of formula VI. Alternatively, the R 4 0 protecting group can be removed simultaneously with the i. L--L_ GC240a -19other pyridone protecting groups immediately following the above-described displacement reaction.
Well known acylation techniques can be used to convert an intermediate of formula VII to a corresponding product of formula I. Exemplary techniques-include reaction of a compound of formula VII with a carboxylic acid (R 1 or corresponding carboxylic acid halide or carboxylic acid anhydride. The reaction with a carboxylic acid proceeds most readily in the presence of a carbodiimide such as dicyclohexylcarbodiimide and a substance capable of forming an active ester in situ such as N-hydroxybenzotriazole. In those instances where the acyl group (R 1 contains reactive functionality (such as amino or carboxyl groups) it may be necessary to first protect those functional groups, then carry out the acylation °o oreaction, and finally deprotect the resulting o<o 20 product.
An alternative procedure for preparing the °compounds of formula I comprises first acylating 0o 0o (acylation techniques have been described above) a 3-amino-2-azetidinone having the formula VIII R 12
SNH
2 2
CH-L
S,+-NH I 30 to yield an intermediate having the formula IX 2 R1-NH 3 __lj _L ~CLI GC240a 0 A -C-NH-SO2-R activating group can be introduced in the 1-position of a compound of formula IX (using the procedures described above) to obtain the corresponding product of formula I. In those instances wherein the acyl side-chain "R contains reactive functionality (such as amino groups), it may be necessary to first protect those functional groups, then carry out the addition of the activating group in the 1-position, and finally deprotect the resulting product.
Still another synthesis for the preparation of compounds of formula I comprises the use of a 3-azido-2-azetidinone having the formula X R N I N3 0 A -C-NH-SO2-R activating group can be introduced in the 1-position of a compound of formula X (using the procedures described above) to obtain the corresponding compound having the formula XI R2
I
It, N_ I ,it CH-- C-R C N-C-NH-SO -R ft 30 2 Reduction of an intermediate of formula XI yields the corresponding intermediate having the formula 4t I t0 I_ r u^ lluruiuw r~-l ll~~-rcrP us*rrrrr.
GC240a -21- VII R 12
NH
2 -CH- -R3 N-C-NH-SO -R.
1 1 2 O 0 The reduction can be accomplished by catalytic palladium on charcoal or platinum oxide) hydrogenation or with reducing agents such as zinc or triphenylphosphine. As described above, from these key intermediates (compounds of formula VII), using conventional acylation techniques, it is possible to prepare the products of formula I.
Alternatively, a 3-azido-2-azetidinone of formula X can be reduced to the corresponding 3-amino-2-azetidinone having the formula VIII R 12 NH2 i H- -R 3 The reduction can be accomplished by catalytic palladium on charcoal or platinum oxide) hydrogenation or with reducing agents such as zinc or triphenylphosphine. A 3-amino-2-azetidinone of formula VIII can be reacted as described above first acylated and then treated as 0 described above to introduce a -!-NH-SO -R 2 activating group in the 1-position) to yield the products of formula I.
Still another synthesis for preparing the compounds of formula I wherein R 2 and R 3 are each hydrogen utilizes a 6-acylaminopenicillanic acid i having the formula
V<
I-
GC240a -22-
XII
R 1-NH H H2
(CH
3 2 N CH-COOH or a salt thereof, as the starting material. By adapting procedures described in the literature, 3-acylamino-2-azetidinone can be obtained from the corresponding 6-acylaminopenicillanic acid of formula XII: see, for example, Chem. Soc. Special Publication No. 28, pg. 288 (1977), The Chemistry of Penicillins, Princeton University Press, pg.
257, and Synthesis, 494 (1977).
As described in the literature 6-acylaminopenicillanic acid, or a salt thereof, can be desulfurized to 3ield a compound having the formula
XIII
R -NH
CH
20 C- -H-CH(CH 3 2
SCOOH
by reduction using Raney nickel. The reaction can be run in water under reflux conditions.
S. Replacement of the carboxyl group of a compound of formula XIII with an acetate group followed by hydrolysis yields the corresponding 3-acylamino-2-azetidinone having the formula
XIV
R
1
-NH
CH- CH2
A-
2 aTreatment of a compound of formula XIII with t cupric acetate and lead tetraacetate in an organic solvent acetonitrile) replaces the carboxyl GC240a -23group with an acetate group. Hydrolysis of the resulting compound can be accomplished using potassium carbonate in the presence of sodium borohydride.
0 A -C-NH-SO2-R activating group can be introduced in the 1-position of a compound of formula XIV (yielding products of formula I wherein R 2 and R 3 are each hydrogen) using the procedures described above.
Still another variation of the abovedescribed synthetic routes for preparing a compound of formula I wherein R 2 and R 3 are each hydrogen comprises first desulfurizing 6-aminopenicillanic acid, acylating the resulting compound to yield a compound of formula XIII and then proceeding as described above to obtain S.first a 3-acylamino-2-azetidinone of formula XIV and then a product of formula I.
The azetidinones of formula I can also be prepared from amino acids having the formula XV OH
NH
2 R2 -CH- C-R
OH
0 The amino group is first protected (with a j protecting group "R 4 t-butoxycarbonyl).
o- The carboxyl group of the protected amino acid is then reacted with an amine having the formula XVI Z-O-NH 2 i wherein Z is alkyl, benzyl or triphenylmethyl, in the presence of a carbodiimide to yield a compound having the formula GC240a -24- XVII OH R4-NH IR2 CH--R3
NH-
0
-Z
The hydroxyl group of a compound of formula XVII is converted to a leaving group with a reagent, such as methanesulfonyl chloride or pyridine-SO 3 complex, The fully protected compound having the formula XVIII OL R4-NH I R2 H-I R3
C----NH-O-Z
is cyclized by treatment with base, potassium a carbonate. The reaction is preferably carried out in an organic solvent or an organic solvent/water 20 mixture under reflux conditions, and yields a compound having the formula XIX R -NH R2 \CH- R3
S-N-O-Z
S* 25 0 °Alternatively, cyclization of a compound of formula XVII can be accomplished without first converting the hydroxyl group to a leaving group.
Treatment of a compound of formula XVII with triphenylphosphine and diethylazodicLrboxylate, "I yields a compound of formula XIX.
SExemplary procedures for the conversion of a compound of formula XVIII to a compound of formula XIX are described in J. Amer. Chem. Soc., 102, 7026 (1980) and J. Org. Chem., 47, 5160 (1982).
GC240a Both of the methods disclosed above for ring closure of a compound of formula XVII result in the inversion of the stereochemistry at the carbon atom bearing the R 2 and R 3 substituents when R 2 and R 3 are not the same.
Removal of the protecting group from the 1-position-of an azetidinone of formula XIX can be accomplished via sodium reduction when Z is alkyl, and yields an intermediate having the formula II R-NH R 4 CH- C-R 3
NH
(at least one of R 2 and R 3 is hydrogen). If Z is benzyl, catalytic palladium on charcoal) hydrogenation will initially yield the corresponding N-hydroxy compound, which upon treatment with titanium trichloride yields an intermediate of formula II. If Z is triphenylmethyl, formic acid or 70% acetic acid/water will initially yield the corresponding N-hydroxy compound.
0 A -C-NH-SO2-R activating group can be introduced in the 1-position of a compound of formula II using the procedures described above, and the resulting compound can be deprotected and acylated.
The nucleophiles of formula V wherein R is 0 0 H -A -N 'N-A 2 A and A and A are each a 1d 2 6and 2 single bond can be prepared by reacting a silylated derivative of 2-imidazoli(inone (HN NH), 1 ~II~ GC240a -26or the anion of 2-imidazolidinone formed with a strong non-nucleophilic base, with an activated, suitably protected derivative of an acid having the formula XX O HO 0 MHA 6 -8-OH
N'
H
to obtain, upon deprotection, the corresponding compound having the formula
XXI
r I.0 OH HN N-C-A N 6
H
The reaction can be run in an inert organic solvent such as dimethylformamide, acetonitrile, dichloromethane, or tetrahydrofuran. The acid of formula XX can be activated with dicyclohexylcarbodiimide, or a combination of dicyclohexylcarbodiimide and hydroxybenzotriazole. An activated and suitably protected derivative of a compound of formula XX can also be the corresponding acid chloride (prepared with reagents such as 25 phosphorus pentachloride, thionyl chloride, oxalyl chloride or triphenylphosphine/carbon tetrachloride) or a mixed anhydride (prepared with such reagents as diphenylphosphoryl chloride, pivaloyl chloride, or isobutyl chloroformate).
The compound of formula XX wherein A 6 is a single bond can be prepared as described in the literature; see Helv. Chem. Acta, 43, 469 (1960) and J. Med. Chem., 17, 1 (1974).
The compound of formula XX wherein A 6 is -CH=CH- can be formed by oxidizing _,.ri"n~LL~rrl ;i GC240a -27-
XXII
(suitably protected) to the corresponding aldehyde having the -formula XXIII 0
HOH
N
H
(suitably protected), reacting the aldehyde with a carboxyl protected derivative XXIV (O -OH and deprotecting to yield XXV 0 4 4, 4r 4 4444 4t 44( 44 4I *I 44 4 4,44 4I 4 4 4 4 s44 4( 4 (4 4 4 4I 44 1 4 The compounds of formula XX wherein A 6 is 25 -(CH 2 and t is 2, 3 or 4 can be formed by conjugation of a compound of formula XXIII (suitably protected) with a Wittig reagent having the formula XXVI O 3( P=CH-(CH2 )t-1 -OH (suitably protected at the carboxyl group), subsequent hydrogenation of the resulting exocyclic double bond, and deprotection to yield
L
I GC240a -28- XXVII O
HO
S(CH2) t
-OH
N
H
wherein t is 2, 3 or 4.
The compounds of formula XX wherein A 6 is -(CH2) t and t is 1 can be formed by reaction of a suitably protected compound having the formula XXVIII 0
HO
H 2
L
(wherein La is a leaving group such as chloride, bromide, methanesulfonyloxy or toluenesulfonyloxy) with cyanide and subsequent hydrolysis and deprotection to yield the compound of formula XXVII wherein t is 1. A compound of formula XXVIII can be prepared from a compound of formula XXII (suitably protected) by methods familiar in the art (such as thionyl chloride or methanesulfonylchloride/triethylamine).
S 25 The nucleophile of formula V wherein R is 0 0 H S-A -N -A 2-C-A- A is a single bond and
A
2 is -NH- can be prepared by reacting an activated and optionally protected derivative of a compound of formula XX with l-amino-2-imidazolidinone (MH N-NH 2 to yield upon deprotection
L-
i GC240a -29-
XXIX
i H HN -NI--A N The nucleophiles of formula V wherein R is 0 II) I -A -N N A is a single bond and 1d 6 1
A
2 is -CH 2
-CH
2 -NH- can be prepared by reacting an activated and optionally protected derivative of a compound of formula XX with l-(2-aminoethyl)-2imidazolidinone (HN N-CCH22NH2) to yield upon deprotection XXX 0H HN N-CH -CH -NH-C-A -N 2- 2- 6 The nucleophiles of formula V wherein R is 0
H
-A -A2C-A N A is a single bond and A 2
H
0 is -C-NH-NH- can be prepared by reacting XXXI 0 0 -O-C-NH-NH-C-Cl with a silylated form of 2-imidazolidinone, the anion of 2-imidazolidinone formed with a strong ,non-nucleophilic base, or with 2-imidazolidinone in the presence of an organic base to yield XXXII 0 0 CH2-O- -NH-NH-C
NH
GC240a Catalytic hydrogenation of the compound of formula XXXII yields the compound having the formula XXXIII 0 H2N-NH- -N
H
which can be coupled with an activated and optionally.protected derivative of a compound of formula XX to yield, upon deprotection,
XXXIV
0 0 1 -H H1 iN-8-NH-NH--A N Alternatively, the compound of formula XXXIII can be prepared by first reacting l-chlorocarbonyl- 2-imidazolidinone with t-butoxycarbonyl protected hydrazine to yield XXXV -3 I, II
-NH-NH-C-O-C(CH
3 3 and deprotecting the compound of formula XXXV.
SThe nucleophiles of formula V wherein R is -A N-A -C-A N, A is and A 2 is 1 a single bond can be prepared by reacting a compound having the formula S, XXXV I 0 0 H Cl-C-N N A- N 0 cH i (suitably protected) with hexamethyldisilazane to yield upon hydrolysis and deprotection a compound having the formula GC240a -31- XXXVII 0 H N-C-N N-C-A6 N 2 6
H
The compounds of formula XXXVI (suitably protected) can be prepared by reacting a silylated form of a compound of formula XXI (optionally protected) with phosgene.
Alternatively, a compound of formula XXXVII can be prepared by reacting a protected form of a compound of formula XXI with chlorosulfonyl isocyanate followed by hydrolysis of the resulting intermediate and cleavage of the protecting groups.
The nucleophiles of formula V wherein R is 15 0 N H 0 -A -N N -C-A A is -NH-C- and A is 1 2 6 1 2 ,0 H -NH- can be prepared by reacting a silylated form of the compound
XXXVIII
HN -NH-Prot wherein the symbol Prot can be an amino protecting group such as t-butoxycarbonyl or benzyloxycarbonyl, with phosgene to yield XXXIX 0 SCl-C-N -NH-Prot, L a I which can be reacted with hexamethylsilazane to yield upon deprotection XL 0o NH N-NH 2 2 f GC240a -32- Reaction of the compound of formula XL with an optionally protected activated form of a compound of formula XX yields upon deprotection
XLI
0 0 OH NH -C-N N-NH--A 2 6H Alternatively, a compound of formula XL can be prepared by reacting the compound having the formula
XLII
HN N-N=CH- /o with chlorosulfonyl isocyanate to yield upon o 0o 15 hydrolysis oo0 0 XLIII SH2N- -N -N=C Treatment of this compound with aqueous acid yields a salt of the compound of formula XL.
The nucleophiles of formula V wherein R is i fi J 0 -A-N N-A2-C-AG 6 N, A 1 is -NH-C- and A 2 is
H
-CH
2
-CH
2 -NH- can be prepared by first deprotecting l-(aminocarbonyl)-3-[2-[[(t-butoxy)carbonyl]amino]ethyl]-2-imidazolidinone and coupling the resulting compound with an activated form of a compound nf formula XX (optionally protected) to obtain after deprotection XLIV 0 0 0 -OH
H
2 N-8-N -CH -CH -NH- lJ GC240a -33- The nucleophiles of formula V wherein R is 0 1 is OH 0 -A-N A -A Ais and A2 is
H
NH-NH- can be prepared by reacting a silylated form of a compound of formula XXXIV (optionally protected) with phosgene followed by hexamethyldisilazane to yield upon hydrolysis and deprotection
XLV
0 O OH H2N-C- N-C-NH-NH-b-A N
H
0 oo 15 Alternatively, a compound of formula XLV o 0 can be prepared by reacting a protected form of a compound of formula XXXIV with chlorosulfonylisocyanate followed by hydrolysis of the resulting intermediate and cleavage of the protecting groups.
Alternatively, compound XXXII can be reacted with chlorosulfonyl isocyanate followed by hydrolysis of the resulting intermediate to yield
XLVI
o NHCO -C-NH-NH-C-0-C Deprotection of XLVI by hydrogenolysis yields Ilrm__^ IPLY1I-^-II-i
I
iir: i ii i' GC240a -34-
XLVII
NH2 N-NH-NH which can be coupled with an activated and optionally protected derivative of a compound of formula XX.to yield upon deprotection a compound of formula XLV.
The nucleophiles of formula V wherein R is 10 O -AI-N -A2- -A-N A is -NH- and A 2 is 1 2 6 1 2
H
a single bond can be prepared by coupling the compound of formula XXXVIII to an activated form of a compound of formula XX (optionally protected) and cleaving the protecting group to yield XLVIII 9 H2N-N N-C-A -I N 2 6 06 H The nucleophiles of formula V wherein R is -A -N _-A 2 and A 2 is -NHcan be prepared by coupling a monoprotected (preferably with t-butoxycarbonyl or benzyloxycarbonyl) derivative of 1,3-diamino-2-imidazolidinone with an activated form of a compound of formula XX (optionally protected) and deprotecting the resulting compound to yield GC240a
XLIX
H2N-N -NH- -A g N
H
Alternatively, a compound of formula XLIX can be formed by nitrosating a protected form of a compound of formula XXIX followed by reduction of the nitroso group and cleavage of the protecting groups.
The nucleophiles of formula V wherein R is 0 0 H -N NA -C-A N is -NH- and A 2 is
-CH
2
-CH
2 -NH- can be prepared by nitrosating a compound of formula XXX (suitably protected) to yield a compound having the formula L 0 O=N-N -N-CH-CH-NH-C-A N 2 2 6 H
H
(suitably protected) and reducing and deprotecting that compound to yield LI 0
H
-HH2N-N N- -CH 2 -NH-C-A6 y The nucleophiles of formula V wherein R is
H
-A -N N-A2 -6A N, A is -NH- and A 2 is 0 -s-NH-NH- can be prepared by nitrosating, reducing and deprotecting a protected derivative of a GC240a -36- Scompound of formula XXXIV. The resulting compound has the formula
LII
H
Y H Alternatively, a compound of formula LII can be prepared by reacting a compound of formula XXXVIII with phosgene to yield LIII 0 Prot-NH-N N-C-C1 which, on reaction with a monoprotected hydrazine in the presence of base, yields 0 15 LIV 0 wo Prot-NH-N N-C-NH-NH-Prot; ooY (The two protecting groups must be different).
00 00 Selective removal of the hydrazide protecting 4 1 20 group yields LV 0 Prot-NH-b -NH-NH SCoupling of a compound of formula LV with an activated optionally protected form of a compound of formula XX, followed by deprotection, yields a compound of formula LII.
The nucleophiles of formula V wherein R is 0 0 H 0 A-N N-A N A is -NH-NH-C- and A is 1 2 6 j 1 2 Y H a single bond can be prepared by reacting a compound of formula XXXVI (preferably a protected derivative thereof) with hydrazine (preferably in monoprotected GC240a -37form) in the presence of a base or with a silylated form of hydrazine or monoprotected hydrazine to yield a protected derivative of
LVI
V -1 S OH
H
2 N-NH- -N 1--A N Y H which can be deprotected using conventional techniques.
Alternatively, a compound of formula XXXV (either a silylated derivative thereof or an anion thereof formed by reaction with a strong base) can be reacted with an activated form of formula XX (suitably protected) and deprotected to yield a 15 compound of formula LVI.
The nucleophiles of formula V wherein R is rr r r Irr r t I ri; r I I -A -N /N-A 1 2 -OH 0 1 is -N-N-I A1 is -NH-NH-C- and A2 is -NH- can be prepared by selective removal of the non-hydrazide protecting group of a compound of formula LIV, followed by coupling with an activated optionally protected compound of formula XX and subsequent deprotection to yield a compound having the formula
LVII
0 OH H2N-NH- -N N-NH-C-A N The nucleophiles of formula V wherein R is -A -N -A
-L
0 is -NH-NH-8- and
A
1 7 liiiiilil r; I-;IUIII~1W'V~-I-
F
GC240a -38- 0 4o oo 0 0 4 U C90 and A 2 is -CH 2
-CH
2 -NH- can be prepared by sequentially reacting a compound of formula XXX (or a protected derivative thereof) with phosgene followed by hydrazine (or a monoprotected derivative thereof) in the presence of a silylating agent such as N-methyl-N-(trimethylsilyl)trifluoroacetamide to yield upon deprotection LVIII 0 0 0 -OH Y H Alternatively, an amino protected derivative of 1-(2-aminoethyl)-2-imidazolidinone (optionally silylated) can be reacted with phosgene, and then 15 with a monoprotected derivative of hydrazine in the presence of a base or a silylating agent N-methyl-N-(trimethylsilyl)trifluoroacetamide or bis(trimethylsilyl)acetamide) to yield a protected derivative of the compound having the formula
LIX
0 H2 N-NH-I-N
-CH
2
-CE
2 -NH2 The groups used to protect the terminal amino groups in a compound of formula LIX should have bee'a chosen so that the protecting group on the aminoethyl group can be selectively removed. The resulting mono-deprotected compound can be coupled with an activated form of an acid of formula XX p.
GC240a -39- (or a protected derivative thereof) to yield (after deprotection) a compound of formula LVIII.
The nucleophiles of formula V wherein R is OH 0 -A A is -NH-NH-- and A 2 S. H is -C-NH-NH- can be prepared by reacting the compound of formula XXXII (optionally as a silylated derivative thereof) with phosgene to yield a protected derivative of the compound having the formula
LX
S 15 0 0 SHN-NH-C N-C-Cl l2 which can be coupled with a protected derivative S' of hydrazine to yield a protected derivative of 2 J LXI 0
H
2 N-NH-C-N N-C-NH-NH 22 The groups used to protect the terminal amino groups in a compound of formula LXI should be chosen so that one of the protecting groups can be selectively removed. The resulting monodeprotected compound can be coupled with an optionally protected activated form of an acid of formula XX to yield (after deprotection) a compound having the formula LXII 0 o 0 o ri -OH H N-NH-C-N L-A-NHNH N 2 H Ii-- GC240a The nucleophiles of formula V wherein R is r^ u J 1 1 un -Al-N N-A 2
-A
6 N can be prepared using the 0A methodology described above for the preparation of the nucleophiles of formula V wherein R is I II OH -A-N N-A 2 -C-A but substituting the 0 A appropriate 2,3-piperazinedione reactants for the 2-imidazolidinone reactants.
The nucleophiles of formula V wherein R is 4 I 15 0
OH
-A1-N -A 5 'N Al is a single bond
H
a single bond can be prepared utilizing protected derivative of the compound LXIII Q and A 5 is a suitably
OH
A compound having the formula LXIV 0
H
O N NH 1 2
H
can be prepared by converting a protected form of the compound having the formula
L.
II u~r- GC240a -41-
LXV
HO 0 N -8-NH-NH 2
H
to a protected form of the compound of formula LXIV by the procedure of K. Heyns et al., Chem. Ber., 87, 1440 (1954), followed by deprotection to yield the compound of formula LXIV, per se.
A compound of formula LXV can be prepared from a suitably protected form of a compound of formula LXIII by conversion to an ester (such as ethyl or methyl), reaction with hydrazine and deprotection. Alternatively, a.suitably protected, activated form of a compound of formula LXIII can be reacted with a monoprotected hydrazine to yield upon deprotection a compound of o formula LXV.
Reaction of the compound of formula LXIV (or a suitably protected derivative thereof) with 2-(chloro- 20 ethyl)isocyanate optionally in the presence of a base (such as triethylamine) or a silylating agent yields upon deprotection the compound having the formula
LXVI
H
Cl-CH 2
-CH
2 -NH-C-NH N
H
Treatment of LXVI (or a suitably protected derivative thereof) with base yields upon deprotection the compound having the formula LXVII 0 HN
N
0 H 1 C r i-L GC240a -42- The nucleophiles of formula V wherein R is 0
OH
-AI IN-A5 N, A 1 is a single bond and A 5 is 1
H
-CH2- can be prepared by reacting the compound having the.formula LXVIII 0 H I
CH
2 NH2
N
H
(or an derivative in which the pyridone is suitably protected and the primary amine is unprotected) with 2-(chloroethyl)isocyanate to obtain the compound having upon deprotection the formula LXIX 0
H
S' C1-CH 2 -CH2-N- -NH-CH 2
N
H
i Treatment of LXIX (or a suitably protected derivative thereof) with base yields the compound having the formula LXX 0
OH
HN N-CH N 2 A compound of formula LXVIII can be prepared from a compound of formula XXVIII (suitably protected) by treatment with azide, reduction of the azide, and deprotection.
L i.
GC240a -43- The nucleophiles of formula V wherein R is
-A
1 N-A N A 1 is a single bond and A 5 is 1 5 1 5
H
-N=CH- or -NH-CH 2 can be prepared by condensing l-amino-2-imidazolidinone with the aldehyde having the formula XXIII (optionally protected) to yield (after deprotection) the compound having the formula
LXXI
II H HN N-N=CH N Y H Reduction of the compound of formula LXXI (optionally protected) by catalytic hydrogenation or using sodium cyanoborohydride yields the compound having the formula
LXXII
OH
HN N-NH-CH 2 H The nucleophiles of formula V wherein R is 0
OH
-A1-N -A 5 A is a single bond and A 5 is Y H -C-NH-(CH2) q can be prepared by reacting l-chloro- S GC240a -44carbonyl-2-imidazolidinone with a compound having the formula LXXIII 0
OH
H
2
N-(CH
2 q- (or a suitably protected derivative thereof) in the presence of a base, or with a silylated derivative of a compound of formula LXXIII, to yield following deprotection the compound having the formula
LXXIV
OH
HN N-C-NH-( CH 2
N
H
The nucleophiles of formula V wherein R is
OH
'N-A N and A 1 is -NHC- can be prepared
H
by reacting a suitably protected derivative of a compound of formula LXVII, LXX, LXXI, LXXII or LXXIV with phosgene to yield a protected derivative of 25 LXXV 1 C-C-N N-A5 N
H
which can be reacted with hexamethylsilazane to yield upon deprotection and hydrolysis LXXVI 0
H
H5 A, ns -A n N Alternatively, nucleophiles of formula V ii 11~ 1-11111__:1 _i I. GC240a
OH
wherein R is A -N N-A 5 Nand A is -NHC- 1 a can be prepared by reacting a suitably protected derivative of a compound of formula LXVII, LXX, LXXI, LXXII-, or LXXIV with chlorosulfonyl isocyanate to yield upon hydrolysis and deprotection a compound of formula LXXVI.
The nucleophiles of formula V wherein R is
OH
-A -N N-A- N and A is -NH- can be prepared by nitrosating a suitably protected derivative of a compound of formula LXVII, LXX, LXXI, LXXII or LXXIV (with, for example, nitrous acid), reducing .OI the resulting compound (using, for example, zinc o 0.
oo o° under acidic conditions) and deprotecting to yield 20 LXXV I o 1OH B 0O 0
H
2 N-N N-A 5
N
o 5 H Alternatively, the compounds of formula S 25 0 LXXVII wherein A is NH-(CH 2 can be prepared by reacting a compound of formula XXXIX with a optionally protected form of a compound of formula S° LXIV or LXVIII in the presence of base or a silylating agent to yield upon deproteciion O LXXVIII SH0 OH S"
H
2 N-NN- NH-(CH 2 2 q GC240a -46- Alternatively, those compounds of formula LXXVII wherein A is -N=CH- or -NH-CH can be 5 2 prepared by reacting monoprotected 1,3-diamino-2imidazolidinone with a compound of formula XXIII (or a protected derivative thereof) and deprotecting the product to yield the derivative of formula LXXVII wherein A is Reduction of that derivative yields the compound of formula LXXVII wherein A5 is -NH-CH 2 The nucleophiles of formula V wherein R is
S-H
-N -A N and A is -NH-NH-C- can be 1 5 N a
H
prepared by reacting a compound of formula LXXV (suitably protected) with a monoprotected hydrazine in the presence of a base or a silylating agent.
The products, after deprotection, have the formula
LXXIX
H
H2N-NH-C-N N-A N 25 The nucleophiles of formula V wherein R is
H
-A -N N-A N, A is a single bond and A is 1 5 a single bond or -CH 2 can be prepared by reacting a compound having the formula LXIV or LXVIII (or a suitably protected derivative thereof) with aziridine or an activated aziridine (activated with such groups as acyl or sulfonyl) to yield upon deprotection
I
GC240a -47- LXXX 0
H
2
N-CH
2
-CH
2
-NH(CH
2 0
H
A compound of formula LXXX (or a suitably protected derivative thereof) can be converted to the desired piperazinedione having the formula LXXX I
H
HN N-(CH by reaction with a dialkyl oxalate (and subsequent deprotection if necessary).
The nucleophiles of formula V wherein R is
H
-A -N N-A N, A 1 is a single bond and A is 0 9 o1 4 -N=CH- or -NHCH 2 can be prepared using the o0,> 20 methodology described above for the preparation of the nucleophiles of formula V wherein R is II i
-A-N-AA'NN-A
5 f, A 1 is a single bond and A5 is 4 25 u H -N=CH- or -NHCH 2 but substituting l-amino-2,3piperazinedione for l-amino-2-imidazolidinone. The resulting compounds would have the formulas
LXXXII
OH
H. HN N-N=CH N and O H i F- GC240a -48-
LXXXIII
HN N-NH-CH N The nucleophiles of formula V wherein R is -A -N N-A--5 A 1 is a single bond and A 5 is g
-NH-(CH
2 q can be prepared by reacting an optionally protected derivative of
LXXXIV
HN N--Cl with a compound of formula LXXIII (or a suitably protected derivative thereof) in the presence of a 20 base or a silylating agent. The resulting intermediate can be deprotected to yield
LXXXV
0 OH HN N--NH-(CH 2
N
2 q I
H
The nucleophiles of formula V wherein R is
OH
-A -N N-A- N and A I is -NH- can be prepared 3 0 H by nitrosation of a protected derivative of a compound having the formula LXXXI, LXXXII, SLXXXIII or LXXXV (with, for example, nitrous acid), reducing the resulting compound (using, for iL7 i- -p-rw~-rr~w*r-3~rrc,; GC240a -49o 4I 44 44 0 4 4 4 4 *n *4 1L §1 example, zinc under acidic conditions) and deprotecting to yield
LXXXVI
H N-N N-A N 0 Alternatively, those compounds of formula LXXXVI wherein A 5 is -N=CH- or -NH-CH 2 can be prepared by reacting monoprotected, 1,4-diamino- 2,3-piperazinedione with a compound of formula XXIII (or a protected derivative thereof) and deprotecting the product to yield a compound of formula LXXXVI, wherein A 5 is -N=CH- which can then be reduced to a compound of formula LXXXVI wherein
A
5 is -NH-CH2-. Alternatively, reduction of -N=CH- can precede deprotection.
The nucleophiles of formula V wherein R is OH' 0 20 -A -N N-A N and A is -NH-NH-- can be
H
prepared by reacting a suitably protected derivative of a compound of formula LXXXI, LXXXII, LXXXIII, or LXXXV with phosgene to yield
LXXXVII
0
OH
Cl-a-N N-Ag N which can be reacted with hexamethyldisilazane to yield upon deprotection a~l hydrolysis
LXXXVIII
I
OH
H2N-C-N N-A N 2 5
L.
GC240a Alternatively, the nucleophiles of formula V IH 0 wherein R is -A -N N-A' and A is -NH can 1 5 H 1 -0 H be prepared by reacting a suitably protected derivative .of a compound of formula LXXXI, LXXXII, LXXXIII, or LXXXV with chlorosulfonyl isocyanate to yield a compound of formula LXXXVIII upon hydrolysis and deprotection.
The nucleophiles of formula V wherein R is 0
H
-NH-A
3 N and A 3 is -(CH 2 )p-have been described;
H
see formula LXIV and LXVIII.
The nucleophiles of formula V wherein R is S4 0 9 I H 0 0 -NH-A N and A is -NH-C-NH- or -NH- -NH-CH- 3 3 2
H
can be prepared by reacting a compound of formula XXXI with a compound of formula LXIV or LXVIII (optionally protected) in the presence of base or 25 a silylating agent, followed by removal of any protecting groups.
Alternatively, nucleophiles of formula V H 0 wherein R is -NH-A3 and A 3 is -NH-C-NH- or 0 -NH- -NH-CH2- can be prepared from a suitably protected form of a compound of formula LXIV or LXVIII by reaction with phosgene followed by treatment with a monoprotected derivative of i GC240a -51hydrazine in the presence of base or a silylating agent and deprotection.
The nucleophiles of formula V wherein R is
H
-NH-A
3 nd A 3 is -CH 2 -NH- or -CH2-CO-NH-CH 2
H
can be prepared by coupling an activated N-protected glycine derivative with a compound of formula LXIV or LXVIII (optionally protected) followed by deprotection.
The nucleophiles of formula V wherein R is
H
-NH-A- and A 3 is -NH-CH 2 can be prepared by
H
reacting an optionally protected derivative of the aldehyde of formula XXIII with hydrazine or monoprotected hydrazine followed by reduction of the carbon-nitrogen double bond and subsequent deprotection.
Alternatively, a monoprotected hydrazine may be monoalkylated on the free amino group with a compound of formula XXVIII (suitably protected) followed by deprotection to give a nucleophile of 1
H
-formula V wherein R is -NH-A 3 N and A 3 is
H
-NH-CH
2 The nucleophiles of formula V wherein R is
OH
-NH-A
3 N and A is -O-CII 2 can be prepared by 3 1 3 2
H
reacting a suitably protected derivative of the it GC240a -52i compound of formula XXII with N-hydroxyphthalimide under Mitsunobu conditions (presence of triphenylphosphine and diethylazodicarboxylate) to yield a protected derivative of the compound LXXXIX 0 Q HI
H
O
N CH2-0-.4
H
which can be deprotected to the compound
XC
0
HO
CH 2-0-NH2
H
Alternatively, the compound of formula XC can be prepared by reacting a compound of formula XXVIII (suitably protected) with N-hydroxyphthalimide in the presence of a base.
The nucleophiles of formula V wherein R is 0 0 OH
-NH-A
4 -Nand A 4 is -NH- can be prepared by P reacting a monoprotected hydrazine with an activated, optionally protected derivative of an acid. of formula XX to obtain, after deprotection, a compound of the formula
XCI
NHi 2 -NH- c-A N
H
Alternatively, the compounds o. formula XCI can be prepared by reacting a carboxylic r- i -li-i C-i i- PIC- I~ GC240a -53acid ester of a suitably protected derivative of a compound of formula XX with hydrazine and then deprotecting.
The nucleophiles of formula V wherein R is -NH-A4-C-A6 N and A4 is -(CH2) p and p is 0
H
can be prepared by reacting ammonia or hexamethyldisilizane with an activated, optionally protected derivative of an acid of formula XX to obtain, after deprotection, a compound having the formula XCII 0 0 OH
NH
2
-C-A
6 The nucleophiles of formula V wherein R is a o C, 91 H o, o, 20 -NH-A 4 -A Nand A is -(CH2) and p is 1 can be
SH
o prepared by treatment of a suitably protected
S
a activated derivative of a compound of formula XX with diazomethane followed by hydrochloric acid to o a 25 yield a protected derivative of a compound having 01 o a the formula
H
ou wherein "Lb is chlorine. A compound of formula XCIII wherein Lb is chlorine can then be treated 0 with an iodide or bromide salt (such as sodium iodide or lithium bromide) to give a protected derivative of a compound of formula XCIII wherein Lb is bromine or iodine. Displacement of the ;ir C C GC240a -54leaving group "Lb" (wherein Lb is chlorine, bromine or iodine) with azide followed by reduction and deprotection yields
XCIV
OH
NH -C H--C-A N 2 2 6 i
S
H
The nucleophile of formula V wherein R is 0 H
-NH-A
4 -C-A Nand A is -(CH 2 -NH- can be prepared by reacting a (optionally monoprotected) compound of formula
XCV
NH -(CH 2 )y-NH with an activated, optionally protected derivative of an acid of formula XX to obtain, after deprotection, a compound having the formula
XCVI
NH2-(CH 2 )y-NH-C-A 6
H
The nucleophiles of formula V wherein R is 0 H 0
-NH-A--A-
6 N and A 4 is -NH- -NH-NH- can be 4 6 4 prepared by reacting a compound of formula XCI (suitably protected) with a compound having the formula XCVII 0 Prot-NH-NH-8-Cl in the presence of a silylating agent and then removing the protecting groups.
L GC240a The nucleophiles of formula V wherein R is 0 H -NH-A N and A is -C-NH-NH- can be 4 6 4
H
prepared by reacting NH 2 NH-NH2 (in the presence i1 of a base or a silylating agent) with an activated, optionally protected derivative of formula XX to obtain, after deprotection, a compound having the formula
XCVIII
0 0 OH NH -NH-NH- -A6- N 2 6 The nucleophile of formula V wherein R is 0 0 0H H2X -NH-A 4-C-A6 N and A 4 is can be prepared
H
by reacting an optionally protected hydrazine derivative of the formula
XCIX
NH2-NH-CH 2
-X
with an activated, optionally protected derivative of an acid of formula XX to obtain, after deprotection, a compound having the formula
C
C CH^X OH NH2- N 0 H Alternatively, compounds of formula C wherein X is hydrogen can be prepared by reacting methylhydrazine with a carbbxylic ester derivative of the acid of formula XX (or a suitably protected derivative thereof).
Wl GC240a -56- The compounds of formula I wherein R is -0 O H -A-N -A 2
-A
6 are preferred. Most preferred are those compounds of formula I wherein R is cj OH -N -NH- N Also preferred are those H 0 compounds of formula I wherein R is -C-C=N-O-R.
1
R
and R is 2-amino-4-thiazolyl and R. is methyl, ethyl, carboxymethyl, 1-carboxy-l-methylethyl, CH -(CH 1 l-carboxy-l-ethyl or -C-COOH, wherein s is 1, 2 or i 3. The use of these preferred R' acyl groups I yields a product which exists as the syn or anti isomer or as a mixture of isomers. The syn isomer exhibits greater activity than the anti isomer.
The following examples are specific embodiments of this invention.
GC240a -57- Example 1 [[[-(2-Amino-4-thiazolyl)-2-[[i-[[[[3- [[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) 2-(Hydroxymethyl)-5-(phenylmethoxy)-4Hpyran-4-one 69 g (3 mol) of sodium were dissolved in 5 1 of methanol. Subsequently 425.3 g (3 mol) of 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one was added and stirred at 30 0 C until a clear solution was obtained. 595 g (3.5 mol) of benzyl bromide was then added and stirred for 1 hour o °under reflux. The warm and very dark colored A solution was poured into 15 1 of ice water. The product crystallized immediately. The crystals were collected and washed first with 8 1 of water and then twice with 2.5 1 of ether. The product was left to stand overnight and finally dried at 0 C for 16 hrs. Yield: 646 g 92.6%.
I 25 B) 4-Oxo-5-(phenylmethoxy)-4H-pyran-2-carboxylic acid 232 g (1 mol) of methoxy)-4H-pyran-4-one were put into a 10 1 stirring flask containing 6.61 of acetone and 400 ml of water. The clear solution was cooled to by means of an ice-bath. While maintaining the temperature at +50 to 10 0 C, 640 ml of Jones Reagent (202 g CrO 3 600 ml water, 174 ml H2SO4) was added dropwise over a period of 1 hr. Stirring was continued for 2 hours without cooling. The L i.Liiiii iii :i GC240a -58reaction mixture was filtered through a glass frit and the dark-green residue washed with 500 ml of acetone. The filtrate was then evaporated until all of the acetone was removed. To the aqueous, partly crystalline product was added 1.2 1 of methanol, and this mixture was then heated to its boiling point. The resulting clear dark-green solution was placed in an ice-bath and the product allowed to crystallize. The crystalline product was filtered and washed with 500 ml of a cold solvent mixture consisting of 250 ml methanol 250 ml water and finally dried. Yield: 195 g 79%. From the mother liquor a further 5% of the product could be isolated.
C) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid 300 g (1.22 mol) of 4H-pyran-2-carboxylic acid was put into a flask and 20 5 1 of 33% NH 4 OH was carefully added with stirring.
The reaction mixture was then stirred under reflux.
After 3 hours, one additional liter of 33% NH 4
OH
was added slowly. Stirring was continued for further 2 hours under reflux. The reaction solution was then evaporated until the product 4 crystallized. The product was transferred back into the reaction flask and water added until a clear solution was obtained (approximately 5 1, pH 6.38). This solution was stirred vigorously while concentrated hydrochloric acid was added dripwise until a pH of 3 was obtained. The precipitated white product was removed by filtration, thoroughly washed with water and dried. Yield: 273 g (1.12 mol) 91.8%.
A
'i I i ir ;l_~l;li GC240a -59- D) 1,4-Dihydro-4-oxo-N-(2-oxo-l-imidazolidinyl)- 5-(phenylmethoxy)-2-pyridinecarboxamide 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid (12.26 g, 0.05 mol) and l-amino-2-imidazolidinone (5.56 g, 0.055 mol) were suspended in 120 ml of dimethylformamide. To the suspension was added 0.3 g of dimethylaminopyridine and 0.4 g of N-hydroxybenzotriazole. After stirring for 30 minutes at room temperature, a solution of 11.35 g of dicyclohexylcarbodiimide (0.055 mol) in ml of dimethylformamide was added dropwise and the mixture was stirred overnight at room temperature.
The precipitate (dicyclohexylurea) was filtered off and the filtrate evaporated in vacuo. The remaining syrup crystallized on treatment with aqueous sodium bicarbonate, yielding 11.7 g of the -title compound, melting point 158-160 0 C. An additional crop of 0.8 g of product, melting point 162-164 0 C, crystallized from the aqueous filtrate.
E) 1,4-Dihydro-5-hydroxy-4-oxo-N-(2-oxo-limiidazolidinyl)-2-pyridinecarboxamide To a suspension of 12 g (0.0365 mol) of 1,4-dihydro-4-oxo-N-(2-oxo-l-imidazolidinyl)-5- (phenylmethoxy)-2-pyridinecarboxamide in 150 ml of acetonitrile was added 36.1 ml (0.146 mol) of bis(trimethylsilyl)acetamide to form a slightly turbid solution. After filtration, 6 g of palladium on charcoal was added and hydrogen was passed through the stirred reaction mixture. After hydrogenation for 60 minutes, the catalyst was filtered off and 15 ml of methanol and 2 ml of acetic acid were added. Stirring was continued overnight; the title compound crystallized out, yielding 6.6 g, melting point 270-275 0
C.
GC240a F) (3S)-[1-[[[[3-[[(l,4-Dihydro-5-hydroxy-4-oxo- 2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester To a suspension of 13.8 g of [[(phenylmethoxy)carbonyl]amino]-2-azetidinone in 500 ml of ethyl acetate was added 5.63 ml (0.0626 mol) of chlorosulfonyl isocyanate. The mixture was stirred for 1 hour at room temperature to form a solution of (S)-l-[[(chlorosulfonyl)amino]carbonyl]-3-[[(phenylmethoxy)carbonyl]amino]-2azetidinone. The solution was cooled to 0°C, at which temperature a solution of silylated 1,4dihydro-5-hydroxy-4-oxo-N-(2-oxo-l-imidazolidinyl)- 2-pyridinecarboxamide (prepared from a suspension of 14.9 g (0.0626 mol) of 1,4-dihydro-5-hydroxy- 0, d 4-oxo-N-(2-oxo-l-imidazolidinyl)-2-pyridinecarboxamide in 500 ml of ethyl acetate by the addition of 46.4 ml of N-methyl-N-(trimethylsilyl)trifluoroacetamide (0.25 mol) and stirring for minutes) was added slowly. Then 150 ml of dichloromethane was added, and the mixture was stirred at room temperature overnight. To the clear solution was added 26.2 ml of triethylamine (0.188 mol), 25 followed by 300 g of ice and 200 ml of water. The pH was 6.5. After stirring for 1 hours, the two phases were separated and the aqueous phase was S washed with three 200 ml portions of ethyl acetate.
After removal of residual ethyl acetate in vacuo, the pH of the aqueous phase was adjusted to 2 by the slow addition of 2 N hydrochloric acid (47 ml) with cooling. The crystals were filtered off, suspended in 200 ml of ethyl acetate and stirred for one hour. Then the crystals were filtered off, washed twice with 30 ml of ethyl acetate and twice with 50 ml of petroleum ether and dried in vacuo,
L
GC24Oa -61to yield 28.6 g of the title compound, melting *1 point 190-200'C, dec.
4 4 441 o 4 a'- G) (3S)-3-Axnino-N-.[3-[[(,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]amino]-.2-oxo-l-imidazolidinyl]sulfonyl] -2-oxo-l-azetidinecarboxamide, trifluoroacetate salt* At room temperature, 4 g (0.00713 mol) of (3S ,4-dihydro-.5-hydroxy-4-oxo-2pyridinyl)carbonyllaminojl-2-oxo-l--imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester was added to a mixture of 15 ml of trifluoroacetic acid and 3.5 ml of thioanisole at 10 0 C. The clear solution was stirred overnight at 10'C. After evaporation in vacuo at room temperature, the remaining syrup was treated with ether to yield the title compound as a yellowish solid. The yield was almost quantitative.
H) [3S(Z)]-2-fjI[-(2-Amino-4-thiazolyl)-2-[[l- ,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) carbonyl] amino] -2-oxo-l-imidazolidinyl] sulfonyl] amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene] amino] oxy] -2-methylpropanoic acid, diphenylmethyl ester To a solution of 3.08 g (0.007 mol) of (Z)-2-amino-u-[[2-(diphenylmethoxy)-l,1-dimethyl- 2-oxoethoxy]imino]-4-thiazoleacetic acid in 70 ml of dimethylformamide was added 2.9 ml (0.021 mol) of triethylamine followed, after cooling to under nitrogen, by 1.55 ml (0.007 mol) of diphenyl chiorophosphate. The mixture was stirred for 1 hour at -30'C. Then 1.95 ml of triethylamine (0.014 mol) was added followed by
V
GC240a -62- 0.007 mol of (3S)-3-amino-N-[[3-[[(1,4-dihydro- 5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2oxo-l-imidazolidinyl]sulfonyl]-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt. The reaction mixture was stirred at -10 0 C for 2 hours and at O'C for 1 hour. Then the solvent was removed in vacuo. Treatment of the residue with water and ethyl acetate yielded an insoluble product which solidified on treatment with ether yielding 8.0 g of crude compound.
I) [3S(Z)]-2-[[[-(2-Amino-4-thiazolyl)-2-[[l- [[[[3-[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]- 2 -oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt Crude 3 S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2- [[1-[[[[3-[[(1,4-dihydro-5-hydroxy-4-oxo-2- 20 pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]- A 4t sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino oxy]-2-methylpropanoic acid, diphenylmethyl ester (8 g) was suspended in ml of anisole. After cooling to -10 0 C, 80 ml of trifluoroacetic acid was added dropwise and the mixture was stirred at -10 0 C for 1 hour. The addition of ether at 0 0 C precipitated the trifluoroacetate salt of the free acid of the product (4.1 g of crude material). The crude material was suspended in water; the pH was adjusted to 5.5 by the addition of sodium bicarbonate solution and the solution formed was freeze dried. The crude sodium salt was then purified by chromatography on The product was eluted with water, A macroreticular styrene-divinylbenzene copolymer resin sold by Mitsubishi Chemical Industries Ltd.
r GC240a -63yielding 0.52 g of product.
NMR (DMSOd 6 6 1.35 3H); 1.40 3H), 3.37 (dd, 1H); 3.47 2H); 3.81 2H dd, 1H); 5.05 1H); 6.75 1H); 7.27 1H); 7.72 (s, 1H); 11.52 (broad s, 1H).
Example 2 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 2-[(l,l-dimethylethoxy)carbonyl]hydrazide roo 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid (61.3 g, 0.25 mol) was suspended in 500 ml of dimethylformamide at room temperature, followed by the addition of 39.65 g SO (0.3 mol) of N-(t-butoxycarbonyl)hydrazine, 1.5 g of dimethylaminopyridine and 2.0 g of N-hydroxybenzotriazole, and the mixture was stirred for minutes at room temperature. Then, 57.7 g (0.28 mol) of dicyclohexylcarbodiimide, dissolved in 100 ml of dimethylformamide, was added dropwise with stirring over 30 minutes, and the mixture was stirred at room temperature overnight. The precipitate (dicyclohexylurea) was filtered off and the filtrate evaporated in vacuo. The remaining syrup crystallized on treatment with diluted sodium bicarbonate solution. The dried crude product was recrystallized from 2 liters of ethyl acetate to yield 69.5 g of the title compound, melting point 173-175 0
C.
A second crop was obtained after evaporation of the mother liquor; 3.2 g, melting point 160-165 0
C.
4 GC240a J-64- B) 1,4-Dihydro-5-hydroxy-4-oxo-2-pyridinecarboxylic acid, hydrazide 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid, 2-[(1,1-dimethylethoxy)carbonyl]hydrazide (69 g, 0.191 mol) was added at 0°C to 370 ml of trifluoroacetic acid. The mixture was stirred for 1 hour at room temperature, then evaporated. The remaining syrup was treated with ether to yield 68.2 g of crude 1,4-dihydro-4-oxo-5- (phenylmethoxy)-2-pyridinecarboxylic acid, hydrazide, trifluoroacetate salt as a solid.
The crude 1,4-dihydro-4-oxo-5-(phenylmethoxy)- 2-pyridinecarboxylic acid, hydrazide, trifluoroacetate salt was dissolved in 250 ml of acetonitrile and stirred with cooling for 1 hour.
The crystals were then filtered off and resuspended in 600 ml of acetonitrile. Bis(trimethylsilyl)acetamide (135 ml) was added followed by 28 g of palladium on charcoal. Then hydrogen was 20 passed through the stirred solution. The hydrogenation was complete after 90 minutes. After filtration, 70 ml of methanol and 2 ml of acetic acid were added. After stirring overnight, the Scrystals formed were filtered off, yielding 19.4 g of the title compound, melting point 290-340 0
C,
dec.
C) (3S)-[l-[[[[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo..3- azetidinyl]carbamic acid, phenylmethvl ester To a suspension of 5.19 g (0.0236 mol) of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2azetidinone in 160 ml of ethyl acetate was added with stirring at room temperature 2.05 g (0.0236 mol) of chlorosulfonyl isocyanate. The u;uui~w ;u*rar -ii GC240a mixture was stirred for 1 hour at room temperature to form a solution of (S)-l-[[(chlorosulfonyl)amino]carbonyl]-3-[[(phenylmethoxy)carbonyl]amino]- 2-azetidinone. The solution was cooled to 0°C, 80 ml of dichloromethane was added followed by 9.9 ml (0.0707 mol) of triethylamine and a solution of silylated 1,4-dihydro-5-hydroxy-4oxo-2-pyridinecarboxylic acid, hydrazide (obtained from a suspension of 3.99 g (0.0236 mol) of 1,4-dihydro-5-hydroxy-4-oxo-2-pyridinecarboxylic acid, hydrazide in 50 ml of ethyl acetate and 8.75 ml of N-methyl-N-(trimethylsilyl)trifluoroacetamide (8.75 ml 0.0472 mol)). The mixture was stirred at room temperature overnight, then ice water was added and stirring was continued for an additional 30 minutes. The aqueous phase was layered with ethyl acetate and acidified to pH The precipitate crystallized after stirring for one Shour, yielding 6.6 g of the title compound.
Evaporation of the ethyl acetate phase and treatment with petroleum ether yielded a second crop of 1.4 g of the title compound.
D) (3S)-3-Amino-N-[[2-[(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]-2oxo-l-azetidinecarboxamide, trifluoroacetate (1:2) salt (3S)-[1-[[[[[[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (6.6 g, 0.0133 mol) was added to a stirred mixture of 22 ml of trifluoroacetic acid and 5.3 ml of thioanisole at room temperature and stirred overnight at room temperature. The trifluoroacetic acid was removed in vacuo and the
L
I
-66- G2O remaining syrup treated with ether to yield the title compound in quantitative yield.
E) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- [(l,4-dihydro-5-hydroxy-4-oxo-2-pyriainyl)carbonyl].
hydrazino]sulfonyl]amino~carbonyl]-2-oxo-3-azetidinyl]> amino] -2-oxoethylidene] amino] oxy] -2-methylpropanoic acid, diphenylmethvl ester To a solution of 5.84 g (0.0133 mol) of (Z)-2-amino-cu-[[2-(diphenylmethoxy)-1,1-dimethylof dimethylformamide was added 5.6 ml of triethylamine and (after cooling to -30 0 C) 3.57 g (0.0133 mol) of diphenyl chlorophosphate. The mixture was stirred for 1 hour at -30 0 C, then 3.72 ml of triethylamine was added, followed by 0.0133 mol of (3S)-3-amino-N-[[2-[(l,4-dihydro- 5-hydroxy-4-oxo-2-pyridinyl )carbonyl]hydrazino] sulfonyl] -2-oxo-l-azetidinecarboxamide, trifluoroacetate salt The mixture was stirred at -100C for 2 hours and at 0 0 C for 1 hour, the solvent was removed in vacuo and the remaining syrup was treated with 150 ml of ethyl acetate and 70 ml of ice water, which was adjusted to pH 1.5-2 by the addition of 2N hydrochloric acid. The insoluble material was removed and triturated with ether to yield 5.3 g of crude product.
F) [3S(Z)]-2-[[fl-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- ,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl )carbonyl] hydrazino] sulfonyl] amino] carbonyl] -2-oxo-3-azetidinyl] amino] -2-oxoethylidene] amino] oxy] -2-methylpropanoic acid, disodium. salt [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- 4-dihydro-5-Iiydroxy-4-oxo-2-pyriiinyl )carbonyl] hydrazino],--ulfonyl] amino]carbonyl]-2-oxo-3-azetidinyl]amino] -2-oy~oethylidene] amino] oxy] -2-methylpropanoic acid, diphenylmethyl ester (5.3 g, 0.0069 .mol) was GC24Oa -67suspended in 10.6 ml of anisole. The suspension was cooled to -10'C and 53 ml of trifluoroacetic acid was added with stirring. The mixture was stirred at t~his temperature for 1 hour, then 200 ml of ether was added at -10'C to precipitate the trifluoroacetic acid salt of the free acid of the title compound; 'the yield was 7.3 g.
The crude material was dissolved in a mixture of 100 ml of water and 50 ml of acetone.
The pH was adjusted to 5 5.5 and the acetone was removed in vacuo. The remaining aqueous solution was lyophilized to yield 8.1 g of crude product, which was purified by HP-20 chromatography, eluting with water. The chromatography yielded 1.05 g of product.
NMR (DMSOd 6 6 1.40 3H); 1.42 3H); 3.25 (dd, 1H); 3.70 (dd, 1H); 5.10 (in, 1H); 6.75 (s, 1H); 7.40 1H); 7.80 1H); 11.32 (broad s, o 1H).
0 1 Example 3 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[1- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl] amino] -2-oxo-l-imidizolidinyl] sulfonyl] amino]carbonyl]-2-oxo-3-azetidinyl]amino1-2-oxoethylidenelaminoloxyl-2-acetic acid, disodium salt A) 3 S(Z)1-2-[[[l-(2-Amino-4-tLhiazolyl)-2-[[l- [[[[3-[[(1,4--dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-1-imidizolidinyl]sulfonyl]amino] carbonyl] -2-oxo-3-azetidinyl] amino] -2-oxoethylidene] amino] oxy] -2-acetic acid, diphenyl- 4 t methyl ester To a solution of 2.06 g (0.005 mol) of (Z)-2-amino-u-[ [2-(diphenylmethoxy)-2-oxoethoxy]imino]-4-thiazole-'cetic acid in 100 ml of dimethyl- GC240a Ol -68formamide was added 2.1 ml (0.015 mol) of trib ethylamine. The mixture was cooled to -30 0 C and 1.1 ml of diphenyl chlorophosphate (0.005 mol) was added with stirring. After stirring for 1 hour at -300C, an additional 1.4 ml of triethylamine (0.1 mol) was added at -300C, followed by 2.7 g of (3S)-3-amino-N-[[3-[[(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt.
The reaction mixture was stirred at -10 0
C
for 2 hours and at 0 0 C for 1 hour. The solvent was evaporated off in vacuo, the oily residue U suspended in water and the pH of the suspension adjusted to 2 by the addition of 2N hydrochloric acid. The suspension was stirred for 30 minutes at room temperature, filtered off, the solid resuspended in water and filtered off again.
After drying in vacuo over phosphorous pentoxide, 5.0 g of crude product were obtained. The material was used in the next step without further purification.
B) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[3-[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidizolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethyv:lidene]aminoloxyl-2-acetic acid, disodium salt g of crude thiazolyl)-2-[[1-[[[[3-[[(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidizolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]aminol-2-oxoethylidene]amino]oxy]-2-acetic acid, diphenylmethyl ester were suspended at -100C in a mixture of 10 ml of anisole and 50 ml of trifluoroacetic acid. The reaction mixture was stirred at -100C for 1 hour, followed by the careful addition i f GC240a -69of 100 ml of ether to precipitate the crude trifluoroacetate salt of the title compound. Yield 3.7 g. The crude material was dissolved in a mixture of 30 ml of water and 60 ml of acetone, and the pH of the mixture was adjusted to 5 by the addition of 0.1 N sodium hydroxide. The acetone was evaporated and the aqueous phase was lyophilized to yield 3.9 g of crude product. The crude material was purified by chromatography on HP-20. The product was eluted with water (fractions of 10 ml each). The fractions containing product were lyophilized to yield 0.6 g of material which was rechromatographed on HP-20 to yield 0.25 g of pure product.
Example 4 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid A) 2-(Hydroxymethyl)-5-(phenylmethoxy)-4(1H)pyridinone A mixture of methoxy)-4H-pyran-4-one (9.65 g, 41.59 mole), ml of concentrated ammonia and 20 ml of ethanol were heated at reflux overnight. An additional ml of ammonium hydroxide was added, the mixture was refluxed for 2 hours and cooled. The resulting brown solid was filtered and washed with water until the washings were neutral. The crude product was suspended in ethanol, filtered, washed with ethanol and hexane and dried in vacuo. The yield of the title compound was 7.61 g.
L7, GC240a B) 2-(Chloromethyl)-5-(phenylmethoxy)-4(lH)pyridinone, monohydrochloride A suspension of methoxy)-4(1H)-pyridinone (3 g, 12.99 mmole) in chloroform (15 ml) was cooled to 0° under argon and treated with thionyl chloride (6.1 ml, 83.62 mmole). Within several minutes, a homogeneous solution was obtained. After stirring an additional 5 minutes, a cream colored solid precipitated. The cooling bath was removed and the mixture was heated at reflux for 45 minutes.
The mixture was cooled to 00 and the white precipitate was filtered, washed with chloroform and hexane and dried in vacuo. The yield of the title compound was 3.65 g.
1 C) 2-(Azidomethyl)-5-(phenylmethoxy)-4(lH)j pyridinone A mixture of methoxy)-4(1H)-pyridinone, monohydrochloride (3.59 g, 12.54 mmole), sodium azide (4.08 g, 62.7 mmole) and diisopropylethylamine (2.19 ml, 12.54 mmole) in 70 ml of dimethylformamide was stirred at room temperature under argon for days. An additional 4.08 g of sodium azide was added and the mixture was heated at 45-500C for 2 hours. After cooling, the reaction mixture was poured into 500 ml of water, producing an insoluble white solid. The pH of the supernatant liquid was lowered from 8.5 to 7.5 with dilute hydrochloric acid, and the white solid was filtered. After washing with water, acetone, and hexane the solid was dried in vacuo. The yield of the title S. compound was 2.81 g.
GC240a -71- D) 2-(Aminomethyl)-4-(phenylmethoxy)-4(1H)pyridinone A mixture of methoxy)-4(lH)-pyridinone (2.03 g, 7.93 mmol) and platinum oxide (200 mg) in 100 ml of dimethylformamide was stirred for 6 hours at room temperature under one atmosphere of hydrogen. The catalyst was removed by filtration and the solution was concentrated in vacuo to afford 1.5 g (82% yield) of the title compound as a grey powder.
E) (3S)-[l-[[[[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinyl]methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester To a stirred suspension of 2-(,ainomethyl)- 5-(phenylmethoxy)-4(lH)-pyridinone (2.330 g, 10.13 mmole) in 60 ml ethyl acetate was added N-methyl-N-(trimethylsilyl)trifluoroacetamide *a4 (3.76 ml, 20.26 mmole). The resulting solution was stirred for 30 minutes at room temperature and Sthen cooled to O0C. Concurrently, to a stirred Sm ysuspension of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone (2.228 g, 10.13 mmole) in 60 ml ethyl acetate was added chlorosulfonyl isocyanate (882 pi, 10.13 mmol). The resulting solution was stirred for 30 minutes at room temperature, cooled to 0 0 C, and finally treated with triethylamine S(4.23 ml, 30.39 mmole) followed by the solution of silylated 2-(aminomethyl)-5-(phenylmethoxy)-4(lH pyridinone described above. The mixture was stirred for two days at room temperature.
4( The mixture was concentrated in vacuo, the Sresidue dissolved in CH 3 CN-water (40-60) and the pH lowered to 2.9 whereupon a thick oil separated.
Upon cooling to 50C, the oil solidified. The GC240a -72solid was separated, washed four times with water, and dried in vacuo to afford 3.4 g crude product.
The crude product was dissolved in a minimum volume of dimethylformamide and loaded on a column (1 1) of HP-20 resin. The column was eluted with a stepwide acetone-water gradient. Desired material eluted with ca. 65% acetone. The relevant fractions were combined and lyophilized to afford 2.69 g of the title compound.
F) [3S(Z)]-2-[[[-(2-Amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid. diphenylmethyl ester (as a mixture of monopotassium and monotriethylammonium salts) A mixture of (3S)-[1-[[[[[1,4-dihydro-4oxo-5-(phenylmethoxy)-2-pyridinyl]methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (912 mg, 1.64 mmole), p-toluenesulfonic acid monohydrate (625 mg, 3.28 mmole), and 10% palladium on charcoal (190 mg) in 16 ml of dimethylformamide was stirred under one atmosphere of hydrogen until 3.28 mmole (73 ml) of hydrogen was consumed (ca. 3 hours).
4 To a stirred solution of (Z)-2-amino-a-[[2- (diphenylmethoxy)-1,1-dimethyl-2-oxoethoxy]imino]- 4-thiazoleacetic acid (846 mg, 1.804 mmole) in 16 ml of dimethylformamide at -20 0 C was added diphenyl chlorophosphate (374 pl, 1.804 mmole) followed by triethylamine (450 pl, 3.28 mmole).
t The solution was stirred for 1 hour at -20 0
C
whereupon the above-described mixture of hydrogenolyzed (3S)-[1-[[[[[1,4-dihydro-4- GC240a -73oxo-5-(phenylmethoxy)-2-pyridinyl]methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester was added. The resulting mixture was stirred at -20 0 C for one hour and then at 5 0 C overnight. The catalyst was removed by filtration, volatiles were removed in vacuo and the resulting oil was dissolved in a minimum volume of acetone-water (75-25, pH 5.2) and added dropwise to a stirred suspension of 20 ml of Dowex 50x2-400* (K in acetone-water 35-65. After minutes, the mixture was filtered and the filtrate lyophilized to afford 2.1 g of solid.
The solid was dissolved in a minimum amount of acetonitrile-water (40-60, pH 5.6) and loaded onto a column (800 ml) of HP-20 resin, eluting with a stepwise acetonitrile-water gradient. Desired material eluted with ca. 30% acetonitrile. The relevant fractions were combined and lyophilized to afford the impure title compound (254 mg).
G) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-Z-oxoethylidene]amino]oxy]-2methylpropanoic acid Trifluoroacetic acid (4.7 ml) was added 1 dropwise to a stirred suspension of the above impure [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2- [[1-[[[[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-cxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, diphenylmethyl ester *Dowex 50x2-400: Styrene-divinylbenzene copolymer gel with -SO 3 groups attached sold by Dow Chemical Co.
i GC240a -74- (mixture of monopotassium and monotriethylammonium salts) (131 mg) in 3 ml dichloromethane and 0.3 ml anisole at O'C. After stirring 45 minutes at 5 0
C,
2 ml of toluene was added and the volatiles were removed in vacuo. The resulting oil was washed with hexane (3x4 ml) and triturated to a solid. with ml ether.. The solid was washed once with ether mi) and dried in vacuo. The above reaction and work-up were repeated on 166 mg of [3S(Z)]-2-[[[-(2-amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, diphenylmethyl ester (mixture of monopotassium and monotriethylammonium salts). The crude products were combined, dissolved in 2 ml CH3CN-water 40-60 (pH 2.5) and chromatographed on a column (200 ml) HP-20 resin, using an acetonitrile-water gradient. The desired material eluted at CH3CN-water 20-80. The relevant 3 fractions were combined and lyophilized to afford 103 mg [3S(Z)]-2-[[[-(2-amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid as a white solid.
C I GC240a Example [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[i-[[[[2- [[2-[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 2-[[(4-methoxyphenyl)methoxy]carbonyl]hydrazide A solution of 4.54 g (0.022 moles) dicyclohexylcarbodiimide in 25 ml dry of dimethylformamide was added to a stirred suspension of 4.90 g (0.020 moles) of 1,4-dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 4.50 g (0.022 moles) of 4-methoxybenzyl carbazate, 0.12 g mmol) of 4-dimethylamino-pyridine and 0.155 g mmol) of l-hydroxybenzotriazole hydrate in 25 ml of dry dimethylformamide at room temperature and stirring was continued overnight. The precipitate was filtered off and the filtrate was evaporated in vacuo. The residue solidified by stirring with ether and aqueous sodium bicarbonate and the solid was collected, washed with water and finally dried in vacuo. The crude material (8.14 g) was extracted in a soxhlet-apparatus with 800 ml CHC13 (7 hours). 5.70 g of pure 1,4-dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 2-[[(4-methoxyphenyl)methoxy]carbonyl]hydrazide crystallized directly from the cold CHCl3-extract, and an additional impure amount g, 18%) of the title compound could be obtained by evaporation of the CHCl3-solution in vacuo; melting point 174.5-178°C.
L--
GC240a -76- B) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid, hydrazide, trifluoroacetate salt A -100C solution of 3.81 ml (35.04 mmol) of anisole in 38 ml of trifluoroacetic acid was added to an ice-cold suspension of I 3.71 g (8.76 mmol) of 1,4-dihydro-4-oxo-5-(phenylmethoxy)-l-pyridinecarboxylic acid, Smethoxyphenyl)methoxy]carbonyl]hydrazide in 15 ml dry dichloromethane. After stirring at 0°C for minutes, the solution was evaporated in vacuo to leave the title compound as a solid which was stirred with few mls of dry ether, collected by suction and dried in vacuo. Yield: 3.25 g melting point 173-175°C, dec.
C) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid, hydrazide 3.84 ml (19.64 mmol) of N-methyl-N-(trimethylsilyl)trifluoroacetamide was added to a suspension of 3.19 g (8.55 mmol) of 1,4-dihydro- 4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, hydrazide, trifluoroacetate salt in 35 ml dry acetonitrile and stirring was continued for minutes at room temperature. After evaporation in vacuo, the residue was taken up in ether, followed I by a dropwise addition of 1 ml methanol. The precipitate was collected by suction, washed with ether and petroleum ether and dried in vacuo to yield 2.05 g of the title compound (melting point 204-208 0 C, dec.).
_li_ GC240a -77- D) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 2-[[2-(phenylmethoxy)carbonyl]hydrazino]carbonyl]hydrazide With cooling, 11.69 ml (0.060 mol) N-methyl- N-trimethylsilyltrifluoroacetamide was added to a suspension of 5.19 g (0.020 mol) of 1,4-dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, hydrazide in 20 ml dry acetonitrile, and stirring was continued for 30 minutes at room temperature. The clear solution was evaporated in vacuo, and the residue was redissolved in 30 ml dry dichloromethane. Then this solution was added dropwise to a stirred solution 0 of 4.57 g (0.020 mol) of PhCH2OCNHNHCOCI Gante, Chem. Ber. 97, 2551 (1964) in 60 ml of dichloromethane at 0-5 0 C. After being stirred at this temperature Sfor 2.5 hours, the solution was evaporated in vacuo and the solid foam was redissolved in 20 ml methanol. Evaporation in vacuo gave the title compound as a solid foam which became crystalline by stirring with dry ether. Yield: 8.87 g melting point >120 0 C, dec.
E) 1,4-Dihydro-5-hydroxy-4-oxo-2-pyridinecarboxylic acid, 2-(hydrazinocarbonyl)hydrazide, dihydrochloride A solution of 4.02 g (8.9 mmol) 1,4-dihydro- 4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid, 2-[[2-(phenylmethoxy)carbonyl]hydrazino]carbonyl]hydrazide in 50 ml methanol containing 2.94 ml (35.6 mmol) cone. hydrochloric acid was 41 hydrogenated in the presence of 0.4 g palladium St on carbon for 10 minutes. The catalyst was filtered off and the solvent was distilled off in vacuo to leave the title compound as a solid ~lrYI--~ IL~~~lL GC240a -78- (2.58 g) which was stirred with few ml dry ether, collected by suction and dried in vacuo. Yield: 2.47 g melting point 235-236 0 C, dec.
F) (3S)-[l-[[[[2-[[2-[(l,4-Dihydro-5-hydroxy- 4-oxo-2-pyridinyl)carbonyl]hydrazino]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]carbamic acid, phenylmethyl ester 4.86 ml (25.0 mmol) of N-methyl-N-trimethylsilyltrifluoroacetamide was added to a suspension of 1.5 g (5.0 mmol) of 1,4-dihydro-5-hydroxy-4oxo-2-pyridinecarboxylic acid, 2-(hydrazinocarbonyl)hydrazide, dihydrochloride in 20 ml of dry acetonitrile. After stirring for 45 minutes at room temperature, the clear solution was evaporated in vacuo, and the residue was dissolved in 20 ml of dry ethyl acetate (Solution A).
To a suspension of 1.10 g (5.0 mrmnol) of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2- 20 azetidinone in 40 ml dry ethyl acetate was added 0.45 ml (5.0 mmol) of chlorosulfonyl isocyanate with stirring, and the mixture was stirred for 1 hour at room temperature and then cooled to 0°C.
After the addition of 10 ml of dry dichloromethane and 2.09 ml (15.0 mmol) of triethylamine, Solution A was dropped in with stirring at 0°C. After stirring overnight at 0 C, the reaction mixture was poured into ice water and the organic layer was separated. Acidification of the aqueous phase to pH 2 by the addition of 1N hydrochloric acid gave the title compound as a sticky precipitate which was collected by suction, washed with water and dried in vacuo. Yield: 1.76 g -a«M .4 GC24Oa -79j G) (3S)-3-Amino-N-[[2-[[2-.[(l,4-dihydro-5hydroxy-4-oxo-.2-pyridinyl]carbonyl]hydrazino] carbonyllhydrazinolsulfonyl]-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt At 0 0 C 1.73 g (3.1 mmol) of ,4-Dihydro-5-hydroxy-4-oxo-2-pyridinyl) carbonyl]hydrazino]carbonyllhydrazino]sulfonyl]amino] carbonyl] -2-oxo-3-azetidinyl] carbamic 4 acid, phenylmethyl ester were added to a mixture of 5.13 ml trifluoroacetic acid and 1.21 ml thioanisole. After stirring overnight at room 4 temperature, the solution was evaporated in vacuo jf and the residue was stirred with dry dichioro- :1 methane. The precipitate was collected by suction, washed with dichloromethane and dried in vacuo to yield 1.78 g of the title compound.
H) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-[[2-[(1,4-dihydro-5-hydroxy-4-oxo-2pyridinyl )carbonyl]hydrazino]carbonyl]hydrazino] sulfo*-yl]amino]carbony]-2-oxo3-azetidinyl]amino]- 2-oxoethylidene] amino] oxy] -2-methylpropanoic acid, I diphenylmethy1 ester Into a -301C solution of 1.10 g (2.5 mmol) of (Z)-2-amino-u-[(2-diphenylmethoxy-)- 1, 1-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic I acid in 22 ml of dry dimethylformamide was added 1.05 ml (7.5 mmol) of triethylamine followed by 0.53 ml (2.5 mmol) of diphenyl chlorophosphate.
After stirring at -A 0 OC for 1 hour, 1.05 ml mmol) of triethylamine was dropped in, followed b y the addition of 1.62 g (2.5 mmol) of (3S)-3amino-N- 4-dihydro-5-hydroxy-4-oxo-2pyridinyl] carbonyl] hydrazino] carbonyl ]hydrazino] sulfonyl]-2-oxo-1-azetidinecarboxamide, trifluoroacetate salt. The mixture was stirred for 2 ~u~~iirurr^unurrrarmn~u~l ~Dlr~-~l GC240a hours at -10 0 C and for an additional hour at 0°C.
The solvent was removed in vacuo and the residue was taken up in few ml of ethyl acetate and ice water. The pH of the mixture was adjusted to pH 2 by the addition of dilute hydrochloric acid. The insoluble material was collected by suction and stirred with few ml ethyl acetate until it became crystalline to yield after drying in vacuo 1.72 g of the title compound.
I) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-[[2-[(1,4-dihydro-5-hydroxy-4-oxo-2pyridinyl)carbonyl]hydrazino]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]- 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt To a suspension of 1.68 g (2.0 mmol) of o° o crude [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)- 4-dihydro-5-hydroxy-4-oxo-2- 20 pyridinyl)carbonyl]hydrazino]carbonyl]hydrazino]- .sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]- 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester in 3 ml of dry dichloromethane was added 2.0 ml of anisole followed by 20 ml of 25 trifluoroacetic acid at -100. After stirring o oat 0°C for 10 minutes, the solvent was removed in vacuo at 0 0 -5 0 C. The residue was taken up in ice water and ether and the pH was adjusted to 6.0 by the addition of dilute sodium hydroxide The organic phase and insoluble material (0.38 g) were separated and the aqueous phase was freeze dried (2.66 The residue from lyophilization was Spurified on XAD-2 resin* (eluting with water) to S" yield upon lyophilization 0.25 g of the title compound as a colorless powder (melting point >213 0 C, dec.).
XAD-2 resin: Macroreticular styrene-divinylbenzene L GC240a -81- Example 6 [3S-[3a(Z),4p]]-2-[[[1-(2-amino-4-thiazolyl)-2- [[1-[[[[2-[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-4-methyl- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]- 2-methylpropionic acid, disodium salt A) (3S-trans)-[l-[[[[2-[[1,4-Dihydro-4-oxo-5hydroxy-2-pyridinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-4-methyl-2-oxo-3azetidinylicarbamic acid, phenylmethyl ester To a suspension of 2.34 g of (3S-trans)- (4-methyl-2-oxo-3-azetidinyl)carbamic acid, phenylmethyl ester in 50 ml of dry ethyl acetate was added 1.41 g of chlorosulfonyl isocyanate.
After stirring for 1 hour at room temperature, a clear solution was formed (Solution A).
To a suspension of 1.70 g of 1,4-dihydro-5hydroxy-4-oxo-2-pyridinecarboxylic acid, hydrazide in 50 ml of dry ethyl acetate was added 6 g of N-mzthyl-N-(trimethylsilyl trifluoroacetamide.
After stirring at 50 0 C for 1 hour, a clear solution formed (solution B).
After cooling to -10 0 C, Solution B was added to Solution A, and the mixture was stirred overnight at room temperature. Upon cooling to -150, 3 g of triethylamine was added, followed by 150 ml of ice water. After stirring for 1 hour at 00, the organic phase was washed with 50 ml of water. The combined water phases were adjusted to pH 2 with lN HC1 and extracted three times with 100 ml of ethyl acetate. The combined organic phases were dried and the solvent was evaporated to yield 3.64 g of the title compound.
-82- GC240a B) (3S-trans)-3-Amino-N-[[2-[(1,4-dihydro-5hydroxy-4-oxo-2-pyridiny..)carbonyl]hydrazino] .:ulfonyl]1-4-methyl-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt of dihydro-4-oxo-5-hydroxy-2-pyridinyll carbonyl] hydrazino] sulfonyl] amino] carbonyl] -4-methyl-2oxo-3-azetidinyllcarbamic acid, phenylmethyl ester in 20 ml of thioanisole was added 50 ml of trifluoroacetic acid at room temperature, and the reaction was then stirred for 13 hours. After addition of 100 ml of ether, 3.2 g of a crude precipitate was obtained. This precipitate was then stirred for 1 hour in 50 ml of isopropanol/ methylene chloride to yield 2.21 g of the title compound.
C) [3S-[3uz(Z),4p]]-2-[[[l-(2-amino-4-thiazolyl)- 2- 4-dihydro-5-hydroxy-4-oxo-2pyridinyl )carbonyl]hydrazino] sulfonyll amino] carbonyl] -4-methyl-2-oxo-3-azetidinyl] amino]- 7 2-oxoethylidene]aminoloxy] -2-methylpropionic acid, diphenylmethvl ester To a solution of 1.8 g of (Z)-2-amino-i- [[2-diphenylmethoxy)-,-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid and 1.2 g of triethylamine in 30 ml of dimethylformamide at were added 2.1 g of diphenyl chlorophosphate.
After stirrng at -300 for 45 minutes, 1.95 g of (3S-trans)-3-amino-N-[[2-[(l,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl )carbonyl]hydrazino] sulfonyl] -4methyl-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt in 10 ml of dimethylformamide was added, followed by 0.8 g of triethylamine.
After stirring at -101C for 2 hours and at 0 0 C for 1 hour, the dimethylformamide was removed in GC240a -83vac' the residue was stirred with 250 ml of ethyl acetate and 400 ml of ice water. The water phas' was adjusted to pH 1.5 with 2N HC1 and. was extracted twice with 200 ml portions of ethyl acetate. The organic phase was dried over sodium sulfate and evaporated to yield 1.3 g of the crude title compound.
D) [3S-[3a(Z),4p]]-2-[[[l-(2-amino-4-thiazolyl)-2- [[l-[[[[2-[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-4-methyl- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]- 2-methylpropionic acid, disodium salt To a solution of 1.2 g of [[[-(2-amino-4-thiazolyl)-2-[[l-[[[[2-[(1,4-dihydro- 5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-4-methyl-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy].-2-methylpropionic acid, diphenylmethyl ester in a mixture of 10 ml methylene chloride and 15 ml of anisole was added ml of trifluoroacetic acid at -5 0 C. After stirring for 30 minutes, 100 ml of ether was added to give 0.8 g of precipitate. This precipitate was suspended in 20 ml of water and the pH was adjusted to 6.5 with sodium bicarbonate. The Sclear solution was then chromatographed on XAD-2 with water as the eluent to give 0.28 g of pure title compound.
r .1 -84- GC24Oa Example 7 [3S(Z)]-l-[[I[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[3- [[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]> amino]-2-oxo--imidazolidinylsulfolylamiflolcarbonyl]- 2-oxo-3-azetidinyl]aminol-2-oxoethylidenelaminoI~oxy] cyclopentanecarboxylic acid, disodium salt A) [3S(Z)]-l-[[[l-(2-Alnino-4-thiazolyl)-2-[[l- [EL 4-dihydro-5-hydroxy-4-oxo-2-pyridilyl carbonyllamino]-2-oxo-l-imidazolidilyl]sulfolyl]aminolcarbonyl]-2-oxo-3-azetidinyll amincol-2-oxoethylidene] axino]oxy]cyclopentanecarboxylic acid, diphenvlmethyl ester To a suspension of 3.9 g (8.3 mmol) of amino-e- [[l-(diphenylmethoxy)carbonyllcyclopentYl]oxylimino]-4-thiazoleacetic acid in 100 ml of dry acetonitrile were added 3.5 ml (25 mmol) of triethylanmine to form a clear solution. After cooling to -30 0 C, 1.8 ml (8.3 mmol) of diphenyl chiorophosphate were added, and the mixture was stirred at -30 0 C for 1 hour (Solution A).
At the same time, 4.5 g (8.3 mmol) of (3S)-3amino-N- 4-dihydro-5-hydroxy-4-oxo-2pyridinyl )carbonyl] amino] -2-oxo-l-imidazolidinyl] sulfonyl] -2-oxo-l-azetidinecarboxamide, trifluoroacetate salt were suspended in 100 ml of dry ethyl acetate. Then, 7.2 ml of bis(trimethylsilyl)acetamide were added at room temperature to give a clear solution after 5 minutes. After stirring for 1 hour, the solution was cooled to 00 (Solution B).
Solution B was added dropwise with stirring to Solution A at -300 over 10 minutes. The mixture was stirred for 1 hour at -10'C and for 1.5 hour at 00. The volatiles were evaporated, GC24Oa and the residue was triturated with water. The residue solidified, and the solids were collected and resuspended in water at approximately pH 2.
After stirring for 30 minutes, the solid was collected and dried to give 12.0 g of the crude title compound.
Crd [3S(Z)]-l-[[l-(2-mino--4-thiazolyl)-.
2--[[[[3-[[(,4-dihydro-5-hydroxy-4-oxo-2riin.) pyidy carbonyl] amino] -2-oxo--1-imidazolidinyl]nlsuflaminolcarbonyl]-2-oxo-3-azetidinyl]amino]-- 2-ethylidene]amino]oxy]cyclopentanecarboxyliccd It pacid iphenylmetyl ester 12og) wias suspened in 20 ml of anisole, and, upon cooling to -10 0
C,
100 ml of trifluoroacetic acid was added. The
F.-
GC240a -86mixture was stirred at -10°C for 1 hour, and 300 ml of ether was added at -10° to yield a precipitate. After stirring for 1 hour, the precipitate was filtered off to give 5.7 g of material. This material was dissolved in a mixture of 30 ml of water and 60 ml of acetone and the pH of the solution was adjusted to 5.5 by the addition of 0.1N NaOH at 0° with stirrirg. The acetone was evaporated in vacuo, and the aqueous solution was freeze-dried to yield 5.7 g of a solid residue. This residue was chromatographed on HP-20 (eluting with water) to yield 1.69 g of pure title compound.
1 H-NMR (DMSO-d 6
CF
3 COOH): 6 1.67 4H); 2.07 4H); 3.65 2H); 3.75 (dd, 1H); 3.97 (dd, 1H); 4.07 2H); 5.07 (dd, 1H); 7.00 1H); 7.67 1H); 8.07 1H); ppm.
t it 4 I I 1 I l
I
GC240a n -87- Example 8 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[1-[[[[3- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]- 2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) methyl)-4(1H)-pyridinone To a suspension of 2.0 g (6 mmol) of methyl)-4(lH)-pyridinone in 20 ml of acetonitrile was added 3.9 g (60 mmol) of sodium azide and 0.1 g of 18-crown-6, and the mixture was heated to reflux for four hours. The salts were filtered off by suction, and the filtrate was evaporated in vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate-methanol 8:2) yielding 1.86 g of the title compound, melting point 120 0
C.
B) methyl)-4(1H)-pyridinone methyl)-4(1H)-pyridinone (1.0 g, 2.89 mmol) was dissolved in 50 ml of methanol and 0.10 g of j platinic oxide was added. Hydrogen was bubbled through the mixture for 30 minutes and the catalyst filtered off by suction over Hyflo. The filtrate was evaporated in vacuo and the oily residue triturated with ether to afford crystalline title compound (0.89 melting point 207 0
C.
t GC240a -88- C) 2-[[[[(2-Chloroethyl)amino]carbonyl]amino]methyl]-5-(phenylmethoxy)-2-(phenylmethyl)-4(1H)pyridinone To a suspension of 48.0 g (0.15 mol) of methyl)-4(1H)-pyridinone in 1.5 1 of ethyl acetate was added 12.8 ml (0.15 mol) of 2-chloroethylisocyanate. The mixture was stirred overnight at room temperature, the product filtered off by suction, washed with ethyl acetate, and dried in vacuo, yielding 59.6 g of the title compound, melting point 130 0
C.
D) 2-[(2-Oxo-l-imidazolidinyl)methyl]-5-(phenylmethoxy)-l-(phenylmethyl)-4(1H)-pyridinone A solution of 7.29 g (0.13 mol) of potassium hydroxide in 500 ml of ethanol was added dropwise to a mixture of 60.8 g (0.13 mol) of 2-[[[[(2-chloro- 2-(phenylmethyl)-4(1H)-pyridinone and 1.3 1 of ethanol. The reaction mixture was heated to reflux for three hours and the solvent evaporated in vacuo. The residue was purified by column chromatography on silica gel using a mixture of ethyl acetate and methanol as eluent, yielding 23.1 g of product, which was further purified by recrystallization from acetonitrile, yielding 17.0 g of the title compound, melting point 1900C, dec.
i GC240a 1 -89- E) 5-Hydroxy-2-[(2-oxo-l-imidazolidinyl)methyl]- 4(lH)-pyridinone, p-toluenesulfonate salt To a solution of 2-[(2-oxo-l-imidazolidinyl)methyl]-5-(phenylmethoxy)-l-(phenylmethyl)-4(lH)pyridinone (4.98 g; 12.8 mmol) in dimethylformamide ml) was added p-toluenesulfonic acid monohydrate (4.86 g; 25.6 mmol) and palladium on charcoal (1.0 and hydrogen was bubbled through the mixture for 30 minutes. The catalyst was filtered off by suction and the filtrate evaporated in vacuo. The residue was triturated with dichloromethane and ether, and the product filtered off by suction, yielding 4.12 g of the title compound, melting point 195 0
C.
F) 5-Hydroxy-2-[(2-oxo-l-imidazolidinyl)methyl]- 4(1H)-pyridinone 5-Hydroxy-2-[(2-oxo-l-imidazolidinyl)methyl]- S4(1H)-pyridinone, p-toluenesulfonate salt (4.0 g; o, 20 10.5 mmol) was dissolved in water (50 ml), and the pH was adjusted to 6.5 by the addition of 2N sodium hydroxide. The precipitate was filtered off by suction, washed with water, and dried in vacuo, yielding 1.5 g of the title compound, melting point 280 0 C, dec.
GC240a G) (S)-[l-[[[[3-[(1,4-Dihydro-5-hydroxy-4-oxo-2pyridinyl)methyl]-2-oxo-l-imidazolidinyl]sulfonyl]amino carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester 1.10 g (5 mmol) of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone was suspended in ml of dry ethyl acetate, and 0.44 ml (5 mmol) of chlorosulfonyl isocyanate added. The mixture was stirred at room temperature for one hour (solution a).
To a suspension of 1.04 g (5 mmol) of 5-hydroxy-2-[(2-oxo-l-imidazolidinyl)methyl]-4(lH)pyridinone in 10 ml of dry ethyl acetate was added 3.70 ml (20 mmol) of N-methyl-N-(trimethylsilyl)trifluoroacetamide, and the mixture was heated to 60 0 C. The resulting clear solution was evaporated in vacuo at 600C and the residue dissolved in ml of dry ethyl acetate (solution b).
Solution was added to solution and the reaction mixture stirred overnight at room temperature. The solvent was removed in vacuo and the residue triturated with ether, yielding 2.91 g of the title compound, melting point 1800C, dec.
H) (S)-3-Amino-N-[[3-[(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)methyl]-2-oxo-l-imidazolidinyl]sulfonyl]-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt (S)-[l-[[[[3-[(1,4-Dihydro-5-hydroxy-4-oxo-2pyridinyl)methyl]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidipyl]carbamic acid, phenylmethyl ester (0.50 g, 0.93 mmol) was added to a mixture of 0.5 ml of thioanisole and 2 ml of trifluoroacetic acid The solution was stirred 4a overnight at room temperature and evaporated in l 35 vacuo. The residue was triturated with ether, (4 GC240a -91filtered off by suction, and dried in vacua, yiedig 049g oftetitle compound, melting fl point 155'C.
I 5 1) E3S(Z)]-2-[L[l-(2-Amino-4-thiazolyl)-2-[l- [[[I[3-[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]-2-Qxo-l-imidazolidinyllsulfonyl~amino]- K carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester To a suspension of 0.41 g (0.93 mmol) of (Z)-2-amino-cu-[[2-(diphenylmethoxy)-1,1-dimethyl- 2-oxoethoxy~imino]-4-thiazoleacetic acid in 20 ml of dry acetonitrile was added 0.39 ml (2.8 mmol) of triethylamine, The mixture was cooled to -30 0
C,
and 0.19 ml (0.93 mmrol) of diphenylchlorophosphate were added dropwise. The reaction mixture was stirred for one hour at -30 0 C (solution a).
(S)-3-Amiino-N-[ [3-I(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)methyl]-2-oxo-1-imidazolidinyl]sulfonyl]-2-oxo-l-azetidinecarboxamide, trifluoroacetate salt (0.48 g, 0.93 mmol) was suspended in 20 ml of dry acetonitrile, and 0.78 ml (3.2 mmrol) of bis-trimethylsilylacetamide added. The suspension was stirred for 30 minutes at room temperature and then added to solution The reaction mixture was stirred for one hour at -10 0 C and then for 1.5 hours at 0 0 C. The resulting clear solution waG evaporated in vacua.1 and 50 ml of water was added to the oily residue.
The mixture was adjusted to pH 2 by the addition Ii-92- GC24Oa of 2N hydrochloric acid, and Ij amino-4--thiazolyl)-2-[[l-[[[[3-[(l,4-dihydro-5hydroxy-4-oxo-2--pyridinyl )methyl] -2-oxo-limidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl] amino] -2-oxoethylidene] amino] oxy]-2--methylpropanoic acid, disodium salt crystallized from the solution. The product was filtered off by suction, washed with water, and dried in vacuo, yielding 0.7 g of the title compound.
J) [(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]- 2-oxo-l-imidazolidinyl] sulfonyl] amino] carbonyl] 2-oxo-3-azetidinyl] amino] -2-oxo.-ethylidene] a~tino] oxy]-2-methylpropanoic acid, disodium salt [[[l-(2-Amino-4-thiazolyl)-2- stirred for onehdorat-hy0 0 C. Ether (100 mnl) wa sution, ased with ethe and5 driwssuned ino in.a mixtur aio eta and waedter and'C te pHr adjutcad os 6.5ed byd the dition f2Nsoiu hydroxde. Medthanlcpia was eovdintevacuof andth tsctitle compoud ths wasd purifed by MPLC:o me Ting pitJfura i acidC dec.a dsole inamxueo ehnladwtradtep adutdt yte diino Nsdu hyrxie Mehnlwsrmvdi a n h aquou souinfez-red th til opudIhswa uiidb PC metn pon GC240a -93- Example 9 r3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[1-[[[[4- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]- 2,3-dioxo-l-piperazinyl]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxyl-2-methylpropanoic acid, disodium salt A) methyl)-4(1H)-pyvridinone, hydrochloride A suspension of 3.21 g (10 mmol) of methyl)-4(1H)-pyridinone in 20 ml of chloroform was cooled to 0 0 C, and 4.65 ml (64 mmol) of thionylchloride was added dropwise. The mixture was stirred for ten minutes at 0 0 C and then heated to reflux for one hour. The solvent was evaporated in vacuo and the residue washed with petroleum ether and dried in vacuo, yielding 3.-66 g of the title compound, melting point 85 0 C, dec.
B) methyl)-4(1H)-pyridinone methyl)-4(1H)-pyridinone, hydrochloride (3.5 g, 9.3 mmol) was dissolved in a mixture of water/ethyl acetate and the layers separated. The organic phase was washed twice with water, dried over magnesium sulfate and evaporated in vacuo. The residue was triturated with petroleum ether, filtered off by suction and dried in vacuo, yielding 2.27 g of the title compound, melting point 115-120 0 C, dec.
'C
t_ C.; GC240a -94- C) N-(Triphenylmethyl)piperazine-2,3-dione A mixture of 2,3-piperazinedione (11.4 g, 100 mmol), bistrimethylsilylacetamide (55.7 g, 270 mmol) and 150 ml of acetonitrile was heated under reflux for one hour. Within 30 minutes, triphenylmethylchloride (22.2 g, 80 mmol) was added dropwise and the mixture was again refluxed for two hours. After stirring overnight at room temperature, 21.6 ml of water was added to the clear solution. The resulting precipitate (3.13 g) was filtered off and the filtrate concentrated in vacuo. The residue was triturated with water and dried to yield 25.5 g of crude title compound which was recrystallized from ethanol. Yield of pure product: 12.19 g, melting point 230-235 0
C.
D) 1-[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-l- (phenylmethyl)-2-pyridinyl]methyl]-4-(triphenylmethyl)-2,3-piperazinedione To a solution of N-(triphenylmethyl)piperazine-2,3-dione (4.19 g, 11.77 mmol) in 95 ml of dry dimethylformamide was added 0.35 g (11.77 mmol) of sodium hydride (80% oil). After the hydrogen evolution had ceased, a solution of 2-(chloromethyl)- 5-(phenylmethoxy)-l-(phenylmethyl)-4(1H)-pyridinone g, 11.77 mmol) in 25 ml of dry dimethylformamide was added to the thick suspension which then turned into a clear solution. After one hour of stirring at room temperature, precipitation started.
After two hours, the crystals were filtered off, washed and dried in vacuo, yielding 5.13 g of the title compound, melting point 165-168 0
C.
I t 6 *i
J
GC24Oa E) 1-f[l1,4-Dihydro-4-oxo-5-(pheflylmethoxy)-l- (phenylmethyl )-2-pyridinyl]methyll 3-piperazinedione To a solution of l-[[l,4-dihydro-4-oxo-5- (phenylmethoxy)-l-(phenylmethyl )-2-pyridinyl] methyl 1-4- (triphenylmethyl -piperazinedione (8.77 g, 13.23 mniol) in 65 ml of dichloromethane was added dropwise at room temperature 65 ml of formic acid. After stirring for three days, the volatiles were distilled off in vacuo and the residue triturated twice with ether to give 5.24 g of 1-f[l1,4-dihydro-.4-oxo-5-(phenylmethoxy)-l- (phenylmethyl )-2-pyridinyl]methyl]-2, 3-piperazinedione, melting point 260-265'C.
F) (S)-[l-[f[[4-.[[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-l- (phenylmethyl )-2-pyridinyl]methyl] 2,3-.dioxo-l-piperazinyllsulfonyl]amino]carbonyl]- 2-oxo-3-azetidinylljcarbamic acid, phenylmethyl ester To a solution of (S)-3-[[(phenylmetLhoxy)carbonyl]amino]-2-azetidinone (0.44 g, 2.0 mmol) in ml of dry ethyl acetate was added 0.28 g minol) of chiorosulfony. isocyanate and the solution was stirred for 30 minutes at room temperature. To this were added 12 ml of dichloromethane, 0.61 g (6 mmol) of triethylamine and a prestirred (three hours) mixture of l-[[l,4-dihydro- (phenylmethoxy)-l-(phenylmethyl )-2-pyridinyll methyl]-2,3-piperazinedione (0.83 g, 2.0 mmol) and N-methyl-N- (trimethylsilyl )trifluoroacetamide ILA, (1.59 g, 8.0 mmol) in 25 ml of dry ethyl acetate.
After stirring for three days at room temperature, ice water was added and the pH was adjusted to one O~A4 with hydrochloric acid. The insoluble residue was GC240a -96filtered off and dried in vacuo yielding 1.15 g of the title compound of 72% purity.
G) (S)-3--Amino-N- [(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)methyl]-2, 3-dioxo-l-pipera~zinyl]sulfonyll -2-oxo-l-azetidinecarboxamide, 4-methylbenzenesulfonic acid salt To a solution of (phenylmethoxy) (phenylmethyl )-2-pyridinyl 1methyl]-2,3-dioxo-1-piperazinyl~sulfonyl]amino]-.
carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (0.98 g, 1.32 mmol) in 20 ml of dimethylformamide was added 0.5 g (2.64 mmol) of 2-toluenesulfonic acid and 0.5 g of palladium on charcoal For one hour, hydrogen was bubbled through the mixture. The catalyst was filtered off, the solvent distilled off in vacuo and the residue triturated with dichloromethane to yield, after drying, 0.82 g of-the title compound, melting point 160-185 0 C, dec.
H) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[l-[[[[4- [14-dihydro-5-hydroxy-4-oxo-2-pyridinyl )methyl] 2,3-dioxo-l-piperazinyljsulfonyl amino~carbonyl]p.
2oxl--etylropnoiaid, dipxehylmdethyl ester To a solution of (Z)-2-amino-u-[[2-(diphenylmethoxy)-1, l-dimethyl-2-oxoethoxy]imino]-4-thiazole.
acetic acid (0.57 g, 1.3 mmol) in 30 ml of dimethylformamide was added at -30 0 C triethylamine (0.39 g, 3.9 mmol) and triphenylchlorophosphate (0.31 g, 1.3 minol). After stirring for one hour, triethylamine (0.39 g, 3.9 mxnol) and (S)-3-amino-N-[[4- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl )methyl] 2,3-dioxo-l-piperazinyl]sulfonyl]-2-oxo-l-azetidine- GC240a -97carboxamide, 4-methylbenzenesulfonic acid salt (0.98 g, 1.3 mmol) were added. The mixture was stirred for two hours at -100C and 1.5 hours at 0 0 C. Water and ethyl acetate were added, and the pH was brought to one with 3N hydrochloric acid.
The precipitate was filtered off, washed with ethyl acetate and dried in vacuo, yielding 0.86 g of the title compound, melting point 130-190 0 C, dec.
I) [3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[l-[[[[4- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]- 2,3-dioxo-l-piperazinyl]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt To a suspension of thiazolyl)-2-[[1-[[[[4-[(1,4-dihydro-5-hye xy-4oxo-2-pyridinyl)methyl]-2,3-dioxo-l-pipera nyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]- 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester (0.8 g, 0.94 mmol) in 1.4 ml of anisole was added at -10 0 C 7 ml of trifluoroacetic acid. After stirring for one hour, 30 ml of ether was added and the resulting precipitate filtered off and dried in vacuo. This trifluoroacetic acid salt was suspended in water and the pH adjusted to 6.5 with 2N sodium hydroxide. Freezedrying of the solution gave 0.66 g of crude product which was chromatographed together with a second sample prepared in the same way (total: 1.55 g) on macroreticular sytrene-divinylbenzene copolymer under MPLC conditions, yielding 0.34 g of the title GC240a -98compound. A second column chromatography on macroreticular styrene-divinylbenzene copolymer furnished 0.18 g of the title compound, melting point 242-270 0
C.
Example [3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[l-[[[[3- [[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methylene]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) 4,5-Bis(phenylmethoxy)-2-pyridinecarboxylic acid, phenylmethyl ester 21.5 g (156 mmol) of potassium carbonate was added to a suspension of 29.4 g (120 mmol) of O-benzylcomenamic acid in 350 ml of dimethylformamide and stirred for one hour at room temperature. Benzylbromide (31 ml, 264 mmol) was added and the mixture was heated to 1000C under stirring for 25 hours. After cooling to room temperature, the dimethylformamide was distilled off in vacuo and the residue triturated with ethyl acetate with short heating to 60 0 C. 40 g of inorganic salts were filtered off, the filtrate was concentrated to ca. 75 ml and chromatographed on silica gel with ethyl acetate:petroleum ether 90:10 as eluent, yielding 35.5 g of the title compound, melting point 116.70C.
GC240a -99- B) 4,5-Bis(phenylmethoxy)-2-pyridinemethanol To a suspension of 95 mg (25 mmol) of lithium aluminum hydride in 10 ml of ether and 10 ml of tetrahydrofuran was added 1.06 g (25 mmol) of 4,5-bis(phenylmethoxy)-2-pyridinecarboxylic acid, phenylmethyl ester in three portions at 0°C. After stirring for 20 minutes at 0°C, 0.2 ml of saturated sodium bicarbonate solution, 0.2 ml of 10% potassium hydroxide solution and additional saturated sodium bicarbonate solution were added until the inorganic precipitate flocked together. The clear organic phase was decanted and evaporated in vacuo to yield an oil which slowly crystallized. Yield: 0.6 g, melting point 96.6 0
C.
SC) 4,5-Bis(phenylmethoxy)-2-pyridinecarboxaldehyde To a solution of 0.54 g (1.7 mmol) of 4,5-bis(phenylmethoxy)-2-pyridinemethanol in 15 ml of acetone was added 1.5 mg (17 mmol) of manganese dioxide and the mixture was stirred overnight at room temperature. The mixture was then filtered over a silica gel column (70-250 mesh), and the aldehyde eluated with acetone. Evaporation of the eluent and trituration of the residue with petroleum ether furnished 0.3 g of the title compound, melting point 104.3 0
C.
I
GC240a -100- D) 1,4-Dihydro-5-hydroxy-4-oxo-2-pyridinecarboxaldehyde To a solution of 2-pyridinecarboxaldehyde (1.9 g, 6.0 mmol) in 25 ml of dry dimethylformamide was added 0.2 g of palladium on charcoal catalyst and hydrogen was bubbled through the mixture for three hours. The catalyst was removed by filtration, the solvent distilled off in vacuo and the residue triturated with ether to give 0.64 g of the title compound, melting point 174-177 0 C, dec.
E) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[3-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methylene]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt To a solution of amino-2-oxo-l-imidazolidinyl)sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-l-(2-amino- 4-thiazolyl)-2-oxoethylidene]amino]oxy]-2propanoic acid, monosodium salt (0.64 g, 1.1 mmol) in 15 ml of dry dimethylformamide 1,4-dihydro- 5-hydroxy-4-oxo-2-pyridinecarboxaldehyde (0.18 g, 1.3 mmol) was added, and, after stirring for hours, an additional 0.02 g (0.14 mmol) of 4 was added. After stirring overnight at room temperature, the solvent was evaporated in vacuo, the residue taken up in 30 ml of water, filtered and the solution freeze-dried. The crude material (0.82 g) was dissolved in 5 ml of water and chromatographed on macroreticular styrene-divinylbenzene copolymer resin with water as eluent, yielding 0.22 g of pure product, melting point 248 0 C, dec.
L7 GC24Oa ii -101- Example 11 I [3S(Z)]-2-f[[[l-(2-Amino-.4-thiazolyl)-2-[[l-[[[[4- I [[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2,3-dioxo-1--piperazinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidenelamino~joxy]-2-methylpropanoic acid, disodium salt A) 4, 5-Bis(phenlme thoxy)-2-pyridinecarboxvlic acid To a solution of 11.8 g (28 mrnol) of (phenylmethoxy)-2-pyridinecarboxylic acid, phenylmethyl ester in 115 ml of tetrahydrofuran was added 16 ml of water and 35 ml of 1N potassium hydroxide.
After stirring overnight at room temperature, 115 ml of water was added and the pH was adjusted to 2.5 with 1N hydrochloric acid. The acid was filtered off, washed with water and dried in vacuo, yielding 8.6 g of the ti'tle compound, melting point 203.6 0
C.
B) N-(2,3-Dioxo-l-piperazinyl)-4,5-bis(phenyl- I methoxy) -2-Dvridinecarboxamide Ii To a suspension of 2-pyridinecarboxylic acid (7.1 g, 21.17 mrnol), hydroxybenzotriazole (0.29 g, 2.12 mmol) and I N-aminopiperazine-2,3-dione (2.73 g, 21.17 mmol) in 140 ml of dry dimethylformamide was added, after I minutes of stirring, 4.80 g (23.3 minol) of dicycloir fexylcarflodJJimide. After stirring for 21 hours at room temperature, dicyclohexylurea was fil*iered off g )and the solvent was evaporated in vacuo.
I t Carrr* l 33 1UI~YII.W- GC240a -102- The solid residue was triturated for 40 minutes with 240 ml of tetrahydrofuran, filtered, washed with tetrahyrofuran and dried in vacuo to yield 7.76 g of the title compound, melting point 231.1 0
C.
C) (S)-[l-.[[[4[4-[[[4,5-Bis(phenylmethoxy)-2pyridinyl]carbonyl]amino]-2,3-dioxo-l-piperazinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenvlmethyl ester To a suspension of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone (2.02 g, 9.18 mmol) in 130 ml of ethyl acetate, chlorosulfonyl isocyanate (1.43 g, 10 mmol) was added, and, after stirring for one hour, triethylamine (2.79 g, 27.54 mmol) was added at 0°C. To this mixture, a prestirred solution (1.5 hours) of N-(2,3-dioxo-l-piperazinyl)- 4,5-bis(phenylmethoxy)-2-pyridinecarboxamide (4.10 g, 9.18 mmol) and N-methyl-N-(trimethylsilyl)- 20 trifluoroacetamide (5.4 g, 27.54 mmol) in 150 ml of a .0 ethyl acetate was added. After stirring overnight at room temperature, 220 ml of ice water was added 1 and the pH was adjusted to 2 (from 10.3) with 3N hydrochloric acid. When the separated organic 25 phase was treated with brine, the title compound precipitated and was filtered, washed with water and dried in vacuo, yielding 5.35 g. When 2.5 g of this material was triturated for one hour with a mixture of 25 ml of water and 37.5 ml of acetone at pH 6.3, 2.12 g of the title compound was obtained.
I-l GC24Oa 4 -103- D) [[(3-Amino-2-oxo-l-azetidinyl)k carbonyl]amino]sulfonyl]-2,3-dioxo-l-piperazinyl]- 1, 4-dihydro-5-hydroxy-4-oxo-2--pyridinecarboxamide To a solution of (phenylmethoxy)-2-pyridinyl]carbonyl]amino]-2,3dioxo-l-piperaziiyl] sulfonyl] amino] carbonyl] -2oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (1.54 g, 2 minol) in 30 ml of dimethylformamide was added 0.77 g of palladium on charcoal, and the mixture was hydrogenolyzed for 45 minutes. The catalyst was removed by filtration over Hyflo and the resulting solution was used for the next step without isolation of the title compound.
E) [3S(Z)]-2-[[[l--(2-Amino-4-thiazolyl)-2-[[l- ,4-dihydro-5-hydroxy-4-oxo--2-pyridinyl) carbonyl] amino] 3-dioxo-l-piperazinyl] sulfonyl] amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene] amino loxy] -2-methylpropanoic acid, 0 4120 diphenylmethyl ester To a solution of (Z)-2-amino-ci-[[2-(diphenylmethoxy)-l, l-dimethyl-2-oxoethoxy] imino] -4thiazoleacetic acid (0.88 g, 2.0 mmol) in ml of dimethylformamide was added triethylamine (0.60 g, 6.0 mnol) and, at -30 0 C and under nitrogen, triphenylchlorophosphate (0.54 g, mmol). After stirring for one hour at -30 0
C,
triethylamine (0.20 g, 2 mmol) and the dimethylformamide solution of (S)-N-[4-[[[(3-amino-2-oxo-lazetidinyl)carbonyl]amino]sulfonyl] '2,3-dioxo-lpiperazinyl] 4-dihydro-5-hydroxy-4-oxo-2-pyridinefl P~r GC240a -104carboxamide were added dropwise. The mixture was stirred for two hours at -10 0 C and for 17 hours at 0°C. The solvent was distilled off in vacuo and the residue partitioned between 40 ml of ethyl acetate and 20 ml of ice water. When the pH was adjusted to 1.5 with dilute hydrochloric acid, an oil separated which was separated from the solvent and dried in vacuo, yielding 1.35 g of the title compound.
F) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[4-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2,3-dioxo-l-piperazinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt To a mixture of 2.6 ml of anisole and 13 ml of trifluoroacetic acid, 4 -thiazolyl)-2-[[1-[[[[4-[[(1,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl)carbonyl]amino]-2,3-dioxo-lpiperazinyl]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, diphenylmethyl ester (1.3 g, 1.48 mmol) was added at -10 0 C, and the mixture was stirred for two hours at 0°C. The volatiles were distilled off in vacuo and the residue triturated with ether to give 1.06 g of trifluoroacetic acid salt after drying. This trifluoroacetic acid salt was suspended in 20 ml of water and the pH was adjusted to 6.5 with lN sodium hydroxide. The freeze dried solution furnished 1.10 g of crude product which was chromatographed on macroreticular styrene-divinylbenzene copolymer under MPLC t GC24Oa -105conditions with water as eluent. Yield: 0.48 g.
This material was again chromatographed twice together with other samples, prepared in the same manner. The second column chromatography was run on macroreticular styrene-divinylbenzene copolymer the third on Organogen, each with water as eluent.
Final yield 0.10 g, melting point 300 0
C.
Example 12 [3S(Z)]-3-[[(2-Amino-4-thiazolyl)[(2-fluoroethoxy)imino]acetyl]aminol-N- Ii[3-L 4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl] sulfonyl] -2-oxo-l-azetidinecarboxamide, ethvldiisoproovlamine salt To a solution of (Z)-2-amino-ca-I(2-fluoroethoxy)imino]-4-thiazoleacetic acid (0.33 g, 1.4 mmol) in 5 ml of dry dimethylformamide was added N-hydroxybenzotriazole (0.19 g, 1.4 mmrol) and N-ethyl-diisopropylamine (0.18 g, 1.4 mmol).
At 0 0 C, dicyclohexylcarbodiimide (0.29 g, 1.4 mmol) was added and the mixture was stirred for one hour. A solution of (3S)-3-amino--N-[[3- [[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl] sulfonyl] -2-cxo-lazetidinecarboxamide, trifluoroacetate salt (0.87 g, 1.6 mrnol; see Example 1G) and N-ethyldiisopropylamine (0.41 g, 3.2 mmrol) in 3 ml of dry dimethylformamide was added and after stirring for 2 hours at 0 0 C, the mixture was stirred for an additional 16 hours at room temperature. The dicyclohexylurea was filtered off, and the solvent distilled off in vacuo. The residual oil was triturated with water until completion of GC240a -106crystallization. The solid (0.82 g) was collected by filtration, the filtrate brought to pH 6.1 and freeze dried. The solid was suspended in 40 ml of water and the pH brought to 6.0 with 0.25 N sodium hycd.-xide. Undissolved material was filtered off ana the filtrate freeze dried. Two portions of freeze dried material were combined (ca. 0.6 g) and chromatographed on macroreticular styrenedivnylbenzene copolymer with water and water: acetonitrile 95:5 as eluent. After freeze drying, the appropriate fractions yielded 0.22 g of the title compound, melting point 163-165 0
C.
Example 13 (carboxymethyl)-2-[(1,4-dihydro-5-hydroxy-4-oxo- 2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, trisodium salt A) N,O-Dibenzyl-comenamyl chloride, hydrochloride Into a suspension of 16.77 g (50.0 mmol) N,O-dibenzyl-comenamic acid in 360 ml of dry 25 dichloromethane was added 11,45 g (55.0 mmol) of phosphorous pentachloride in portions at 0-5 0
C.
Stirring was continued for 1 hour at room temperature, and the precipitate was collected by suction, washed with 20 ml of dry dichloromethane and dried in vacuo, yielding 15.02 g of the title compound, melting point 126-127 0 C, dec.
S01 00 q 00 I( a I 0 4 0 r Qb. 4 0$ 4r d 4 4 t 0 .4 t a. 0 04 4 4414r 44 0.
Ot 44 0 4 GC240a -107- B) [2-[(Phenylmethoxy)carbonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester Into a stirred solution of 6.65 g (0.040 mol) of N-[(phenylmethoxy)carbonyl]hydrazine in 40 ml of dimethylformamide was dropped a solution of 8.58 g (0.044 mol) of t-butyl bromoacetate in 20 ml of dimethylformamide followed by a solution of 8.2 ml (0.048 mol) of N,N-diisopropylethylamine in 8 ml of dimethylformamide. After the mixture had been stirred at room temperature for one day, the solvent was distilled off in vacuo and the residue was taken up in ether and water. The organic layer was washed three times with water, dried (magnesium sulfate) and evaporated in vacuo to leave an oil (10.6 which was purified by column chromatography on silica gel eluting with ethyl acetate/toluene The appropriate fractions were evaporated in vacuo and the residue was stirred with petroleum ether yielding 6.0 g of the title compound, melting point 61-62 0
C.
C) [l-[[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]carbonyl]-2-[(phenylmethoxy)carbonyl]hydrazino]acetic acid, l,l-dimethylethyl ester 15.6 ml (80.0 mmol) of N-Methyl-N-trimethylsilyltrifluoroacetamide was added to a solution of 11.2 g (40.0 mmol) of [2-[(phenylmethoxy)carbonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester in 60 ml of dry acetonitrile. After stirring for minutes at room temperature, the clear solution was F i. L C C_ I i *1 GC240a -108evaporated in vacuo and the residue was dissolved in 45 ml of dry dichloromethane. This solution was dropped into a suspension of 15.61 g of N,Odibenzyl-comenamyl chloride, hydrochloride in 60 ml of dry dichloromethane at room temperature. After stirring overnight, the reaction mixture was evaporated in vacuo to leave a residue which was stirred with 10 ml of methanol, evaporated in vacuo again and then chromatographed on silica gel eluting with ethyl acetate and ethyl acetate/ methanol After evaporation in vacuo, the appropriate fractions yielded a solid foam which became crystalline by stirring with ether. Yield: 12.7 g; melting point 177-1780C, dec.
D) [l-[(1,4-Dihydro-5-hydroxy-..4-oxo-2-pyridinyl)carbonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester A suspension of 7.17 g (12.0 mmol) of 20 [1-[[l,4-dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]carbonyl]-2-[(phenylmethoxy)carbonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester in 400 ml of methanol was hydrogenated in the presence of 1.6 g of palladium on charcoal for minutes. The catalyst and the precipitated product were filtered off and washed well with 300 ml of dry dimethylformamide to dissolve the precipitated product. From the combined filtrates the solvents were removed in vacuo to leave a residue which crystallized by stirring with ether (1.68 g; melting point 221 0 C, dec.). Recrystallization from methanol yielded the pure compound.
Yield: 1.26 g; melting point 225 0 C, sint. 229 0
C,
dec.
-u34~~ GC240a -109- E) (3S)-[l-[(l,4-Dihydro-5-hydroxy-4-oxo-2pyridinyl)carbonyl]-2-[[[[2-oxo-3-[[(phenylmethoxy)carbonyl]amino]-l-azetidinyl]carbonyl]amino]sulfonyl]hydrazino]acetic acid, 1,2-dimethylethyl ester ml (46.2 mmol) of N-methyl-N-trimethylsilyltrifluoroacetamide was added to a suspension of 3.2 g (11.0 mmol) of 4-oxo-2-pyridinyl)carbonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester in 120 ml of dry ethyl acetate. At room temperature, stirring was continued for 1 hour to give a clear solution (solution A).
To a suspension of 2.42 g (11.0 mmol) [[(phenylmethoxy)carbonyl]amino]-2-azetidinone in ml of dry ethyl acetate 0.99 ml (11.0 mmol) chlorosulfonyl isocyanate was added with stirring.
The mixture was stirred for 1 hour at room temperature and then cooled to 0°C. Solution A was dropped in at 0 C and stirring was continued overnight at room temperature. After the addition of 4 ml of triethylamine, the mixture was evaporated in vacuo. The residue was dissolved in 10 ml of methanol-water This solution was dropped into a mixture of 30 ml methanol/water, the pH of which was maintained at pH 2 to leave a residue (10.25 g) which became crystalline by stirring with few ml of water and methanol. The precipitate was purified by successive washing (stirring) with isopropanol/wa-er methanol, methanol/ether and ether. Yield after drying in vacuo: 2.39 g.
L i
~~IIC~
GC240a -110- F) (S)-3-Amino-l-[[[[2-(carboxymethyl)-2-[(1,4dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyllamino]carbonyl]-2-azetidinone, trifluoroacetate salt At OOC, 2.39 g (3.9 mnol) of dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]-2- [2-oxo-3-[[(phenylmethoxy)carbonyl]amino]-1azetidinyl]carbonyl]amino]sulfonyl]hydrazino]acetic acid, 1,1-dimethylethyl ester was added to a mixture of 7.0 ml of trifluoroacetic acid and 1.66 ml of thioanisole. After stirring overnight at room temperature, the solution was evaporated in vacuo. The residue was successively washed (stirred) with ethyl acetate, ethyl acetate/ petroleum ether petroleum ether and dichloromethane and then dried in vacuo. This crude salt was used in the next step without any further purification. Yield: 2.15 g.
G) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-(carboxymethyl)-2-[(1,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester 0.70 ml (3.24 mmol) of diphenylchlorophosphate was dropped into a -30 0 C cold mixture of 1.42 g (3.24 mmol) of (Z)-2-amino-u-[[2-(diphenylmethoxy)-l,l-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid and 1.81 ml (12.96 mmol) of triethylamine in 30 ml of dry acetonitrile (solution A).
3.27 ml (12.96 mmol) of bistrimethylsilyl acetamide was added to a suspension of 2.13 g mmol) crude (S)-3-amino-l-[[[[2-(carboxymethyl)-2-[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonylihydrazino]sulfonyl]amino]carbonyl]-2azetidinone, trifluoroacetate salt in 30 ml of dry ethyl acetate at room temperature. After stirring p.- GC240a -111for 1 hour, the clear solution was cooled and dropped into the -30 0 C solution A. The mixture was stirred for 1 hour at -10 0 C, for an additional 1.5 hours at 0 C, and it was then evaporated in vacuo. The residue was stirred with few ml of water, the pH of which was adjusted to pH 2 by the addition of dilute hydrochloric acid.
The precipitate was filtered off, washed with water, redissolved in water/acetone at pH 5.5-6.0 (addition of dilute sodium hydroxide) and purified by MPLC on macroreticular styrene-divinylbenzene copolymer eluting with water-methanol gradient Freeze drying of the appropriate fractions yielded 270 mg of the purified products. A suspension of this salt, in a few ml of cold water, was acidified with dilute hydrochloric acid at pH 2 to precipitate the free acid, which was collected by suction and dried in vacuo; yielding 0.19 g; melting point >180°C, dec.
H) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-(carboxymethyl)-2-[(l,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, trifluoroacetic acid salt 0.17 g (0.2 mmol) of amino-4-thiazolyl)-2-[[l-[[[[2-(carboxymethyl)- A- "2-[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2oxo-3-azetidinyl]amino]-2-oxo-ethyidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester i GC240a -112was slowly added to a -100C cold, stirred solution of 0.62 ml (8.0 mmol) of trifluoroacetic acid and 0.087 ml (0.8 mmol) of thioanisole. Stirring was continued for 15 minutes at O'C. The suspension was evaporated in vacuo at 0-5 0 C, and the residue was stirred with dry ether, collected by suction, washed with dry ether and dried in vacuo, yielding 0.14 g; melting point >230 0 C, dec.
I) [3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-(carboxymethyl)-2-[(1,4-dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxo-ethylidene]amino]oxy]-2-methylpropanoic acid, trisodium salt 115 mg (0.146 mmol) of amino-4-thiazolyl)-2-[[1-[[[[2-(carboxymethyl)-2- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, trifluoroacetic acid salt was suspended in ml of water and the pH was adjusted to 5.5 by dropwise addition of dilute sodium hydroxide. The solution was passed through two successive columns of macroreticular styrene-divinylbenzene copolymer (0.05 0.1 mm) and cross-linked dextran gel (25 100 pm) eluting with water. The appropriate fractions were combined and lyophilized yielding 100 mg of the title compound.
-ri llil~llii~ GC240a -113- Example 14 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[3- [[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)acetyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylii dene]amino]oxy]-2-methylpropanoic acid, disodium salt A) methyl)-4(1H)-pyridinone i To a suspension of 2.0 g (6 mmol) of methyl)-4(1H)-pyridinone in 20 ml of acetonitrile was added 3.9 g (60 mmol) of potassium cyanide and 0.1 g of 18-crown-6; the mixture was heated to i reflux for 2.5 hours. The salts were filtered off Sby suction, and the filtrate was evaporated in vacuo. The resulting residue was purified by column chromatography on silica gel using ethyl acetate/methanol as eluent; yielding 0.55 g of the title compound, melting point 175-180 0
C.
B) 1,4-Dihydro-5-hydroxy-4-oxo-l-(phenylmethyl)- 2-pyridineacetic acid A mixture of 2.45 g (7.16 mmol) of 2-(cyanomethyl)-5-(phenylmethoxy)-l-(phenylmethyl)-4(1H)pyridinone and 40 ml of concentrated hydrochloric i acid was stirred for 4 hours at 70 0 C and then evaporated in vacuo. The residue was suspended in 15 ml of ice cold water and the pH was adjusted to by the addition of 5N sodium hydroxide. The precipitate was filtered off, washed with ice water and ether and dried in vacuo (1.71 The i-~ I -L-IMIC GC240a -114crude acid was dissolved in 20 ml of 0.5N sodium hydroxide, reprecipitated by acidification (pH 1.8) with 2N hydrochloric acid, collected by suction and washed with ice water. Yield: 1.52 g; melting point 231-235 0
C.
C) 1,4-Dihydro-5-hydroxy-4-oxo-N-(2-oxo-limidazolidinyl)-1-(phenylmethyl)-2-pyridineacetamide 4.99 ml (35.83 mmol) of triethylamine was added to a suspension of 9.29 g (35.83 mmol) of 1,4-dihydro-5-hydroxy-4-oxo-l-(phenylmethyl)- 2-pyridineacetic acid, 0.28 g (1.79 mmol) of N-hydroxybenzotriazole, 0.22 g (1.79 mmol) of N-dimethylaminopyridine, 3.62 g (35.83 mmol) of N-aminoimidazolidinone and 8.13 g (39.41 mmol) of dicyclohexylcarbodiimide in 115 ml of dry dimethylformamide. Stirring was continued overnight at room temperature. The precipitated dicyclohexylurea was filtered off, washed with dimethylformamide, and the filtrate was evaporated in vacuo to leave a residue, which became crystalline by stirring with 110 ml of dichloromethane. The precipitate was collected by suction and dried in vacuo. To a suspension of this crude material in ml of dry acetonitrile, 14.0 ml (71.6 mmol) of I N-methyl-N-trimethylsilyltrifluoroacetamide was Sadded. After having been stirred for 30 minutes at room temperature, the undissolved dicyclohexylurea was filtered off and the filtrate was evaporated in vacuo. The oily residue was boiled in 70 ml of methanol for 15 minutes and cooled. The precipitate was collected by suction, washed successively with methanol, methanol/ether and ether and dried in vacuo. Yield: 8.7 g; sint. 242 0 C, melting point 260-265 0 C dec.
L- GC240a -115- D) (S)-[l-[[[[3-[[[1,4-Dihydro-5-hydroxy-4-oxo-l- (phenylmethyl)-2-pyridinyl]acetyl]amino]-2-oxo- 1-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo- 3-azetidinyl]carbamic acid, phenylmethyl ester, monosodium salt 5.86 ml (30.0 mmol) of N-methyl-N-trimethylsilyltrifluoroacetamide was added to a suspension of 3.42 g (10.0 mmol) of 1,4-dihydro-5-hydroxy-4oxo-N-(2-oxo-l-imidazolidinyl)-1-(phenylmethyl)- 2-pyridineacetamide in 50 ml of dry ethyl acetate and stirring was continued for 1 hour at room temperature (solution A).
To a solution of 2.20 g (10.0 mmol) of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2azetidinone in 50 ml of dry ethyl acetate, 0.90 ml (10.0 mmol) of chlorosulfonyl isocyanate was added with stirring, and the mixture was stirred for 1 hour at room temperature and then cooled to 0°C.
o Solution A was dropped in with stirring at 0°C.
20 After stirring overnight at room temperature, the mixture was evaporated in vacuo and the residue was taken up in a few ml of methanol and water. The pH was adjusted to 5.5 by the addition of dilute sodium hydroxide and the filtered solution was freeze dried. MPLC on macroreticular styrenedivinylbenzene copolymer eluting with water/acetone and freeze drying of the relevant pure S1 fractions yielded 0.40 g of the title compound.
The impure fractions were purified by a second MPLC using the same conditions. Yield: 0.60 g.
t i d GC240a -116- E) (S)-N-[3-[[[(3-Amino-2-oxo-l-azetidinyl)carbonyl]amino]sulfonyl]-2-oxo-l-imidazolidinyl]- 1,4-dihydro-5-hydroxy-4-oxo-2-pyridineacetamide, trifluoroacetate salt A solution of 0.90 g (1.3 mmol) of [[[[3-[[[1,4-dihydro-5-hydroxy-4-oxo-l-(phenylmethyl)-2-pyridinyl]acetyl]amino]-2-oxo-limidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo- 3-azetidinyl]carbamic acid, phenylmethyl ester, monosodium salt in 13 ml of dry dimethylformamide containing 0.50 ml (6.5 mmol) of trifluoroacetic acid was hydrogenated in the presence of 0.15 g palladium on carbon for 20 minutes. The catalyst was filtered off and washed with a few ml of dimethylformamide. Evaporation of the filtrate in vacuo gave an oily residue which became crystalline by stirring with a few ml of ethyl acetate. Yield: 0.675 g; melting point >150 0
C,
dec.
Simple stirring of this crude title compound in dry ethyl acetate for 1 hour, followed by filtration, washing with ethyl acetate and drying in vacuo improved the purity; yield: 80%, melting point >165 0 C, dec.
0 t1 p Sr I I It GC240a -117- F) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[3-[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)acetyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester 1.1 ml (4.45 mmol) of bistrimethylsilyl acetamide was added to a suspension of 0.75 g (1.35 mmol) of (S)-N-[3-[[[(3-amino-2-oxo-lazetidinyl)carbonyl]amino]sulfonyl]-2-oxo-limidazolidinyl]-1,4-dihydro-5-hydroxy-4-oxo-2pyridineacetamide, trifluoroacetate salt in 12 ml of dry ethyl acetate. After stirring for 1 hour at room temperature, the clear solution was evaporated in vacuo and the oily residue was dissolved in 12 ml of dry ethyl acetate (solution A).
Into a -30 0 C cold suspension of 0.60 g (1.35 mmol) of (Z)-2-amino-a-[[2-(diphenylmethoxy)- S1' l,l-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic 20 acid in 12 ml of dry acetonitrile, 0.57 ml (5.4 mmol) of triethylamine was dropped, followed by 0.29 ml (1.35 mmol) diphenylchlorophosphate.
Stirring was continued for 1 hour at -30 0 C and an additional hour at 0 C. The solvent was removed in vacuo and the residue was precipitated by stirring with a few ml of water The precipitate was collected by suction, washed with cold water, suspended in water at pH 2 (addition of few drops of dilute hydrochloric acid), filtered off, washed successively with water, methanol and ether and dried in vacuo. Yield: 1.07 g; melting point >180 0 C, dec. This crude material was used in the next step without any further purification.
Lj_) GC240a -118- G) [3S(Z)]-2-[[[-(2-Amino-4-thiazolyl)-2-[[l- [[[[3-[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)acetyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt 1.01 g (1.17 mmol) of crude (2-amino-4-thiazolyl)-2-[[l-[[[[3-[[(1,4-dihydro- 5-hydroxy-4-oxo-2-pyridinyl)acetyl]amino]-2-oxo-limidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, diphenylmethyl ester was added to a -10 0 C solution of 2.0 ml of anisole in 10 ml of trifluoroacetic acid. After being stirred for 20 minutes at -10'C, the solvent was removed in vacuo at +10 0 C. The residue was stirred with a few ml of dichloromethane, filtered off, stirred once more with a few ml of dichloromethane, collected by suction, washed with hexane and dried in vacuo. This crude product (1.06 g) was suspended in a few ml of water/acetonitrile and then dissolved by adjusting the pH to 6.0 by the addition of lN sodium hydroxide. After concentrating in vacuo, the aqueous solution was chromatographed (MPLC) on macroreticular styrenedivinylbenzene copolymer eluting with water. The appropriate fractions were combined and freeze dried. Yield: 0.10 g, melting point >255 0
C.
L7 I -119-GC24Oa Example [3S(Z)]-2-[[[l-(2-Axnino-4-thiazolyl)-2-[El-[L[[3- [13-(1,4-dihydro-5-hydroxy-4-oxo-2-pyridiny.)-loxo-2-propenylj amino] -2-oxo-l-imidazolidinyl] sulfonyl]amino]carbonyl]-2-oxo-3-azetidinylilamino]- 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) 4(lH)-Dvridinone g of 2-(hydroxymethyl 4(lH)-pyridinone and 26 g of manganese dioxide (activated) were stirred in 100 ml of methanol overnight at room temperature. Crystals of product were formed. After boiling the reaction mixture for ten minutes, followed by hot filtration through .3yflo, and washing the filtercake two times with 50 ml of boiling methanol, the combined filtrates were evaporated and the residue stirred with 50 ml of ethyl acetate. White ocrystals of poutwere fone.Yield: 9.7g melting point 156 0 C dec.
B) 3-[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pvridinyl]-2-propenoic acid, ethyl ester g of p-toluenesulfonic acid, 6.26 g of 2- (1-hydroxy-l-methoxymethyl (pheny-lmethoxy) 4(1H)-pyridinone and 8.35 g of carbethoxymethylenetriphenylphosphorane were stirred for 3 hours in 100 ml of dioxane at 70 0 C. A clear, dark-colored rolution was formed. Evaporation of the solvent in vacuo yielded an oily residue of the title GC240a -120compound and triphenylphosphine oxide. The residue was dissolved in 30 ml of isopropanol and crystals of product began to separate. After standing in a refrigerator overnight, the crystals were filtered off, washed with ether and recrystallized from isopropanol. Yield: 5.72 g, melting point 188 0
C.
C) 3-[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinvll-2-propenoic acid 3-[l,4-dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid (1.5 g) and 0.29 g of potassium hydroxide were stirred in 30 ml of ethanol for 2 hours at 50 0 C. After evaporation of the solvent, the residue was dissolved in 100 ml of water and filtered. To the filtrate was added 2N hydrochloric acid until pH 5.0. Crystals of the title compound separated from the solution. They were filtered and washed with water and dried in vacuo.
Yield: 1.14 g, melting point 236 0
C.
D) 3-[l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-N-(2-oxo-l-imidazolidinyl)-2-propenamide 3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid (10.85 1 g of N-hydroxybenzotriazole, 0.01 g of N,N-dimethylaminopyridine and 8.24 g of dicyclohexylcarbodiimide were stirred for 30 minutes in 100 ml of dimethylformamide. After cooling to 0°C, 4 g of N-aminoimidazolidinone was added and stirring continued for 1 hour at 0 C and 10 hours at room temperature.
The resulting suspension was then heated to and filtered. It was again suspended in 50 ml of i~ GC240a -121dimethylformamide and heated to 60 0 C and filtered again. The combined filtrates were evaporated at 0 C (oil vacuo). The oily residue was stirred with 50 ml of water containing 2 g of sodium bicarbonate. After the filtration, the solid was washed with water, acetone and ether. 12.3 g of solid was obtained after drying. It was stirred together with 8 g of p-toluenesulfonic acid in 100 ml of dichloromethane for 1 hour. Filtration yielded 12.98 g of a white solid. This material was suspended in water. Recrystallization from water/dimethylformamide yielded 8.49 g of the title compound, melting point 271 0
C.
E) (3S)-[l-[[[[3-[[3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinyl]-l-oxo-2-propenyl]amino]-2oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]-2oxo-3-azetidinyl]carbamic acid, phenylmethvl ester S3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2o-c 20 pyridinyl]-N-(2-oxo-l-imidazolidinyl)-2-propenamide (3.55 g) was suspended in 100 ml of ethyl acetate and 6.3 g of N-methyl-N-(trimethylsilyl)trifluoroacetamide was added. After stirring for 1 hour, a clear solution was obtained. The solution was then 25 added within 10 minutes to a cooled solution (0°C) of 3.3 g of (S)-l-[[(chlorosulfonyl)amino]carbonyl]- 3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone in ml of ethyl acetate. After stirring overnight, the solvent was evaporated and the oily residue was stirred for 1 hour with 50 ml cf isopropanol. The resultant precipitate was isolated by filtration and washed with isopropanol and ether. Yield: 5.91 g.
GC240a -122- F) (3S)-3-Amino-N-[[3-[[(l,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl]I-l-oxo-2-propenyl Iamino] -2-oxo-limidazolidinyl] sulfonyl] -1-azeti.dinecarboxamide, trifluoroacetate salt (3S)-[l-[[[[3-[[3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinyl]-l-oxo-2-propenyllamino]-2oxo-l-imidazolidinyl] sulfonyl] amino] carbonyl] -2oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (6.8 g) was stirred at room temperature overnight in 60 ml of trifluoroacetic acid/thioanisole After evaporation of the resulting solution to 1/3 of its volume, 50 ml of isopropanol and 10 ml of ether were added. (3S)-3-Axnino-N-[[3-[[(l,4dihydro-5-hydroxy-4--oxo-2-pyridinyl]-l-oxo-2propenyllamino]-2-oxo-l-imidazolidinyl]sulfonyl]- 1-azetidinecarboxamide, trifluoroacetate salt was obtained as a white precipitate. It was washed 0 with ether several times and dried. Yield: 4.30 g.
G) [3S(Z)]-2-[[[l-(2-Axnino-4-thiazolyl)-2-[Ll- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) 0 l-oxo-2-propenyl] amino] -2-oxo-l-imidazolidinyl] sulfonyl] amino] carbonyl] -2-oxo-3-azetidinyl] amino] 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt dimethyl-2-oxoethoxy] imino] -4-thiazoleacetic acid (2.2 g) and 1.5 g of triethylamine was dissolved in 150 ml of acetonitrile. At -30 0 C, 1.4 g of diphenylchlorophosphate was added dropwise and 'he mixture was stirred for 1 hour.
r- GC240a -123- (3S)-3-Amino-N-[[3-[[(1,4-dihydro-5-hydroxy- 4-oxo-2-pyridinyl]-l-oxo-2-propenyl]amino]-2-oxo-limidazolidinyl]sulfonyl]-l-azetidinecarboxamide, trifluoroacetate salt (3.3 g) suspended in 100 ml of ethyl acetate was treated with 6 ml of N-methyl-N-(trimethylsilyl)trifluoroacetamide and stirred for 1 hour at room temperature. The solution was added dropwise to the activated acid at -30°C (15 minutes). It was then stirred for 1 hour at -10 0 C, and 30 minutes at 0°C. The solvent was evapo-ated in vacuo and the remaining oil was stirred with ice water at pH 2 (2N phosphoric acid). The ice water was discarded and the residue washed with ice water again and then dissolved in 100 ml of tetrahydrofuran. The solution was dried over sodium sulfate and the filtrate evaporated.
The diphenylmethyl ester of the title compound was isolated as a solid foam, 1.81 g.
g of the material was stirred in 30 ml of trifluoroacetic acid/anisole at 0°C for minutes and after adding 100 ml of ether, 1.7 g of the trifluoroacetic acid salt of the title compound was isolated by filtration. This was dissolved in 10 ml of water, and sodium bicarbonate was added until the pH was 5.5. The filtered solution was chromatographed on macroreticular styrene-divinylbenzene copolymer (400 g) using water as the eluent. Appropriate fractions contained 0.64 g of product. Bioautography showed one minor bioac:-ive side product. The material was subjected to a second column chromatography on Merck Lobar C ,t using water as an eluent. Appropriate fractions contained 0.17 g of the title compound.
s GC24Oa -124- Example 16 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl oxo-2-propenyl]hydrazinolsulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]joxyl-2-methylpropanoic acid, disodium salt A) 3-[l,4-Dihydro--4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid, 2- 1-dimethylethoxy) carbonyl Ihydrazide 3- 4-Dihydro-4-oxo-5 (phenylmethoxy) -2pyridinyl]-2-propenoic acid (1.36 0.75 g of N-hydroxybenzotriazole, 0.01 g of N,N-dimethylaminopyridine and 1.06 g of dicyclohexylcarbodiimide were stirred in 20 ml of dimethylformamide at 0 0 C for 20 minutes. 0.66 g of N-(t-butoxycarbonyl)hydrazine was added. After stirring overnifght, the formed dicyclohexylurea was filtered off and the filtrate was washed with 10 ml of dimethylformamide. The filtrate was evaporated to dryness and the residue was suspended in 30 ml of water, 1 g of sodium bicarbonate was added, and after stirring, the title compound was isolated byfiltration. Recrystallization from dimethylformamide/water gave white crystals. Yield: 1.47 g, melting point 141 0
C.
p.
GC240a -125- B) 3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid, hydrazide 3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid, 2-[(1,1-dimethylethoxy)carbonyl]hydrazide (3.86 g) was stirred for one-half hour in 30 ml of trifluoroacetic acid at 0 C. The trifluoroacetic acid salt of the title compound precipitated after adding 50 mi of diethylether. The salt was suspended in 30 ml of water, stirred with 2 g of sodium bicarbonate for minutes, and the title compound was filtered off, washed with water and dried yielding a beige powder.
Yield: 2.75 g.
C) (3S)-1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid, 2-[[[[2-oxo-3-[[(phenylmethoxy)carbonyl]amino]-1-azetidinyl]carbonyl]amino]sulfonyl]hydrazide 3-[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]-2-propenoic acid, hydrazide (2.86 g) and 8.1 g of N-methyl-N-(trimethylsilyl)trifluoroacetamide were stirred for 1 hour in 50 ml of ethyl acetate. To the resulting clear solution was added a solution of 3.27 g of (S)-l-[[(chlorosulfonyl)amino]carbonyl]-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone in 30 ml of ethyl acetate (addition within 10 minutes) at 0 0 C. After stirring overnight, the solvent was evaporated and the residue was stirred with 50 ml of isopropanol and one drop of acid. The title compound was filtered off and washed with isopropanol and ether.
Yield: 5.42 g.
GC240a -126- D) (3S)-3-[l,4-Dihydro-5-hydroxy-4--oxo-2-pyridinyl]- 2-propenoic acid, 2-[[[(3-amino-2-oxo-l-azetidinyl)carbonyl] amino] sulfonyl]hydrazide, trifluoroacetate salt (3S)-l,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinecarboxylic acid, 2-[[[[2-oxo-3-[[(phenylmethoxy )carbonyl Iamino] -1-azetidinyl Icarbonyl] amino~sulfonyl]hydrazide (5.2 g) was stirred in ml of trifluoroacetic acid/thioanisole at room temperature overnight. To the clear solution was added a mixture of 100 ml of ether/isopropanol The resultant precipitate was filtered off and washed with ether. Yield: 4.01 g after drying.
E) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) l-oxo-2-propenyl Ihydrazino] sulfonyl] amino] carbonyl I- 2-oxo-3-azetidinyl]a'ino]-2-oxoethylidene]amino]- O ox 1-2-methvlpropanoic acid, disodium salt (Z)-2-Amino-u-[[2-(diphenylmethoxy)-1,1dimethyl-2-oxoethoxy] imino] -4-thiazoleacetic acid g) and 1 g of triethylamine were dissolved in 100 ml of acetonlit. le. At -30 0 C, 1 g of diphenylchiorophosphate was added dropwise and the mixture was stirred for 1 hour.
4-Dihydro-5-hydroxy-4-oxo-2- 'pyridinyl]-2-propenoic acid, 2-[[f(3-amino-2oxo-l-azetidinyl)carbonyl]a-mino]sulfonyl]hydrazide, trifluoroacetate salt (2.0 g) and 5.5 ml of N-methyl-N- (trimethylsilyl )trifluoroacetami~e were stirred in 50 ml of ethyl acetate at room temperature GC240a -127for 1 hour. A clear solution was formed and after cooling was added dropwise to the activated acid at The mixture was stirred for 1 hour at 0 C, 30 minutes at -10 0 C and 1 hour at 0°C. The solvents were then evaporated in vacuo, and the residue stirred with 50 ml of isopropanol. A solid was formed. It was isolated by filtration and stirred with 100 ml of ice water for 20 minutes at pH 2 (phosphoric acid). Filtration yielded the diphenylmethyl ester of the title compound which was washed three times with 50 ml portions of ice water and dried (1.78 1.5 g of the ester was stirred with 50 ml of trifluoroacetic acid/anisole for 30 minutes at 0°C. After adding 150 ml of ether, the trifluoroacetic acid salt of the free acid of the title compound was isolated by filtration (1.65 g).
"0 1 g of that material was suspended in 5 ml of water and the pH was adjusted to 6.0 (sodium bicarbonate). The clear solution was then chromatographed on 400 g of macroreticular styrenedivinylbenzene copolymer using water as eluent, yielding 413 gm of the title compound. 400 mg of that material was rechromatographed on Merck Lobar C using water as eluent; yield: 160 mg.
00 GC240a -128- Example 17 [[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]ethyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt A) N-(4-Methoxybenzyl)-O-benzylcomenamic acid O-Benzylcomenic acid (10 g) and 10 ml of 4-methoxybenzylamine in 60 ml of water were refluxed for four hours. Acidification of the reaction mixture at room temperature with 2N hydrochloric acid to pH 2 yielded 15 g of crystals.
Recrystallization from dioxane yielded 12.3 g of the title compound, melting point 175 0
C.
co° B) 1,4-Dihydro-l-[(4-methoxyphenyl)methyl]-4-oxoo 5-(phenylmethoxy)-N-[2-[(phenylmethyl)amino]ethyl]- 2-Dyridinecarboxamide S[ N-[(4-Methoxyphenyl)methyl]-O-benzyl-comenamic acid (3.69 1.50 g of N-hydroxybenzotriazole and 2.05 g of dicyclohexylcarbodiimide were stirred for 1 hour at room temperature in 50 ml of dioxane. A solution of 1.35 g of N-benzylethylenediamine in ml of dioxane was then added dropwise. After stirring overnight, the formed dicyclohexylurea was filtered off and the dioxane of the filtrate evaporated. The residue (oil) was dissolved in 50 ml of dichloromethane and extractEd with two ml portions of 10% sodium bicarbonate, and washed with water. After drying the dichloromethane solution over sodium sulfate and evaporation, the remaining solid was recrystallized from ethanol yielding crystals (4.2 g) of the title compound, melting point 112 0
C.
L7 GC240a -129- C) N-(2-Aminoethyl)-1,4-dihydro-5-hydroxy-4-oxo- 2-pyridinecarboxamide, p-toluenesulfonate salt 1,4-Dihydro-l-[(4-methoxyphenyl)methyl]-4-oxo- 5-(phenylmethoxy)-N-[2-[(phenylmethyl)amino]ethyl]- 2-pyridinecarboxamide (9.95 g) and 7.7 g of p-toluenesulfonic acid in 100 ml of methanol were treated with 3 g of palladium on charcoal and hydrogen was bubbled through the reaction mixture at 45-50°C over six hours. A stream of argon was then bubbled through the reaction mixture for minutes. Filtration and evaporation of the filtrate yielded beige crystals of the title compound which were washed first with 20 ml of cold methanol and then 50 ml of ether. Yield: 10.5 g, melting point 2710C.
D) N-(2-Aminoethyl)-1,4-dihydro-5-hydroxy-4-oxo- 2-pyridinecarboxamide, dihydrochloride o N-(2-Aminoethyl)-1,4-dihydro-5-hydroxy-4-oxo- 2-pyridinecarboxamide, p-toluenesulfonate salt (5.42 g) was dissolved in 50 ml of formic acid and ml of formic acid/hydrochloric acid gas (2.2 equivalents hydrochloric acid) was added followed by 150 ml of ether; white crystals of were obtained.
Isolation by filtration and washing with 200 ml of ether yielded 2.60 g of the title compound, melting point 287 0
C.
4- GC240a -130- E)(SIl[[[-[14Dhdo5hdoy4 oxo-2-pyridinyl)carbonyl]aminolethyllamino]sulfonyl]amino]carbonyl]-2.-oxo-3-azetidinyl]carbamic acid, phenylmethvl ester To a 4.38 g of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone suspended in 50 ml of ethyl acetate was added 2.83 g of chiorosulfonyl isocyanate at room temperature. A clear solution was obtained after 30 minutes of stirring.
N-(2-Anminoethyl)-1,4-dihydro--5-hydroxy-4-oxo- 2-pyridinecarboxamide, dihydrochloride (5.40 g) in ml of acetonitrile was stirred together with 24 g (6 equivalents) of N-methyl-N-(trimethylsilyl)trifluoroacetamide at 50 0 C for 1 hour. The volatiles were then evaporated in vacuo. To the remaining oily residue was added 50 ml of ethyl acetate.
The above-prepared solutions were cooled to' o a 0 0 C and the second solution was added to the first while stirring. After stirring overnight, 200 ml of isopropanol was added under stirring at 0 0 C to yield the title compound in the form of beige crystals. Yield: 8.77 g, melting point 145'C.
F) (3S)-N-[[[[(3-Amino-2-oxo-l-azetidinyl)carbonyl]amino] sulfonyl] amino]ethyl] 4-oxo-2-pyridinecarboxamide, 2.0 trifluoroacetate salt (3S)-I[l-[I[[12-[(,4-Dihydro-5-hydroxy-4oxo-2-pyridinyl )carbonyl] amino] ethyl] amino] sulfonyl]amino]carbonyl]-2-oxc-3-azetildinyl]carbamic acid, phenylmethyl ester (2 g) was stirred l l 111~ I iX1 lli(_ iii-Y*iillli-1YI -Y lllll GC240a -131in 20 ml of thioanisole/40 ml of trifluoroacetic acid at 0°C for 12 hours. After adding 100 ml of ether, white crystals (fine) of the title compound were isolated by filtration. Washing with 50 ml of isopropanol and 100 ml of ether yielded 2.12 g of the title compound, melting point 136 0 C, dec.
G) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[[2-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]ethyl]amino]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester (Z)-2-Amino-a-[[2-(diphenylmethoxy)-l,ldimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid (4.40 g) and 3 g of triethylamine were dissolved ao in 150 ml of acetonitrile. At -30 0 C, 2.8 g of diphenylchlorophosphate was added dropwise and the o mixture was stirred for 1 hour.
(3S)-N-[[[[(3-Amino-2-oxo-l-azetidinyl)carbonyl]amino]sulfonyl]amino]ethyl]-1,4-dihydro-5-hydroxy- 4-oxo-2-pyridinecarboxamide, 2.0 trifluoroacetate salt (6.13 g) and 17 g of N-methyl-N-(trimethylsilyl)trifluoroacetamide were stirred for 2 hours in 100 ml of ethyl acetate. The solvent of the clear solution was distilled off in vacuo and the remaining oil was evaporated for 2 hours at 30 0
C
(oil vacuo 0.01 mm). The residue was dissolved again in 100 ml of ethyl acetate and added dropwise to the activated acid at -30°C
L
GC240a -132minutes). The mixture was stirred for 1 hour at 0 C and 1 hour at 0°C. The solvent was evaporated and the remaining oily residue stirred with ice water at pH 3 (2N phosphoric acid). The ice water was discarded and the residue washed with ice water and dried. Yield: 7.8 g beige crystals.
H) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[[2-[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]ethyl]amino]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[2-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]ethyl]amino]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]- 'o oxy]-2-methylpropanoic acid, diphenylmethyl ester o: (3 g) was stirred for 30 minutes in 30 ml of trifluoroacetic acid/anisole. The trifluoroacetic acid salt of the free acid was isolated after precipitation with ether. 7.9 g of this material was suspended in 20 ml of water and the pH was adjusted to 6.0 with sodium bicarbonate. After stirring for one-half hour, the suspension was filtered and the solution chromatographed on macroreticular styrene-divinylbenzene copolymer with water as eluent yielding 0.24 g. This material was chromatographed again on a Merck Lobar C Column; yield: 0.078 g, melting point 275 0 C, dec.
i GC24Oa -133- Example 18 pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl] amino] carbonyl I-2-methyl-4-oxo-3azetidinyl] amino] -2--oxoethylidene] amino] oxy] -2methvlpropanoic acid, disodium salt A) (2S-trans)-[l-[[[[3-[[[l,4-Dihydro-4-oxo-5- (phenylmethoxy)-2-pyridinyllcarbonyl]amino]-2-oxol-imidazolidinyl]sulfonylllamino]carbonyl]-2-methyl- 4-oxo.-3-azetidinyli carbamic acid, phenylmethvl ester (3S-trans (4-methyl-2-oxo-3-azetidinyl carbamic acid, phenylmethyl ester (2.35 g) and 1.41 g of chlorosulfonyl isocyanate were stirred for I hour at 00-50C in 50 ml of ethyl acetate. A C, clear solution was obtained (solution 1,4- Dihydro-4-oxo-:N- (2-oxo-l-imidazolidinyl (phenylmethoxy)-2-pyridinecarboxamide (3.28 g) and 6 g of N-metLhyl-N-(trimethylsilyl)trifluoroacetamide were.
4 stirred in 50 ml of ethyl acetate for 1 hour at (solution B).
To the cooled (0 0 C) solution A was added solution B during 30 minutes of stirring. After continuous stirring overnight, the solvent was 0%4 4#.evaporated and the residue (oily) stirred with 1 50 ml of isopropanol and 1 drop of acetic acid.
The title compound was formed as a beige precipitate; melting point 163 0 C, dec.; 4.3 g.
GC24Oa -134- B) (2S-trans (3-Amino-2-methyl-4oxo-1-azetidinyl )carbonyl] amino] sulfonyl] -2-oxo- 1-imidazolidinyl] 4-dihydro-5-hydroxy-4-oxo- 2-pvridinecarboxamide, di-p-toluenesulfonate (2S-trans)-fl-ffff3-f[[f,4-Dihydro-4-oxo-5- (phenylmethoxy)-2-pyridinyl]carbonyl] amino] -2-oxo- 1-imidazolidinyl] sulfonyl] amino] carbonyl] -2-methyl- 4-oxo-3--azetidinyl]carbamic acid, phenylmethyl ester (5.9 g) in 50 ml of dimethylformamide and 3.8 g of hydrated p-toluenesulfonic acid and 2.5 g of palladium on charcoal were hydrogenated at room temperature for 1 hour. After filtration over Hyflo, the dimethylformamide was distilled off in vacuo. The oily residue was stirred with 100 ml of dichloromethane. The title compound (5.8 g) was immediately formed as a white crystalline material.
eastC) f2S-f2c,3p(Z)]]-2-ff[l-(2-Amino-4-thiazolyl)- 2-f fl-f f f3-f f(1, 4-dihydro-5-hydroxy-4-oxo-2pyridinyl)carbonyllamino]-2-oxo-l-imidazolidinyl]sulfonyl] amino] carbonyl] -2-methyl-4-oxo-3azetidinyl] amino] -2-oxoethylidene] amino] oxy] -2methylpropanoic acid, disodium salt (Z)-2-Amino-cu-ff2-(diphenylmethoxy)-1,1dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid (4.40 g) and 3.0 g of triethylamine were dissolved '0 in 150 ml of acetonitrile. At -30 0 C, 2.8 g of diphenylchloruphosphate was added dropwise and stirred fqr 1 hour.
(2S-trans)-N-f3-f ff(3-Amino-2-methyl-4oxo-l-azetidinyl )carbonyl]amino]sulfonyl]-2-oxo- GC240a -135- 1-imidazolidinyl]-l,4-dihydro-5-hydroxy-4-oxo- 2-pyridinecarboxamide, di-p-toluenesulfonate (7.90 g) and 2.02 g of triethylamine were stirred for 5 minutes at -20'C in 50 ml of dimethylformamide.
The above-prepared suspension and solution were combined at -30 0 C and stirred for 1 hour at 0 C, 1 hour at -10 0 C and overnight at 0-10 0
C.
The solvents were then distilled off in vacuo and the residue stirred with 100 ml of ice water at pH 3 (phosphoric acid). The diphenylmethyl ester of the title compound was filtered off and washed with water. Yield: 6.13 g, beige powder.
2 g of the ester was stirred in 30 ml of trifluoroacetic acid/anisole for 30 minutes at 0 C. By adding 100 ml of ether, the trifluoroacetic acid salt of the free acid was precipitated.
It was suspended in 10 ml of water and the pH was adjusted to 6.0. After filtration, the filtrate was passed through an macroreticular styrenedivinylbenzene copolymer column (water as eluent).
Yield: 0.48 g.
A second column chromatography on Merck Lobar C with water as eluent gave 0.17 g of the title compound.
L
t f- GC240a -136- Example 19 [3S(Z)]-2-Aiino-N-1-[[[[3-[(1,4-dihydro-5hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2oxo-l-imidazolidinyl]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]-u-(methoxyimino)-4-thiazoleacetamide, monopotassium salt To a suspension of 0.6 g nf (Z)-2-amino-a- (methoxyimino)-4-thiazoleacetic acid (0.003 mol) was added, at room temperature, 2.14 ml (0.009 mol) of tributylamine. The suspension was cooled to 0 C, at which temperature 0.66 ml of diphenylchlorophosphate (0.003 mol) was added. The reaction mixture was stirred at -300C for 1 hour (mixture A).
To a suspension of 1.62 g of (3S)-3-amino-N- [[3-[(I,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]- 2-oxo-l-azetidinecarboxamide (0.003 mol) 00 in 20 ml of ethyl acetate was added, at room 7 20 temperature, 2.6 ml of bis-trimethylsilylacetamide to form a clear, brownish solution, which was stirred for 1 hour at room temperature, then cooled to OOC (solution B).
to mixture A, while the temperature was maintained at -301C (ca. 10 minutes). The mixture was stirred at -10 0 C for 1 hour and at O'C for an additional 11, hours and evaporated in vacuo. The remaining syrup was dissolved in 50 ml of t
I
I
I
GC240a -137acetone. To the solution was added 6 ml of 1-molar potassium ethyihexanoate to precipitate 3.0 g of crude product. Addition of ether to the filtrate provided an additional 0.2 g of crude material. Chromatography of the crude material on macroreticular styrene-divinylbenzene copolymer yielded 1.85 g of the title compound.
Example I [(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino] -2-oxo-l-imidazolidin-l] sulfonyl] amino] carbonyl] -2-oxo-3-azetidinyl] amino] -2-oxoethylidene] aminol oxy] -2-methyl~rcpanoic acid [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2- 4-dihydro-5-hydroxy-4-oxo-2pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl] sulfonyl]aminojjcarbonyl]-2-oxo-3-azetidinyl]amino]- 2-oxoethylidene] amino ]oxy] -2-methylpropanoic acid, 20 disodi.,,n salt (2.2 g; see Example 1) was dissolved in 20 ml of acetone/water and the pH was adjusted to pH 2 with 2N hydrochloric acid.
Chromatography using macroreticular styrene-divinylbenzene copolymer yielded 0.7 g of the title compound.
o 00 00 0 0000 0 04 0 0 0 000 0 00'~ Ot j GC240a Example 21 [3S(Z)]-2-[[jl-(2-Amino-4-thiazolyl)-2-[[l-[[[[3- [[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]sulfonyl]amino~carbonyl]- 2-oxo-3-azetidinyl]amino]-2--oxoethyiidene]amino]oxy]- N-hvdroxv-2-methylpropanamide, monosodium salt (Z)-2-Amino-a-f[l,l-dimethyl-2-oxo-2-[(triphenylmethoxy) amino] ethoxy] imino] -4-thiazoleacetic 4 acid (4.72 g) was suspended in 65 ml of acetonitrile and, at -30 0 C, 3.72 ml of triethylamine was added.
After 10 minutes of stirring, 1.97 ml of diphenyl- 4 chlorophosphate was dropped in. Stirring was then continued for 90 minutes (solution A).
I (3S )-3-amino-N- 4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl] sulfonyl] -2-o',o--azetidinecarboxamide (8.9 ml) was suspended in 70 ml of acetonitrile, and 7.7 ml of bis-trimethyls-ilylacetamide was added. A clear solution was obtained after stirring 420 for 1 hour at -10 0 C and 1 hours at 0 0 C. The solvent and formed trifluoroacetic acid trimethylsilyl ester were evaporated in vacuo and the remaining oil was dissolved in 70 ml of ethyl acetate (solution B).
Solution A was then dropped into the stirred solution B at -20 0 C during 30 minutes. Continuous stirring at -10 0 C for 1 hours and at 0 0 C for 1 hour finished the reaction.
'ij.
LI 3 P"P~*-rrr GC240a -139- The solvents were then distilled off in vacuo and the oily residue was stirred with 300 ml of ice water whose pH was adjusted to 4.0 with phosphoric acid The formed solid was then filtered off, washed with water and dried in vacuo overnight. Yield: 9 g of crude.
The crude product (4.5 g) was stirred with ml of formic acid and 4.5 ml of dichloromethane at 0 C for one hour. The title compound (2.3 g) was obtained by precipitation with diethylether.
Example 22 [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- [[3-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, disodium salt £0 2 0 0 A) 2-[[(Phenylmethoxy)carbonyl]amino]-2- 0 imidazolidinone wa l-Amino-2-imidazolidinone (26 g, 0.257 mol) was dissolved in 200 ml of water. The solution was layered with 200 ml of ethyl acetate and 43.8 g of chloroformic acid, benzyl ester So(0.257 mol) was dropped into the mixture with stirring while maintaining the pH of 8.5-9 by the J addition of saturated sodium bicarbonate solution.
o 30 After stirring overnight at room temperature, the o 1 4 O 44 o a t GC240a -140- 3 title compound was filtered off, washed first with water and then with ethyl acetate. Yield: 46.7 g, melting point 140-144 0
C.
B) l-[[(Phenylmethoxy)carbonyl]amino]-3-(chlorocarbonyl)-2-imidazolidinone To a.suspension of 69.9 g (0.297 mol) of 2-[[(phenylmethoxy)carbonyl]amino]-2-imidazolidinone in 1 liter of dichloromethane was added a solution of 35 g of phosgene in 200 ml of dichloromethane. The mixture was stirred overnight at room temperature to form a clear solution. The solvent was removed in vacuo and the remaining syrup triturated with ether. Yield: 76.0 g, melting point 102-105 0
C.
C) 3-[[(Phenylmethoxy)carbonyl]amino]-2-oxo-limidazolidinecarboxylic acid, 2-[(1,1-dimethyl- *ethoxy)carbonyl]hydrazide l-[[(Phenylmethoxy)carbonyl]amino]-3-(chlorocarbonyl)-2-imidazolidinone (76 g, 0.255 mol) was added at room temperature to 1.5 liters of ethyl acetate. After cooling to 0-5 0 C, a solution of 39.6 g (0.9 mol) of N-(t-butoxycarbonyl)hydrazide and 41.8 ml of triethylamine (0.3 mol) in 150 ml of ethyl acetate were dropped in within 30 minutes.
The mixture was stirred overnight. The precipitate was filtered off, dried, stirred with 800 ml of water to remove triethylamine hydrochloride, filtered, washed with water and dried. Yield: 71.2 g, melting point 195-198 0
C.
L
GC240a -141- D) 2-[[3-[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)- 2-pyridinyl]carbonyl]amino]-2-oxo-l-imidazolidinyl]carbonyl]hydrazinecarboxylic acid, 1,1-dimethylethyl ester 3-[[(Phenylmethoxy)carbonyl]amino]-2-oxo-limidazolidinecarboxylic acid, 2-[(l,l-dimethylethoxy)carbonyl]hydrazide (31.5 g, 0.08 mol) was dissolved in 400 ml of dimethylformamide, 16 g of palladium on charcoal was added and hydrogen was passed through the stirred reaction mixture.
After 1 hour, the catalyst was filtered off. To the filtrate was added 19.62 g of O-benzylcomenamic acid (0.08 mol), 0.48 g of dimethylaminopyridine and 0.64 g of N-hydroxybenzotriazole. The mixture was stirred for one hour at room temperature.
A solution of 18.13 g of dicyclohexylcarbodiimide (0.088 mol) was added at room temperature and the mixture was stirred overnight. The precipitate 0 00 (dicyclohexylurea) was filtered off, the filtrate S0 20 evaporated in vacuo, and the residue triturated with water to which sodium bicarbonate was added to 00400 adjust the pH to 7.5. The precipitate was filtered i off to yield 36 g of the title compound.
E) 3-[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]carbonyl]amino]-2-oxo-l-imidazolidinecarboxylic acid, hydrazide 2-[[3-[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)- 2-pyridinyl]carbonyl]amino]-2-oxo-l-imidazolidinyl]carbonyl]hydrazinecarboxylic acid, 1,1-dimethylethyl ester (36 g) was added, at -10 0 C with stirring, to 300 ml of trifluoroacetic acid. The mixture L LliLLil_ :l-L t -LtllCIYII~I:- I l.i- U II -I GC240a -142was stirred at 0°C for 1 hour, the trifluoroacetic acid was removed in vacuo and the residue triturated with ether to yield 41 g of the trifluoroacetate salt of the title compound. The trifluoroacetate salt was suspended with cooling in water and the pH was adjusted to 7 by the addition of 2N sodium hydroxide. The precipitate was filtered off to yield 21.9 g of the title compound.
F) 3-[[(l,4-Dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinecarboxylic acid, hydrazide 3-[[[1,4-Dihydro-4-oxo-5-(phenylmethoxy)-2pyridinyl]carbonyl]amino]-2-oxo-l-imidazolidinecarboxylic acid, hydrazide (21.9 g) was suspended in 250 ml of acetonitrile. To the suspension was added 75 ml of bis-trimethylsilylacetamide and the Smixture was stirred to form a solution. To the solution was added 10 g of palladium on charcoal and hydrogen was passed through the vigorously stirred mixture. The debenzylation was complete after 1 hour. After filtration, 15 ml of methanol and 10 drops of acetic acid were added to precipitate the title compound. Yield: 10.8 g.
This crude material was stirred with 150 ml of ethanol to yield 8.8 g of the title compound, melting point <205 0 C, dec.
L: GC240a -143- G) (S)-[1-[[[[2-[[3-[[(1,4-Dihydro-5-hydroxy-4oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]- 2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester To a suspension of 5.9 g (0.02 mol) of crude 3-[[(l,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]amino]-2-oxo-l-imidazolidinecarboxylic acid, hydrazide, 14.9 ml (0.08 mol) of N-methyl-N- (trimethylsilyl)trifluoroacetamide was added and the mixture was stirred at 50 0 C to form a solution (solution A).
To a suspension of 4.4 g of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone (0.02 mol) in 160 ml of ethyl acetate, 1.76 ml of chlorosulfonyl isocyanate was added at room temperature.
The mixture was stirred for 1 hour (solution B).
Solution A was added (with cooling, ice) to solution B. After stirring for 1 hour, 2.8 ml (0.02 mol) of triethylamine was added to the 20 mixture, which was then stirred overnight at room temperature. An additional 2.8 ml of triethylamine (0.02 mol) was added, followed by ice water. The mixture was stirred thoroughly for 1 hour and the layers were separated. The aqueous phase was 25 acidified to pH 3 and the precipitate isolated by filtration. Yield: 5.3 g of crude title compound.
The crude material was dissolved in acetone/ water and the pH of the solution was adjusted to by the addition of 2N sodium hydroxide. After removal of the acetone in vacuo, the aqueous solution was filtered and lyophilized to yield 0 n 0 u .4~ 4 SI 44 4 4 4tt 444 4 41 4 GC24Oa -144- 0 0 .00.
8 g of the crude sodium salt of the title compound. Chromatography of the crude sodium salt on macroreticular styrene-divinylbenzene copolymer yielded 0.64 g of purified material. This was dissolved in water and acidified with 2N hydrochloric acid to precipitate the title compound. Y(ield: 0.5 g.
H) (S)-N-[3-L[2-LE[(3-Amnino-2-oxo-l-azetidinyl)carbonyl]amino]sulfonyl]hydrazino]carbonyl]-2-oxo- 1-imidazolidinyl] 4-dihydro-5-hydroxy-4-oxo-2pyrdi nec arb ox ami de g of hydroxy-4-oxo-2-pyridinyl )carbonyl] amino] -2-oxo-l- 15 imidazolidinyl]carbonyl]hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3--azetidinyl]carbamic acid, phenylmethyl ester was added to a mixture of 0.5 ml of thioanisole and 2 ml of trifluoroacetic acid. The mixture was stirred overnight at room temperature and evaporated in vacuc. The residue was triturated with ethyl acetate to provide the title compound j'n quantitative yield.
I) [3S(Z)]-2-[[[l-112-Amino-4-thiazolyl]-2-f[lt[[[2-[f3-[(1,4-dihydro-5-hydroxy-4-oxo-2pyridinyl )carbonyl] amino] -2-oxo-l-imidazolidinyl] carbonyl]hydrazino] sulfonyl] amino] carbonyl] -2--oxo- 3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylbropanoic acid, diphenvlmethvl ester To a solution of 0.35 g (0.0008 mol) of (Z)-2-amino-a.-[[2-(diphenylmethoxy)-l,l-dimethyl- 2-oxoethoxy]imino]-4-thiazoleacetic acid in 10 ml of acetonitrile, 0.34 ml of triethylamine was added.
GC240a.
-145- The mixture was cooled to 30'C and 0.17 ml of diphenyichiorophosphate was added. The reaction mixture was stirred at -30 0 C for 1 hour (solution A).
To a suspension of 0.008 mol [[[(3-amino-2-oxo-l-azetidinyl)carbonylljamino]sulfonyl]hydrazino]carbonyl]-2-oxo-l-imidazolidinyl]- 1, 4-dihydro.-5-hydroxy-4-oxo-2--pyridinecarboxamide in 6 ml of ethyl acetate, 0.7 ml of bis-trimethylsilylacetamide was added (solution B).
Solution B was added to solution A at -~300C. The mixture was stirred at -10'C for 2 hours and at 000 for 1 hour and evaporated in vacuo. After treatment of the residue with water, 0.7 g of crude title compound was obtained, 0"00 15 melting point 15500, dec.
0 0-0 a00 0o 0 J) [3S(Z)]-2-[[[l-(2-Amino-4-thiazolyl)-2-[[lco000 1: 0[EL 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) 20carbonyl~amino]-2-oxo-l-imidazolidinyl]carbonyl]acid, disodium salt To a suspension of 0.7 g amino-4-thiazolyl] 4-dihydro- 1-imidazolidinyl]carbonyl]hydrazino]sulfonyl]amino]amino] oxy] -2-methylpropanoic acid, diphenylmethyl ester (0.00077 mol) in 2. ml of anisole, 6 ml of trifluoroacetic acid was adCad at 100C. The mixture was kept at -1l00C for 1 hour. At -100C, ether was added to precipitate the trifluoroacetate of the free acid of the starting material, yield g.
li GC240a -146- The precipitate was suspended in water with cooling and the pH was adjusted to 5.5 by the addition of 2N sodium hydroxide. Freeze drying yielded 0.55 g of crude material. The crude material was purified by chromatography on macroreticular styrene-divinylbenzene copolymer to yield 0.1 g of purified title compound.
Example 23 [3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[l-[[[[2- [(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]- 2-methylhydrazino]sulfonyl]amino]carbonyl]-2-oxo- 3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, disodium salt S 0000 oo A) 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-l-(phenylmethyl)-2-pyridinecarboxylic acid, l-methylhydrazide N,O-Dibenzylcomenamyl chloride (0.15 mol) was suspended in 150 ml of dichloromethane with ice cooling. To the suspension, 26.2 ml (0.5 mol) of methylhydrazine was added, followed by 150 ml of acetonitrile. The mixture was stirred overnight at room temperature. The turbid solution was evaporated in vacuo and triturated with 300 ml of water. The solid material obtained was filtered and dried to yield 26.3 g of crude material. Recrystallization of the crude material from water yielded 12.7 g of ,pure title compound, melting point 138-142 0
C.
-Ir*u~ arT; GC240a -147- B) (S)-1,4-Dihydro-4-oxo-5-(phenylmethoxy)-l-(phenylmethyl)-2-pyridinecarboxylic acid, l-methyl-2-[[[[2oxo-3-[[(phenylmethoxy)carbonyl]amino]-l-azetidinyl]carbonyl]amino]sulfonyl]hydrazide 1,4-Dihydro-4-oxo-5-(phenylmethoxy)-l-(phenylmethyl)-2-pyridinecarboxylic acid, l-methylhydrazide (1.82 g, 0..005 mol) was suspended in 20 ml of ethyl acetate. At room temperature, a total of 1.85 ml of N-methyl-N-(trimethylsilyl)trifluoroacetamide (0.01 mol) was added. The mixture was stirred for 4 hours at 60 0 C (suspension A).
(S)-3-[[(Phenylmethoxy)carbonyl]amino]-2azetidinone (1.1 g, 0.005 mol) was suspended in ml of ethyl acetate at room temperature and 0.5 ml of chlorosulfonyl isocyanate was added.
o ,i The mixture was stirred at room temperature for 1 Shour to form a solution (solution B).
To solution B, 1.2 ml of triethylamine was 0 added (with ice cooling) followed by 20 ml of 0 4 dichloromethane and suspension A. The suspension was stirred overnight at room temperature. To the slightly turbid solution, 30 ml of dichloromethane and 20 ml of water was added and the mixture was stirred for 1 hour at room temperature.
25 The pH of the aqueous phase was 6.5-7.
ml of ethyl acetate was added, the organic layer separated and the aqueous phase washed twice with a mixture of dichloromethane/ethyl acetate The combined organic phases were dried (magnesium sulfate) and evaporated to yield 4.5 g of a syrup which cryscallized on standing over the weekend. After treatment with ether, 2.6 g of crude title compound was obtained.
L. r A GC240a -148- C) 1 ,4-Dihydro-5-hydroxy-4-oxo-2-pyridinecarboxylic acid, 2-[[[(3-amino-2-oxo-l--azetidinyl)carbonyl]amino] sulfonyl]l -methyvlhydrazide, trifluoro- :1 acetate salt To a solution of 2 g of (S)-l,4-dihydro-4-oxo- (phenylmethoxy)-l- (phenylmethyl )-2-pyridinecarboxylic.acid, l-methyl-2-[[[[2-oxo-3-[[(phenylmethoxy)carbonyl]amino]-l-azetidinyl]carbonyl]amino]sulfonyl]hydrazide in 60 ml of dimethylformamide, 1.1 ml of trifluoroacetic acid was added, followed by one gram of palladium on charcoal After flushing with nitrogen, hydrogen was passed through the solution for minutes with stirring, the catalyst was removed by filtration, the filtrate evaporated in vacuo and the residue triturated with ether to yield 1.1 g I of crude title compound. Yield: 86.6%.
D) fS(Z)-2-[[[l-(2-Ain-4-thiazolyl)-2-[[l- [[[[2-[(l,4-dihydro.-5-hydroxy-4-oxo-2-pyridinyl)carbonyl] -2-methylhydrazino] sulfonyl] amino Icarbonyl] 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxyl -2-methvlpropanoic acid, diphenylmethvl ester To a suspension of 0.88 g of (Z)-2-amino-u- [[2-(diphenylrnethoxy)-l, l-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid (0.002 mol) in 30 ml of acetonitrile 0.7 ml (0.005 mol) of triethylamine was added, followed, at -30'C, by 0.44 ml of diphenylchlorophosphate (0.002 mol). The mixture was stirred at -30'C for 1 hour (solution A).
To a suspension of 1.2 g (0.002 mol) of 1, 4-dihydro-5-hydroxy-4-oxo-2-pyridinecarboxylic acid, 2-[[[(3-amino-2-oxo-l-azetidinyl)carbonyl]i C-xY-lr
I
GC240a -149jj amino]sulfonyl]-l-methylhydrazide, trifluoroacetate salt in 30 ml of ethyl acetate, 2 ml of bis-trimethylsilylacetamide (ca. 0.008 mol) was added at room temperature to form, after minutes, a clear solution (solution B).
At -30°C, solution B was added dropwise to solution A.(ca. 10 minutes). The temperature was kept at -10 0 C for 1 hour and at 0°C for another hour. The solvent was evaporated and the residue treated with water, to yield, after filtration and drying, 2.4 g of crude title compound.
E) [3S(Z)]-2-[[[1-(2-Amino-4-thiazolyl)-2-[[1- [[[[2-[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)- 15 carbonyl]-2-methylhydrazino]sulfonyl]amino]carhonyl]- 2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, disodium salt o 0o 00 0 0 00 0 4 i
A
11i
A,
At -100C, 2.4 g of crude amino-4-thiazolyl)-2-[[1-[[[[2-[(1,4-dihydro-5- 20 hydroxy-4-oxo-2-pyridinyl)carbonyl]-2-methylhydrazino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]- 2-methylpropanoic acid, diphenylmethyl ester was added to a mixture of 20 ml of trifluoroacetic acid and 4 ml of anisole. The mixture was stirred at for 1 hour and the reaction product was precipitated by the addition of ether at -100C; Yield: 1.12 g of the crude trifluoroacetate of the title compound.
The crude material was converted to the sodium salt by the addition of 2N sodium hydroxide to a suspension in acetone-water and lyophilization.
The sodium salt was purified by chromatography on macroreticular styrene-divinylbenzene copolymer (elution with water). Yield: 0.25 g.
L
GC240a -150o 0 o 0 0 00. 0 0 0 0 a 04, E a s Example 24 dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]- 2-oxoethylidene]amino]oxy]-2-methylpropanoic acid A) 2-(Hydroxvmethyl)-5-(phenylmethoxy)-4H-pyran-4-one A suspension of 5-hydroxy-2-(hydroxymethyl)-4Hpyran-4-one (56.8 g, 0.4 mole) in 400 ml of methanol was treated with sodium hydroxide, (16 g, 0.4 mole) in 200 ml of warm methanol followed by 50.6 g (46 ml, 0.4 mole) of benzyl chloride. The mixture was heated to reflux for 3.5 hours, cooled, and poured in 1 L of water. The resulting solid was 15 filtered and washed with ca. 1.5 L of water, 200 ml of ethanol and 400 ml of hexane. After drying under high vacuum, the weight of product was 55.7 g.
20 B) 1,4-Dihydro-2-(hydroxymethyl)-5-(phenylmethoxy)- 4-pyridinone A mixture of 4H-pyran-4-one (9.65 g, 41.59 mmole), 95 ml of concentrated ammonia and 20 ml of ethanol and heated at reflux overnight. An additional 75 ml of ammonium hydroxide was added, the mixture was refluxed for 2 hours and cooled. The resulting brown solid was filtered and washed with water until the washings were neutral. The crude product was suspended in ethanol, filtered, washed with ethanol and hexane and dried in vacuo. The yield of the title compound was 7.61 g.
D
I GC240a I -151- C) l-(Chloromethyl)-1,4-dihydro-5-(phenylmethoxy)- I 4-pyridinone, hydrochloride I A suspension of 1,4-dihydro-2-(hydroxymethyl)- 5-(phenylmethoxy)-4-pyridinone (3 g, 12.99 mmole) in chloroform (15 ml) was cooled to 0°C under argon and treated with thionyl chloride (6.1 ml, 83.62 mmole).
Within several minutes, a homogeneous solution was obtained. After stirring an additional 5 minutes, a cream colored solid precipitated. The cooling 10 bath was removed and the mixture was heated at i reflux for 45 minutes. The mixture was cooled to 0°C and the white suspended material was filtered, Swashed with chloroform and hexane and dried in vacuo. The yield of the title compound was 3.65 g.
D) 2-(Azidomethyl)-l,4-dihydro-5-(phenoxymethyl)- 4-pyridinone A mixture of (phenylmethoxy)-4-pyridinone, hydrochloride (3.59 g, 12.54 mmole), sodium azide (4.08 g, 62.7 mmole) and diisopropylethylamine (2.19 ml, 12.54 mmole) in 70 ml of dimethylformamide was I stirred at room temperature under argon for days. An additional 4.08 g of sodium azide was f 25 added and the mixture was heated at 45-50 0 C for 2 i1 hours. After cooling, the reaction was poured into 500 ml of water, producing an insoluble white Ssolid. The pH of the supernatant liquid was lowered from 8.5 to 7.5 with dilute hydrochloric acid, and the white solid was filtered. After washing with water, acetone, and hexane, the solid was dried in vacuo. The yield of the title compound was 2.81 g.
GC240a -152- E) 2-(Aminomethyl)-4-oxo-5-(phenylmethoxy)pyridine A suspension of 2-(azidomethyl)-l,4-dihydro-5- (phenoxymethyl)-4-pyridinone (2.030 g, 7.93 mmole) and platinum oxide (200 mg) in 100 ml of dimethylformamide was stirred for six hours at room temperature under one atmosphere of hydrogen. The catalyst was removed by filtration and the solution was concentrated in vacuo to afford 1.5 g of the title compound as a grey powder.
F) (3S)-1-[[[[[(l,4-Dihydro-5-hydroxy-4-oxo-2pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]- 2-oxo-3-[[(phenylmethoxy)carbonyl]amino]azetidine To a stirred suspension of 2-(aminomethyl)-4oxo-5-(phenylmethoxy)pyridine (2.330 g, 10.13 mmole) "'in 60 ml of ethyl acetate was added N-methyl-N- (trimethylsilyl)trifluoroacetamide (3.76 ml, 20.26 mmole). The resulting solution was stirred for 30 minutes at room temperature and then cooled to 0°C. Concurrently, to a stirred suspension of (S)-3-[[(phenylmethoxy)carbonyl]amino]-2-azetidinone (2.228 g, 10.13 mmole) in 60 ml of ethyl acetate was added chlorosulfonyl isocyanate (882 pl, 10.13 mmol). The resulting solution was stirred for 30 minutes at room temperature then cooled to 0°C and treated with triethylamine (4.23 ml, 30.39 mmole) followed by the solution of silylated 2-(aminomethyl)-4-oxo-5-(phenylmethoxy)pyridine described above. The mixture was stirred for two 30 days at room temperature.
The mixture was concentrated in vacuo, the residue dissolved in acetonitrile-water (40-60) GC240a -153and the pH lowered to 2.9 whereupon a thick oil separated. Upon cooling to 5 0 C, the oil solidified. The solid was separated, washed four times with water, and dried in vacuo to afford 3.4 g of crude title compound. The crude was dissolved in a minimum volume of dimethylformamide and loaded .on a column (1L) of macroreticular styrene-divinylbenzene copolymer. The column was eluted with a stepwise acetone-water gradient.
Desired material eluted with ca. 65% acetone. The relevant fractions were combined and lyophilized to afford 2.69 g of the title compound.
G) (3S)-2-[[[l-(2-Amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid, diphenylmethyl ester [(,4-Dihydro-5-hydroxy-4-oxo-2pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]- 2-oxo-3-[[(phenylmethoxy)carbonyl]amino]azetidine (912 mg, 1.64 mmole), p-toluenesulfonic acid mono- S" hydrate (625 mg, 3.28 mmole) and 10% palladium on 0 charcoal (190 mg) in 16 ml of dimethylformamide were stirred under one atmosphere of hydrogen until K, 3.28 mmole (73 ml) of hydrogen was consumed (ca. 3 hours).
To a stirred solution of (Z)-2-amino-a-[[2- (diphenylmethoxy)-, l-dimethyl-2-oxoethoxy]imino] 4-thiazoleacetic acid (846 mg, 1.804 mmole) in 4 0 16 ml of dimethylformamide at -20 0 C was added diphenylchlorophosphate (374 1, 1.804 mmole) followed by triethylamine (450 pl, 3.28 mmole).
L7 GC240a -154- The solution was stirred for 1 hour at whereupon the above-described mixture of hydrogenolyzed compound was added. Triethylamine (921 pi, 6.6 mmole) was then added. The resulting mixture was stirred at -20 0 C for one hour and then at 5 0
C
overnight. The catalyst was removed by filtration, volatiles were removed in vacuo and the resulting oil was dissolved in a minimum volume of acetonewater (75-25) (pH 5.2) and added dropwise to a 10 stirred suspension of 20 ml of Dowex 50x2-400 Sin acetone-water (35-65). After 40 minutes, the mixture was filtered and the filtrate lyophilized to afford 2.1 g of solid. The solid was dissolved in a minimum amount of acetonitrile-water (40-60) (pH 5.6) and loaded onto a column (800 ml) of macroreticular styrene-divinylbenzene copolymer, eluting with a stepwise acetonitrile-water gradient.
Desired material eluted with ca. 30% acetonitrile.
The relevant fractions were combined and lyophilized to afford the title compound.
H) (3S)-2-[[[1-(2-Amino-4-thiazolyl)-2-[[l- [[[[[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2methylpropanoic acid Trifluoroacetic acid (4.7 ml) was added dropwise to a stirred suspension of (2-amino-4-thiazolyl)-2-[[l-[[[[[(l,4-dihydro-5hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonvl] amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, GC240a -155diphenylmethyl ester (131 mg, 0.113 mmole) in 3 ml of dichloromethane and 0.3 ml anisole at 0°C.
After stirring 45 minutes at 5 0 C, 2 ml of toluene was added and the volatiles were removed in vacuo.
The resulting oil was washed with hexane (3x4 ml) and triturated to a solid with 10 ml of ether.
The solid was washed once with ether (10 ml) and dried in vacuo. The above reaction and work-up were repeated on 0.166 mmole of amino-4-thiazolyl)-2-[[l-[[[[[(1,4-dihydro-5hydroxy-4-oxo-2-pyridinyl)methyl]amino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester. The crude solids were combined, dissolved in 2 ml of acetonitrilewater (40-60) (pH 2.5) and chromatographed on a o column (200 ml) of macroreticular styrene-divinyl- .o benzene copolymer, using an acetonitrile-water gradient. The desired material eluted at acetonitrile-water (20-80). The relevant fractions were combined and lyophilized to afford 103 mg of the title compound as a white solid, melting point 180 0 C, dec.
I3I ^o Q
Claims (23)
1. A compound having the formula R R 1 -NHR3 C .N-C-NH-SO 2 -R or a pharmaceutically acceptable salt thereof wherein R is -A 1-N 7 7 -A 2 a o a a a a a fr#~ a, 'a 20 -A -M N N O 1 IH -A 1-N NA -NH-A 3 N) H or 3 I H 0 0 OH -NH-A 4-C-A 6 'N R 1is an acyl group derived from a carboxylic acid; 2 and R 3 are the same or differen is hydrogen, alkyl, alkenyl, alkynyl, -y r 1 4- A 11 i Ax C t and each cloalkyl, L-7- 156a phenyl, substituted phenyl or a 4, 6 or 7-membered heterocycle as hereinbefore defined. 4 4, 0 4 .44' 44 44 a 444 4 4044 a 0 44 4' 4 .4 4 4 .4 GC240a -157- hydrogen and the other is azido, halomethyl, dihalomethyl; trihalomethyl, alkoxycarbonyl,
2-phenylethenyl, 2-phenylethynyl, carboxyl, x x -CH 2 x 1 S sx 2 OX2 4 s-c x 4or 0 x x -A-J-NX 6 x 7 xis azido, amino, hydroxy, carboxyl, alkoxycarbonyl, alkanoylamino, phenylcarbonylamino, (substituted phenyl )carbonylamino, alkylsulfonyl- oxy, phenylsulfonyloxy, (substituted phenyl sulfonyloxy, phenyl, substituted phenyl, cyano, 0 11 -A-C-NX 6 X 7 S-X 2 or X 2 is alkyl, substituted alkyl, phenyl, a 00 0:000 substituted phenyl, phenylalkyl, (substituted 0 phenyl)alkyl, alkanoyl, phenylalkanoyl, (sub- 00 0 stituted phenyl)aikanoyl, phenylcarbonyl, (sub- stiute phny~cabonl-,orheteroarylcarbonyl; one of X3and X4is hydrogen and the other is hydrogen or alkyl, or X3and X4when taken together with the carbon atom to which they are 0 attached form a cycloalkyl group; X i s formyl, alkanoyl, phenylcarbonyl, 4(substituted phenyl)alcarbonyl, cnyarboylabnl j} alkoxycarbonyl, aminocarbonyl, (substituted amino)carbonyl, or cyano; xand X7are the same or different and each is hydrogen, alkyl, pher.y or substituted phenyl, orxi yrgnadX saio usiue or ishdoe7n saio usiue amino, alkanoylamino or alkoxy, or X6and X7when taken together with the nitrogen atom to which they are attaehe4 fer 1 C r a 41 e' hetereeyele, r 157a attached form a 4, 5, 6 or 7-membered heterocycle as hereinbefore defined; If ii I 44 t4~ 4 444444 I 4 44 4 44 8 4 4 I '444 *I4~ 414 *14 *44 I *4 4 444 044444 0 0 GC240a A is -CH=CH-, -(CH9-f -(CH 2 0-, -(CH92)-NE- or -CH 2 -CH 2- m is 0, 1 or 2; 0 A 1 is a single bond, -NH- or 0 A 2is a single bond, -CH2 -CH -Io 2 H 2 00 A 3 i s -(CHlL2) p- -NHItNH-, -NH-CH 2 0 0 -0-CH 2 CH -g or -CH -LNC A4is -(CH 2 P-,I -(CH 2 Y-NH-, 00 0 CjH X 04 -iNr-8-iNr-NH-, -C-NH-NH-, or A is a single bn, -CH -NH-CH 2 20 aNC ort Ais a single bond, -C2H o)(Ht; p is 0 or 1; y is 2, 3 or 4; gis 0 or 1; a 4 tt is 1, 2, 3 or 4; and X is hydrogen, carboxyl or carbamoyl. 2. A compound in accordance with claim 1 0 0i OH, heei Ris -A -NY -A-C-A 6 N wh r i 4 p. -i i; I- rrnru-a~~ GC240a -159- o *4 00 0 0000 o 0 0 0 00 0 4 o e i 44o 4 Oa t t 20 4 4 1 B;
3. A compound in accordance with claim 1 0 OH wherein R is -A1-N NA O- O H
4. A compound in accordance with claim 1 OH wherein R is -A -N N-A--N 6 H A compound in accordance with claim 1 (OH wherein R is -A -N N S 5 H
6. A compound in accordance with claim 1 0 1 OH wherein R is -NH-A- N H
7. A compound in accordance with claim 1 e A OH wherein R is -NH-A A N H
8. A compound in accordance with claim 2 wherein Al is a single bond.
9. A compound in accordance with claim 2 wherein A2 is -NH-. A compound in accordance with claim 2 wherein A6 is a single bond. I GC240a -160- o 00 00 0 0 0
11. A compound in accordance with claim 1 wherein R is -E 1N-NH-8!! 1N' OH H
12. A compound in accordance with claim 1 wherein R -and R3are each hydrogen.
13. A compound in accordance with. claim 1 0 wherein Ris and R is 2-amino-4- thiazolyl and R.i is methyl, ethyl, carboxymethyl, 1-carboxy-l-methylethyl, l-carboxy-l-ethyl, or C-(CH z\ 2 s -IC--COOH, wherein s is 1, 2 or 3.
14. A compound in accordance with claim 1 0 wherein R 1 is P.CNO- is 2-amino-4-thiazolyl Ig and is carboxymethyl, l-carboxy-1-methylethyl, 1 l-carboxy-1-ethyl, or C-COOH, wherein s is 1, 2 or 3. A compound in accordance with claim 2 0 wherein R 1 is -J-C=N-0-R.i and R is 2-amino-4- thiazolyl and R is methyl, ethyl, carboxymethyl, l-carboxy-l-methylethyl, l-carboxy-1-ethyl or CH ,(CH2)s -C00H, wherein s is 1, 2 or 3. GC240a -161-
16. A compound in accordance with claim 2 0 wherein R1 is =N--Ri R g is 2-amino-4-thiazolyl R g and R. is carboxymethyl, l-carboxy-l-methylethyl, CH 2 -(CH 2 )s l-carboxy-l-ethyl or C-COOH, wherein s is 1, 2 or 3.
17. A compound in accordance with claim 11 wherein is JC=N-O-R and R is 2-amino-4- 1 g thiazolyl and R. is methyl, ethyl, carboxymethyl, l-carboxy-l-methylethyl, l-carboxy-l-ethyl or C. -NCH2)s _C-COOK, wherein s is 2 or 3.
18. A compound in -cordance with claim 11 wherein R 1 is -1'=N-O-Ri R is 2-amino-4-thiazolyl R and R. is carboxymethyl or l-carboxy-l-methylethyl. iii
19. A compound in accordance with claim 11 wherein Rand R 3 are each hydrogen. The compound in accordance with claim 1, [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2-[[l-[[[[3- [[(1,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl)carbonyl]- amino]-2-oxo-1-imidazolidinyl]sulfonyl amino]- carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethyl- idene]amino]oxy]-2-methylpropanoic acid, or a pharmaceutically acceptable salt thereof. GC240a -162-
21. The compound in accordance with claim 1, [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2-[[l-[[[[2- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl )carbonyl] hydrazino]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]- amino] -2-oxoethylidene] amino]oxy] -2-methyipropanoic acid, or a pharmaceutically acceptable salt thereof.
22. *The compound in accordance with claim 1, [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2-[[l- ,4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) carbonyl]amino]-2-oxo-l-imidizolidinyl]sulfonyl]- amino]carbonyl] -2-oxo--3-azetidinyl] amino] -2-oxo- ethylidene]amino]oxy]-2-acetic acid, or a pharmaceutically acceptable salt thereof.
23. The compound in accordance with claim 1, [3S(Z)]-2-[[[l-(2-.amino-4-thiazolyl)-2-[[l- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) ~methyl] amino] sulfonyl] anino]carbonyl] -2-oxo-3- azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2- methylpropanoic acid, or a pharmaceutically acceptable salt thereof.
24. The compound in accordance with claim 1, [3S(Z)]-2-[[[l-(2-amino-4-thiazolyl)-2-[[l-[[[[2- 4-dihydro-5-hydroxy-4-oxo-2-pyridinyl) carbonyl]hydrazino]carbonyl]hydrazino] sulfonyl] amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxo- ethylidene]amino]oxy]-2-methylpropanoic acid, or a pharmaceutically acceptable salt thereof. 4 25. The compound in accordance with claim [[l-[[[[2-[(1,4-dihydro-5-hydroxy-4-oxo--2-pyridinll)- carbonyl]hydrazino] sulfonyl] amino]carbonyl] -4-methyl- 2-oxo-3-azetidinyl] amino] -2-oxoethylidene] amino] oxy] 2-methylpropionic acid, or a pharmaceutically acceptable salt thereof. GC240a -163-
26. The compound in accordance with claim 1, [3S(Z)1-l-[[[l-(2-amino-4-thiazolyl)-.2-[[l-[[[[3- [[(l,4-dihydro--5-hydroxy-4-oxo-2-pyridinyl)carbonyl]- amino]-2--oxo-l-imidazolidinyl]sulfonyl~amino]carbonyl]- 2-oxo-3-azetidinyl]amino] -2-oxoethylidene]amino]oxy]- cyclopentanecarboxylic acid, or a pharmaceutically acceptable .salt thereof.
27. A process for preparing compounds according to claims 1-26 characterized by acylating a compound of the formula H N-C-KS 2 too wth anR 1 acyl group derived from anR carboxylic acid, or introducing a -CO-NH-SO R activating 0 0 group to a compound of the formula 12 R -N I \CH- -R 3 9 4 PHILLIPS FITZPATRICK Attorneys for: 0O 4 E. R. _SQUIBB SONS, 8 1 I 164 wherein 0 0 OH R is -Al-N N-A 2 -C-A 6 (N 0 I H 0 -OH -Aj-N N-A 5 NI 0 0O H 0 -NH-A 3 N ,O or 0 0; 0 0 4004 qo 0 0 000 4 000010 4 0 00 04 0 a 0 U II' 0 0 OH IfI H Ris an acyl group derived from a carboxylic acid; R2and R 3 are the same or different and each is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, substituted phenyl or a 4, 5, 6 or 7-membered heterocycle as hereinbefore defined or one of R2and R 3 is 0 004 00 t0 0 4~
40.04 A-Lw1 U,* L7~ GC24Oa -165- hydrogen and the other is azido, halomethyl, dihalomethyl; trihalomethyl, alkoxycarbonyl, 2-phenylethenyl, 2-phenylethynyl, carboxyl, x x -CH 2 X 1 1 -S-X 2 -O-X 2 1 _U xV 4 o 0 -NX 6 X 7 xis azido, amino, hydroxy, carboxyl, alkoxycarbonyl, alkanoylamino, phenylcarbonylamino, (substituted phenyl )carbonylamino, alkylsulfonyl- oxy, phenylsulfonyloxy, (substituted phenyl)- suitfonyloxy, phenyl, substituted phenyl, cyano, a 0 a -A-C-NX X, S-X 2 or xis alkyl, substituted alkyl, phenyl, 0 2 0: substituted phenyl, phenylalkyl, (substituted phenyl)alkyl, alkanoyl, phenylalkanoyl, (sub- o stituted phenyl )alkanoyl, phenylcarbonyl, (sub- stituted phenyl)carbonyl, or heteroarylcarbonyl; one of X3and X4is hydrogen and the other is hydrogen or alkyl, or X3and X4when taken a00 0. o20 together with the carbon atom to which they are 0 oo attached form a cycJloalkyl group; xis formyl, alkanoyl, phenylcarbonyl, (substituted phenyl )carbonyl, phenylalkylcarbonyl, substituted phenyl )alkylcarbonyl, carboxyl, alkoxycarbonyl, aminocarbonyl, (substituted 0 amino)carbonyl, or cyano; o X and Xare the same or different and each is hydrogen, alkyl, phenjil or substituted phenyl, I or xis hydrogen and Xis amino, substituted 6 x 7 amino, alkanoylamino or alkoxy, or X6and X7when taken tocether with the nitrogen atom to which they are attA--seAzd fzrm a Sub-ect4-ittd or uncubctirtutcd, aroemati= er non dzefltie oru znan ne or more nitrQgen, oxHygen or 1/' II 165a attached form a 4, 5, 6 or 7-membered heterocycle as hereinbefore defined; 4 4 4 444 4. GC24Oa -166- A is CH=:CH-, -(CH 2 )m-t (CH 2 -(CH 2 )M-NH- or -CH 2 S-CH 2 m is 0, 1. or 2; 0 A 1is a single bond, -NHf- or 0 A2 is a single bond, -CH 2 -CH 2 or 0 HN- A is 0N-~NHC 3 2) p-N- N-NHC 2-' 0 0 -NH-CE 2 -0-CE 2 -CH 2 NH-, or-C N-H Ais -(CH 2 -(CH 2 NH-, *Q4 Q H N-N-NH- NH-NH-, o A is a single bond, -CH 2 -NHI-CE 522 or N-H2q' A 6 is a single bond, -CE=CH- or -C p isO0 or 1; y is 2, 3 or 4; q is 0 or 1; t is 1, 2, 3 or 4; and X is hydrogen, carboxyl or carbamoyl. hr~ GC240a -167- 28. A compound according to claim 1 substantially as hereinbefore described with reference to any one of the examples. 29. A process according to claim 27 substantially as hereinbefore described with reference to any one of the examples. DATED: 3rd November, 1989 PHILLIPS ORMONDE FITZPATRICK Attorneys for:a E R SQUIBB SONS, INC ;Z' I 0 00 00 0 000 0 0o 0 00 00 00 0I 0 00 o 4 0 00~ 00 1 0 0 0
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78047985A | 1985-09-26 | 1985-09-26 | |
| US780479 | 1985-09-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6315686A AU6315686A (en) | 1987-04-02 |
| AU600912B2 true AU600912B2 (en) | 1990-08-30 |
Family
ID=25119699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63156/86A Ceased AU600912B2 (en) | 1985-09-26 | 1986-09-26 | 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines |
Country Status (31)
| Country | Link |
|---|---|
| JP (1) | JPS6284082A (en) |
| KR (1) | KR900001013B1 (en) |
| CN (1) | CN86106980A (en) |
| AT (1) | ATA257986A (en) |
| AU (1) | AU600912B2 (en) |
| BE (1) | BE905502A (en) |
| CA (1) | CA1308719C (en) |
| CH (1) | CH670828A5 (en) |
| DD (1) | DD250121A5 (en) |
| DE (1) | DE3632876A1 (en) |
| DK (1) | DK460386A (en) |
| EG (1) | EG18314A (en) |
| ES (1) | ES2001995A6 (en) |
| FI (1) | FI863890A7 (en) |
| FR (1) | FR2587700B1 (en) |
| GB (1) | GB2181130B (en) |
| GR (1) | GR862449B (en) |
| HU (1) | HU198044B (en) |
| IE (1) | IE59686B1 (en) |
| IL (1) | IL80160A (en) |
| IT (1) | IT1214533B (en) |
| LU (1) | LU86611A1 (en) |
| NL (1) | NL8602446A (en) |
| NO (1) | NO863837L (en) |
| NZ (1) | NZ217704A (en) |
| PH (1) | PH23315A (en) |
| PL (1) | PL151546B1 (en) |
| PT (1) | PT83440B (en) |
| SE (1) | SE8604089L (en) |
| YU (1) | YU46177B (en) |
| ZA (1) | ZA867373B (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01502660A (en) * | 1986-05-23 | 1989-09-14 | ジ・アップジョン・カンパニー | N-1 substituted sulfonylaminocarbonyl, C-4 substituted monobactams |
| US5006650A (en) * | 1987-02-11 | 1991-04-09 | The Upjohn Company | Novel N-1 substituted beta-lactams as antibiotics |
| KR890700588A (en) * | 1987-02-11 | 1989-04-25 | 로버어트 에이 아미테이지 | New N-1 Substituted β-lactams As Antibiotics |
| KR890700586A (en) * | 1987-02-27 | 1989-04-25 | 로버어트 에이 아마테이지 | Antibacterial beta-lactam containing pyridone carboxylic acid or acid derivative |
| CA1317298C (en) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| US4762922A (en) * | 1987-07-01 | 1988-08-09 | Squibb Corporation | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| US4772693A (en) * | 1987-07-01 | 1988-09-20 | E. R. Squibb & Sons, Inc. | 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines |
| US5015737A (en) * | 1987-07-22 | 1991-05-14 | The Upjohn Company | Therapeutically useful beta-lactams |
| WO1989000569A1 (en) * | 1987-07-22 | 1989-01-26 | The Upjohn Company | THERAPEUTICALLY USEFUL beta-LACTAMS |
| US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| US4889930A (en) * | 1987-12-21 | 1989-12-26 | E. R. Squibb & Sons, Inc. | Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein |
| US4871841A (en) * | 1987-12-23 | 1989-10-03 | E. R. Squibb & Sons, Inc. | 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| EP0336667A3 (en) * | 1988-04-04 | 1991-04-10 | E.R. Squibb & Sons, Inc. | [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate |
| US4959470A (en) * | 1988-08-17 | 1990-09-25 | E. R. Squibb & Sons, Inc. | 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines |
| EP0604365B1 (en) * | 1992-12-23 | 1999-05-26 | Novartis AG | Imidazole derivatives and their use as agrochemical agents |
| EP0671654B1 (en) * | 1994-03-11 | 1997-09-10 | Agfa-Gevaert N.V. | Photographic material containing a new type of hydrazide |
| KR100596360B1 (en) * | 2003-07-15 | 2006-07-03 | 한국생명공학연구원 | A pharmaceutical composition containing Novel 2-oxo-piperidine derivative compound I for treating cancer disease |
| EP1698375B1 (en) * | 2003-12-25 | 2014-04-02 | Ono Pharmaceutical Co., Ltd. | Azetidine ring compounds and drugs comprising the same |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| JO3115B1 (en) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | Pyridazinone Compounds and Their Use as DAAO Inhibitors |
| AU2012337781B2 (en) | 2011-11-15 | 2017-07-06 | Takeda Pharmaceutical Company Limited | Dihydroxy aromatic heterocyclic compound |
| GB201222711D0 (en) | 2012-12-17 | 2013-01-30 | Takeda Pharmaceutical | Novel compounds |
| CN106986820B (en) * | 2017-02-24 | 2019-05-21 | 浙江工商大学 | Preparation and use of multifunctional hydroxypyridone derivatives and their hydrates |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU568086B2 (en) * | 1982-08-04 | 1987-12-17 | E.R. Squibb & Sons, Inc. | B-lactam azetidine compounds |
| AU7348987A (en) * | 1986-06-23 | 1987-12-24 | E.R. Squibb & Sons, Inc. | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199981A (en) * | 1981-04-09 | 1985-08-16 | Squibb & Sons Inc | 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines |
| CA1272726C (en) * | 1982-01-04 | 1990-08-14 | 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines |
-
1986
- 1986-09-25 EG EG603/86A patent/EG18314A/en active
- 1986-09-26 DE DE19863632876 patent/DE3632876A1/en not_active Ceased
- 1986-09-26 AU AU63156/86A patent/AU600912B2/en not_active Ceased
- 1986-09-26 YU YU165986A patent/YU46177B/en unknown
- 1986-09-26 FI FI863890A patent/FI863890A7/en not_active Application Discontinuation
- 1986-09-26 PL PL1986261575A patent/PL151546B1/en unknown
- 1986-09-26 CA CA000519170A patent/CA1308719C/en not_active Expired - Lifetime
- 1986-09-26 SE SE8604089A patent/SE8604089L/en not_active Application Discontinuation
- 1986-09-26 KR KR1019860008067A patent/KR900001013B1/en not_active Expired
- 1986-09-26 GR GR862449A patent/GR862449B/en unknown
- 1986-09-26 ZA ZA867373A patent/ZA867373B/en unknown
- 1986-09-26 HU HU864124A patent/HU198044B/en not_active IP Right Cessation
- 1986-09-26 IE IE254786A patent/IE59686B1/en not_active IP Right Cessation
- 1986-09-26 IL IL80160A patent/IL80160A/en not_active IP Right Cessation
- 1986-09-26 GB GB8623151A patent/GB2181130B/en not_active Expired
- 1986-09-26 LU LU86611A patent/LU86611A1/en unknown
- 1986-09-26 CN CN198686106980A patent/CN86106980A/en active Pending
- 1986-09-26 DD DD86295013A patent/DD250121A5/en not_active IP Right Cessation
- 1986-09-26 IT IT8621834A patent/IT1214533B/en active
- 1986-09-26 DK DK460386A patent/DK460386A/en not_active Application Discontinuation
- 1986-09-26 ES ES8602204A patent/ES2001995A6/en not_active Expired
- 1986-09-26 JP JP61229474A patent/JPS6284082A/en active Pending
- 1986-09-26 BE BE0/217217A patent/BE905502A/en not_active IP Right Cessation
- 1986-09-26 PT PT83440A patent/PT83440B/en unknown
- 1986-09-26 NO NO863837A patent/NO863837L/en unknown
- 1986-09-26 FR FR8613466A patent/FR2587700B1/en not_active Expired
- 1986-09-26 NL NL8602446A patent/NL8602446A/en active Search and Examination
- 1986-09-26 CH CH3860/86A patent/CH670828A5/fr not_active IP Right Cessation
- 1986-09-26 PH PH34303A patent/PH23315A/en unknown
- 1986-09-26 AT AT0257986A patent/ATA257986A/en not_active Application Discontinuation
-
1988
- 1988-09-26 NZ NZ217704A patent/NZ217704A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU568086B2 (en) * | 1982-08-04 | 1987-12-17 | E.R. Squibb & Sons, Inc. | B-lactam azetidine compounds |
| AU7348987A (en) * | 1986-06-23 | 1987-12-24 | E.R. Squibb & Sons, Inc. | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU600912B2 (en) | 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines | |
| US4576749A (en) | 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones | |
| US4743685A (en) | 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines | |
| JPH0368021B2 (en) | ||
| EP0303286A1 (en) | 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines | |
| JPH0372616B2 (en) | ||
| EP0085291B1 (en) | 2-oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)azetidines | |
| EP0251143B1 (en) | 2-Oxo-1-[[(Substituted Sulfonyl)Amino]-Carbonyl]Azetidines | |
| JPS588060A (en) | Arylthioazetidinone sulfonates | |
| NL8203124A (en) | 2-OXO-AZETIDINES AND METHODS FOR PREPARING AND USING THESE COMPOUNDS. | |
| US4959470A (en) | 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines | |
| CA1322006C (en) | 2-oxo-1-{[(substituted sulfonyl)amino] -carbonyl}azetidines | |
| CA1323029C (en) | 2-oxo-1-[(substituted sulfonyl)amino]carbonyl]azetidines | |
| CA1323368C (en) | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines | |
| EP0191989A1 (en) | Antibiotic isoxazole derivatives, their production and use | |
| JPS5988462A (en) | Azetidinylsulfonic acid and homologue | |
| US5068331A (en) | Certain (2-carboxy or 2-propenoic or 2-carbonyl)-3-halo-4,5-dioxy pyridine intermediates and the corresponding 1,4-dihydro-4-pyridones) | |
| EP0321844A2 (en) | Process for making 2-oxo-1-(((substituted sulfonyl)-amino)carbonyl)azetidines and intermediates used therein | |
| JPS6094958A (en) | Azetidinones | |
| JPS62201886A (en) | Tetrahydrofurancarboxylic acid derivative and production thereof |